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ABSTRACT 
Aerobic and resistance exercise have been promoted as a key component of exercise 
recommendations for weight control because exercise is an effective method of increasing 
energy expenditure and it may paradoxically, lead to a short term hunger suppression. This 
phenomenon has been termed 'exercise induced anorexia' but the mechanisms are unclear so 
the relationship between exercise and hunger has led to a need for investigators to study the 
role of gut hormones in mediating exercise-induced hunger changes. The effect of acute 
exercise bouts on total plasma ghrelin concentrations is controversial and no studies have 
reported the effects of exercise on acylated ghrelin. There is also a paucity of data on the 
effects of exercise on total PYY. 
Several limitations are apparent in the research literature regarding exercise and gut 
hormones. Most studies have measured gut hormone responses for relatively short periods 
and few studies have assessed post-exercise gut hormone responses to feeding over a 
prolonged period or attempted to relate these responses to changes in hunger. Moreover, no 
studies have examined acylated ghrelin and PYY responses to resistance exercise. Therefore 
the purpose of the studies presented in this thesis is to investigate the acute effects of exercise 
on hunger and acylated ghrelin and the fmal study measured total PYY in healthy fasted 
participants to try and explain the mechanisms for' exercise induced anorexia.' 
The aim of study 1 (Chapter 4) was to confirm if high intensity exercise results in 'exercise 
induced anorexia.' The inclusion of a low intensity exercise and control trial would provide 
evidence as to whether there is an effect of exercise per se or if the suppression of hunger 
during exercise is merely the result of distraction. In addition problems were identified with 
the use of visual analogue scales (VAS) that measured hunger published by Flint et al (2000) 
during exercise. The study provided an opportunity to test the validity of the ratings of 
perceived hunger (RPH) scale developed by Burns et al (2007). Twelve healthy Caucasians 
participated in three, 5 hour trials (high intensity exercise, low intensity exercise and control). 
On the high intensity exercise trial participants ran for 60 minutes at 71 ± 2 % of maximum 
oxygen uptake and on the low intensity exercise trial participants ran for 60 minutes at 37 ± 1 
% of maximum oxygen uptake resting for 4 hours after exercise. On the' control trial 
. participants rested for 5 hours. When using the RPH, hunger was suppressed as a result of 
exercise; main effect of trial (P = 0.035) main effect of time (P < 0.0005), trial x time 
interaction (P < 0.0005) and similar statistical fmdings and trends were found when using the 
V AS. Post hoc analysis shows that high intensity aerobic exercise leads to 'exercise induced 
anorexia' and there is a clear physiological role of exercise since suppressed subjective 
. feelings of hunger is not merely the result of distraction as there was no suppression of 
hunger in the low intensity trial. Exercise intensity and energy expenditure is an important 
determinant and the RPH scale should be used to measure hunger during exercise. 
Since causal mechanisms for 'exercise induced anorexia' remain to be elucidated the purpose 
of study 2 (Chapter 5) was to assess the effect of a single bout of treadmill running on the 
appetite stimulating hormone plasma acylated ghrelin. Nine healthy males participated in 2, 9 
hour trials (exercise and control) in a random crossover design. On the exercise trial 
participants ran for 60 minutes at 72 ± 6 % of maximum oxygen uptake. After this they 
rested for 8 hours and consumed a test meal at 3 hours (i.e. two hours after exercise). On the 
control trial participants rested for 9 hours and at 3 hours they consumed an identical test 
meal to that consumed on the exercise trial. Plasma acylated ghrelin concentration was 
suppressed during and following the run on the exercise trial and after feeding on both trials 
i.e. at 4 hours (two-way ANOVA, main effect of trial P = 0.022, main effect of time P = 
0.048, trial x time interaction P = 0.043). Hunger declined during the run on the exercise trial 
and after feeding on both trials (two-way ANOVA, main effect of trial P = 0.19, main effect 
of time P < 0.0005, trial x time interaction P = 0.001). The findings show that acylated 
ghrelin is suppressed during prolonged, high intensity running and this coincides with 
suppressed feelings of hunger suggesting the suppression of hunger during exercise could be 
mediated by acylated ghrelin. 
Having shown an association between acylated ghrelin and hunger during high intensity 
exercise study 3 (Chapter 6) sought to confirm these findings and examine the influence of 
low intensity exercise on acylated ghrelin. Whilst hunger was not suppressed during low 
intensity exercise in study 1 (Chapter 4), acylated ghrelin was not measured and also the 
energy expenditure of the two exercise trials was not matched. Nine healthy males 
participated in three trials being high intensity, low intensity and control in a random 
crossover design. Participants ran for 36 ± 2 minutes at 75.0 ± 1.0 % of maximum oxygen 
uptake on the high intensity trial and for 54.9 ± 2.0 minutes at 52.5 ± 1.0 % of maximum 
oxygen uptake on the low intensity trial and then rested thereafter. Exercise energy 
expenditure did not differ between trials being 2504 ± 55 kJ versus 2580 ± 51 in the high 
intensity and low intensity trials respectively (P = 0.376). Participants rested on the control 
trial and each trial lasted 4 hours with runs performed at the start of this period. Two-factor 
ANOVA revealed no effect of trial (P = 0.747), but a main effect of time (P < 0.0005) and a 
trial x time interaction (P = 0.024) for acylated ghrelin concentrations. At 0.5 hours plasma 
acylated ghrelin was lower on the high intensity trial compared with the low intensity and 
control trials (P = 0.065 after Bonferroni adjustment for high intensity versus control). 
Results confirm that high intensity running suppresses acylated ghrelin but there was no 
corresponding suppression of hunger, possibly due to the short duration of exercise. Acylated 
ghrelin was not suppressed during low intensity running despite matched energy expenditure 
highlighting that exercise intensity is a determinant of the exercise induced suppression of 
acylated ghrelin. 
Studies I and 3 demonstrated that exercise intensity is a determinant of 'exercise induced 
anorexia' so Study 4 (Chapter 7) examined the effect of exercise duration on plasma acylated 
ghrelin concentrations. Nine healthy Caucasian males undertook three main trials, short 
duration run (45 minutes, 70 ± 0.7 % of maximum oxygen uptake); long duration run (90 
minutes, 70 ± 0.7 % of maximum oxygen uptake) and control in a random crossover design 
with each trial lasting 9 hours. Two-factor ANOVA revealed a main effect of trial (P = 
0.001) for plasma acylated ghreJin, while time (P = 0.063) and interaction (P = 0.097) effects 
approached significance. For the effect of trial, Bonferroni post hoc tests indicated that 
control trial values differed significantly from values on the short duration (P = 0.041) and· 
the long duration (P = 0.005) exercise trials. Acylated ghrelin was suppressed during both 
exercise trials with a longer lasting suppression on the long duration trial. Ratings of 
perceived hunger were also suppressed on the exercise trials (main effect of trial P = 0.039, 
II 
time P < 0.0005 and trial x time interaction P < 0.0005) and this suppression coincided with 
the suppression of acylated ghrelin. These fmdings demonstrate that the duration of 
suppression of hunger and plasma acylated ghrelin during high intensity treadmill running is 
proportional to the duration of exercise. 
Since studies 1-4 focused on aerobic exercise It IS important to clarify the effects of 
resistance exercise on hunger and gut hormones as contradictory effects have previously been 
reported (Kraemer and Castracane, 2007). Study 5 (Chapter 8) examined the effect of 
treadmill rmming and free weight resistance exercise on plasma acylated ghrelin and total 
PYY concentrations. Twelve healthy males undertook 3, 8 hour trials (aerobic, resistance and 
control) in a random crossover design. On the aerobic trial participants ran for 60 minutes at 
68 ± 2 % of maximum oxygen uptake then rested for 7 hours. On the resistance trial 
participants completed a 90 minute free weight session performing 3 sets of 12 reps of 10 
different exercises at 80% of 12 rep max, then rested for 6.5 hours. On the control trial 
participants rested for 8 hours. Acylated ghrelin was suppressed during resistance and 
aerobic exercise (two-way ANOVA, time P = 0.001, trial x time P = 0.035). Total PYY 
increased during aerobic but not during resistance exercise (two-way ANOV A, trial P < 0.0 I, 
time P < 0.0 I, trial x time interaction P = 0.027). Tile findings show acylated ghrelin is 
suppressed and total PYY increases during high intensity treadmill running. Resistance 
exercise suppresses acylated ghrelin but there is no effect on total PYY. These hormonal 
changes are associated with hunger suppression in both modes of exercise. 
In conclusion, high intensity treadmill running suppresses hunger and acylated ghrelin 
concentration and increases total PYY and whilst resistance exercise suppresses hunger and 
acylated ghrelin it has no effect on total PYY. There is a threshold of exercise intensity, 
duration and expenditure which needs to be reached before 'exercise induced anorexia' is 
experienced and these factors affect hunger and the change in gut peptide hormones. Whilst 
the findings of this thesis are useful in identifying potential causal mechanisms for the 
influence of exercise on hunger, more work is needed to address the effect of exercise on 
energy intake and how exercise can play a more effective role in the prevention of 
overweight and obesity, weight loss and the prevention of weight regain. 
Key words: Acylated ghrelin, aerobic exercise, appetite, hunger, peptide YY, resistance 
exercise 
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Triacylglycerol 
Visual Analogue Scale 
Maximum oxygen uptake 
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CHAPTER I 
Introduction 
The Health Select Committees report (Health Select Committee, 2004) has highlighted 
that the prevalence of obesity has increased by almost 400% in England since 1980. This 
increase in prevalence reflects a worldwide trend which is most marked in, though not 
restricted to developed countries and has been described by the World Health 
Organization (WHO) as: 'a global epidemic' (WHO, 1998). A recent Health Survey for 
England examined overweight and obesity and found that 22.1 % of men and 22.8% of 
women in England are classified as clinically obese (Sproston and Primatesta, 2003) 
which is defined as a body mass index (BM!) of 2: 30 kg'm-2 (calculated as weight in 
kilograms divided by the square of the height in metres). If recent rates of growth 
continue, the National Audit Office predicts a third of all adults will be obese by 2010 
(National Audit Office, 2001). 
Some people are genetically more susceptible to obesity than others, but it is unlikely that 
the gene pool has changed that dramatically in recent years to cause an obesity epidemic 
(Stunkard et ai, 1986). Lifestyle choice is likely to be the causal factor as a result of an 
imbalance between energy expenditure and energy intake. Although the relative 
contributions of each at the individual level vary, obesity is thought to be the result of 
people being insufficiently active to balance the energy consumed from food and drink, 
leading to positive energy balance. This translates in the longer term to overweight and 
obesity. 
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Buchwald et al (2004) comment that diet therapy with and without support organisations 
is relatively ineffective in treating obesity in the long term and in severe cases bariatric 
surgery is recommended for the morbidly obese (BM!::: 40 or::: 35 kg'm-2 in the presence 
of significant comorbidities). In conducting a systematic review of published 
obserVational and interventional trials, Buchwald et al (2004) fOUfld that bariatric surgery 
eliminates or significantly ameliorates diabetes, hyperlipidaemia, hypertension and 
obstructive sleep apnea. However, there are risks and the operative 30-day mortality rates 
were 0.1% for restrictive procedures, 0.5% for gastric bypass and 1.1% for duodenal 
switch. 
Drug therapy can facilitate weight loss or long term weight maintenance. Orlistat is an 
anti obesity agent that works in the gastrointestinal tract to reduce dietary fat absorption. 
The mechanism of action is inhibition of the activity of gastrointestinallipases decreasing 
the hydrolysis and subsequent \lbsorption of ingested fat by up to 30% (Zhi et al 1994). 
0' hill et al (1999) conducted a multicenter, double-blind, placebo-controlled study to 
test the hypothesis that orlistat is significantly more effective than a placebo in preventing 
weight regain. Obese participants who had lost::: 8% body weight during a 6 month lead 
in were randomly assigned to receive placebo, 30 mg orlistat, 60 mg orlistat, or 120 mg 
Orlistat 3 times daily for 1 year in combination with a maintenance diet to help prevent 
weight regain. After 1 year, participants treated with 120 mg orlistat 3 times daily 
regained less weight than did placebo-treated SUbjects. Moreover, more participants in the 
120 mg orlistat group than in the placebo group regained::: 25% of lost weight, showing 
the use of orlistat during periods of attempted weight maintenance minimises weight 
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readjustment and facilitates long-term improvement ill obesity-related disease risk 
factors. 
Anotber drug, sibutramine (a serotonin-norepinephrine re-uptake inhibitor) is also 
frequently prescribed, as it appears to modify internal signals that control hunger and 
satiation (Barkeling et ai, 2003). Many weight loss medications are prescribed with 
minimal or- no lifestyle modification and the combined effect of lifestyle and 
pharmacological interventions is unknown (Phelan et ai, 2002). Wadden et al (2005) 
therefore examined the effectiveness of sibutramine with or without lifestyle intervention. 
Two hundred and twenty four obese adults were randomly assigned to receive IS mg of 
sibutramine per day alone; lifestyle-modification counselling alone, delivered in 30 group 
sessions; sibutramine plus 30 group sessions of lifestyle-modification counselling (i.e., 
combined therapy); or sibutramine plus brief lifestyle-modification counselling delivered 
by a primary care provider in eight visits of lO to IS minutes each. All participants were 
prescribed a diet of 1200 to 1500 Kcal per day and the same exercise regimen. At one 
year, participants who received combined therapy lost more weight tban those receiving 
sibutramine alone, those treated by lifestyle modification alone and those receiving 
sibutramine plus brief therapy. The results underscore the importance of prescribing 
weight-loss medications in combination with lifestyle modification which includes tbe 
. prescription of physical activity and exercise. 
Although there are exceptions, there is general agreement from observational studies that 
overweight and obese individuals are less physically active than non-obese individuals 
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(Wareham et al 2005). The role of exercise in reducing weight and preventing weight· 
gain is widely accepted and it has been quoted that' exercise alone is an effective strategy 
for reducing obesity and related comorbidities' (Ross et ai, 2000, pi). 
A recent review of lifestyle intervention studies concluded that the average weight loss 
from combined diet and exercise programmes is 3 to 5 kg compared with no treatment or 
usual care. Moreover, in most studies with long-term follow-up, the initial weight loss is 
followed by weight regain (Jain, 2005). Similarly Jakicic et al (1999) combined a diet and 
exercise intervention which resulted in a 13 kg weight loss in participants who performed 
an average of 285 minutes of exercise every week (approximately 40 minutes per day) 
over an 18 month period. Moreover, high physical activity levels (11 830 kJ/week) have 
been identified (along with low energy and fat intakes) as a common feature of 
individuals who are successful at long-term maintenance of substantial weight loss (Klem 
et al 1997; Wing and Phelan, 2005). 
There is some evidence that genetic factors play a role in the 'extent to which weight loss 
occurs with exercise. Bouchard and colleagues (1994) studied. seven pairs of 
monozygotic twins over a period of 93 days while they were kept on a constant daily 
energy intake. Participants cycled for close to an hour, twice a day, for 9 out of 10 days. 
This led to an estimated energy deficit of 244 MJ by the end of the training period. 
Although the average weight loss was 5 kg, weight loss varied between individuals from 
I to 8 kg. However, the variance between twin pairs was much greater than the variance 
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within twin pairs. These findings suggest that exercise will be more effective as a means 
4 
of weight loss in some individuals compared with others and that this is due in part to 
genetic factors. 
The benefits of exercise in preventing and treating obesity is the direct result of energy 
expenditure during exercise but there is potential for exercise to help control weight by 
suppressing hunger. Hunger is defined as a strong desire or need for food which has been 
used synonymously with the term appetite. Suppressing hunger during and in the ,: 
immediate post-exercise period could modulate energy intake leading to a phenomenon 
which has been termed 'exercise induced anorexia' (Blundell et ai, 2003; King et ai, 
1994) but the mechanisms are complex as the regulation of hunger and bodyweight 
includes neural, metabolic and endocrine signals from the periphery that communicate 
the short and long term status of energy balance. A ceqtral neural network centred in the 
hypothalamus receives and integrates signals from the adipostat factors leptin and insulin 
and the gut hormones, cholecystokinin (CCK), ghrelin and peptide YY (PYY) , 
stimulating appropriate responses of hunger and expenditure. 
Leptin was discovered by Zhang et al (1994) and is expressed and secreted by adipocytes 
in white adipose tissue and circulates in plasma at concentrations proportional to fat mass. 
Peripheral or Central Nervous System (CNS) administration of leptin to rodents reduces 
,food intake and body weight and increases energy expenditure (Friedman & Halaas, 
1998). The hyperphagic and obese ob/ob mouse lacks functional leptin (Zhang et ai, 
1994) yet the vast majority of obese humans have normally' functioning ob genes and 
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high plasma leptin levels reflecting their high fat mass (Considine et ai, 1996) so is not 
the main cause of obesity. 
Insulin may play a similar role to leptin as an adiposity signal. Basal circulating levels of 
insulin correlate with body adiposity level (Polonsky, 1988; Woods & Seeley, 1998) and 
disruptions of insulin sensitivity are associated with both obesity and diabetes (Kahn & 
Flier, 2000). Insulin has been suggested to be involved in short-term hunger regulation 
(Flint et ai, 2007) but the results of infusion studies have been conflicting. Rodin et al 
(1985) found increased insulin promoted hunger and subsequent energy intake yet 
Gielkins et al (1998) found no such effect with insulin infusion. 
The increase in hunger before and the reduction following a meal cannot be explained by 
the ~ small changes in plasma leptin alone (Murphy and Bloom, 2003) and the acute 
postprandial rise in insulin does not appear to reduce hunger directly (Chapman et ai, 
1998). Postprandial satiety might be explained by a gut sensor system, signalling from the 
gut to the appetite centres in the brain since Murphy and Bloom (2003) highlight that 
CCK was the first gut hormone implicated in the control of hunger. The anorectic effects 
of CCK have been confirmed in rodent and human studies (Kissileff et ai, 1981; 
Muurahainenn et ai, 1988; Moran & Schwartz, 1994). The presence of digestive products 
in ~the intestinal lumen stimulates the release of CCK from the proximal small intestine 
and preprandial administration of CCK antagonists increases meal size in humans 
(Beglinger et ai, 2001). 
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Ghrelin is a 28-amino acid peptide hormone that was identified through studies looking at 
the regulation of growth hormone (GH) secretion (Kojima et aI, 1999). Glp:elin is 
secreted predominantly by the stomach (Kojima et aI, 1999) and exhibits a diurnal 
rhythm, gradually rising throughout the day, reaching a zenith between 0100 and 0200 
hours and a meal response, rising 1-2 hours before the initiation of a meal and falling to 
trough levels 1-2 hours after. This provides support for the involvement of ghrelin in 
hunger regulation (Cummings et aI, 2001). This is supported by e.vidence that the 
infusion of ghrelin stimulates feeding (Wren et aI, 200Ia). Ghrelin has the opposite action 
of PYY which is a 36 amino acid hormone secreted from endocrine L-cells of the distal 
ileum and colon (Bottcher et aI, 1984). It exists in two endogenous forms being PYYI-36 
and PYY3-36 and increased concentrations of PYY3-36 inhibits food intake by altering 
central nervous system appetite circuits within the arcuate nucleus of the hypothalamus or 
area postrema (Batterham and Bloom, 2003). 
The potential effect of exercise in suppressing hunger is not widely promoted because the 
evidence is conflicting and the causal mechanisms are not clear since the research 
evidence of how hunger related hormones respond to exercise is limited (O'Connor et aI, 
2006). Since exercise is a major component of the energy balance equation, examining 
how hunger related hormones respond to exercise is of importance. Despite the 
accumulation of a large body of research on ghrelin and PYY, few studies have examined 
the effects of exercise on these gut peptide hormones. The primary purpose of the studies 
in this thesis is therefore to examine hunger during and immediately post aerobic and 
resistance xercise to see if there are any co-inciding changes with plasma acylated 
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ghrelin and total PYY. It was hypothesized that exercise would cause a temporary 
suppression of hunger and that this would be associated with reduced concentrations of 
plasma acylated ghrelin and increased concentrations oftotaI PYY. It was posited that the 
extent of these changes was likely to be dependent on the duration, intensity and/or mode 
of exercise. 
Study I (Chapter 4) examined the effect of exercise intensity on hunger by looking at low 
and high intensity aerobic exercise compared with control. Study 2 (Chapter 5) measured 
acylated ghrelin and hunger responses to high intensity aerobic exercise compared with 
control. Study 3 (Chapter 6) measured acylated ghrelin and hunger responses to low and' 
high intensity aerobic exercise compared with control. Study 4 (Chapter 7) measured 
acylated ghrelin and hunger responses to short and long duration aerobic exercise 
compared with control. Finally, study 5 (Chapter 8) measured acylated ghrelin, hunger 
responses and total PYY to high intensity aerobic and resistance exercise compared with 
control. 
. Reports indicate that obese people do not compensate for energy expenditure as a result 
of treadmill running by increasing energy intake (Pi-Sunyer and Woo, \985) and Staten 
et al (199\) found normal weight young adults are in negative energy balance during and 
in the post exercise period. The physiological signific~ce of an exercise-induced 
decrease in acylated ghrelin and increase in total PYY is whether it provides the added 
benefit of suppressing hunger and creating a negative energy balance. This is a novel area 
of research which is warranted to initially confirm an exercise induced effect on hunger 
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related hormones therefore contributing to the understanding of the effects of exercise on 
hunger suppression. This could have important implications regarding the role of exercise 
in weight control, weight regain and the prevention of overweight and obesity since 
exercise offers a safer, long term approach without the deleterious side effects associated 
with pharmacological interventions or surgery. 
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CHAPTERII 
Review of Literature 
2.1 Introduction and overview 
This review will address the literature on the effects of exercise on hunger, ghrelin 
and PYY. The review begins by describing hunger regulation moving on to explaining 
the production and secretion of ghrelin and PYY and how these gut peptide hormones 
influence hunger and energy regulation. The potential role of exercise for suppressing 
hunger is highlighted and thereafter the influence of exercise on ghrelin and total PYY 
and how this may result in 'exercise induced anorexia is reviewed'. The purpose of 
the review is to present the findings of previous work and to make the case for 
undertaking the studies in this thesis and the manner in which they were undertaken. 
2.2 Hunger regulation 
Appetite is the desire to eat food, felt as hunger so the terms appetite and hunger will 
be used synonymously throughout this thesis. Hunger is controlled by a variety of 
peripheral signals that change in response to food intake or fasting which act in the 
brain to alter feelings of hunger and fullness (satiety) to determine meal initiation 
(hunger) and meal termination (satiation). 
The hypothalamus is the key central nervous system (eNS) region involved in hunger 
regulation, though other brain regions, including the nucleus tractus solitarius and the 
area postrema, also play a role. L~sioning and stimulation experiments led to a 'dual 
centre' hypothesis which proposed that the ventromedial hypo thalamic nucleus was a 
'satiety centre' and the lateral hypothalamus a 'feeding centre' (Kalra et aI, 1999). Over 
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time this simple picture has changed into a more sophisticated model in which a 
number of discrete neuronal pathways within specific hypothalamic nuclei have been 
shown to form a more complex, integrated neural network with numerous 
neurotransmitters and modulators thought to be involved in the hypothalamic 
regulation of appetite (Vettor et ai, 2002). 
The hypothalamus interprets and integrates a number of neural and humoral 
(circulating in the blood) inputs to coordinate feeding and energy expenditure in 
response to conditions of altered energy balance. Long-term signals communicating 
information regarding the body's energy stores, endocrine status and general health 
are predominantly humoral. Short-term signals, including gut hormones and neural 
signals from higher brain centres and the gut, regulate meal initiation and termination. 
Both short- and long-term signals can also affect energy expenditure via sympathetic 
nervous outflow to brown adipose tissue and by affecting the secretion of various 
pituitary hormones (Schwartz et al. 1999). 
The hypothalamic arcuate nucleus (ARC), which is known as the infundibular nucleus 
in man, appears to play a crucial role in receiving and integrating such signals. The 
ARC is situated at the base of the hypothalamus and is incompletely isolated from the 
general circulation by the blood-brain barrier, allowing direct access of circulating 
factors to ARC neurones. There are two main populations of ARC neurones involved 
in the regulation of food intake: appetite-inhibiting pro-opiolflelanocortin (POMC) 
neurones, and appetite-stimulating neuropeptide Y (NPY) and agouti-related peptide 
(AgRP) coexpressing neurones (Williams et al. 2001). 
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Both the POMC and NPY/AgRP neuronal populations project to other hypothalamic 
nuclei, in particular the paraventricular nucleus (PVN), which is known to be critical 
in the regulation of food intake and energy expenditure. The PVN also assimilates 
inputs from other hypo thalamic nuclei, including the lateral hypothalamic area, the 
ventromedial nucleus and the dorsomedial nucleus (Murphy and Bloom, 2004). 
Neurons containing alpha melanocyte-stimuluating hormone (u-MSH) suppress 
hunger. u-MSH derives from POMC and acts to suppress hunger through a 
melanocortin receptor (MC4). Neurons containing NPY and AgRP stimulate feeding 
and weight gain by interfering with the actions of u-MSH. 
Figure 2.1 illustrates the hormones that influence energy homeostasis via the arcuate 
nucleus. The experimental work of this thesis has included the measurement of the 
gut peptide hormones PYY and acylated ghrelin. In summary, the mechanism of 
ghrelin action asserts that within the hypothalamus ghrelin activates NPY and AgRP 
neurons while inhibiting POMC neurons in the ARC (Neary et ai, 2004) increasing 
hunger. PYY exists in two forms PYYI.36 and PYY3.36. Wbilst the mechanism of 
action for PYY is not completely understood, after crossing the blood-brain barrier, 
PYY3.36 inhibits NPY and AgRP neurons in the ARC suppressing hunger. The effect 
is likely to be mediated through the Y2 receptor because its inability to inbibit feeding 
is abolished in Y2 receptor knockout mice (Tovar et ai, 2004). In contrast to this PYY 
1-36 acts through the Yl and Y5 receptors increasing hunger. 
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Figure 2.1 
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Circulating hormones influencing energy homeostasis via the arcuate nucleus. 
Continuous lines indicate stimulatory effects e.g. ghrelin stimulates NPY via the Yl 
and Y5 receptor increasing food intake. Key: AgRP, agouti-related peptide; aMSU, 
alpha-melanocyte-stimulating hormone; NPY, neuropeptide Y; POMC, pro-
opiomelanocartin; PYY, peptide YY. Adapted for human's from Murphy and 
Bloom's (2004) animal. There are limitations of inferring from animal studies since 
whilst hormonal responses may be similar, hormonal structures are different e.g. rat 
and human ghrelin differs at amino acids 11 and 12. 
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2.3 Ghrelin 
Ghrelin is a gut peptide honnone that is involved in hunger regulation as shown in 
figure 2.1 
2.3.1 Structure, production and secretion 
Ghrelin is a 28 amino acid peptide that is acylated in its active fonn (acylated ghrelin) 
compared with its inactive fonn (des-acylated ghrelin) (Kojima et ai, 1999; Hosoda, 
2002). Modified ·at the amino acid ser 3 with an n-octanoic acid, acylated ghrelin 
(Figure 2.2) is the first known example of a bioactive peptide modified by an acyl 
acid (Kojima et ai, 2001). Acylation of ghrelin is thought to be essential for ghrelin to 
bind to the growth-honnone-secretagogue receptor and to cross the blood brain barrier 
(Kojima et ai, 1999; Murphy et ai, 2006). The ratio of acylated to des-acylated ghrelin 
is approximately the same in tissues that synthesize ghrelin suggesting that acylation 
occurs in the cells of origin (Date et ai, 2000). In humans des-acylated ghrelin does 
not possess the pituitary and pancreatic activity of acylated ghrelin (Broglio et ai, 
2003). 
~ 
C-O 1-
(CH2)6CH3 
n-Octanoyl group 
CO OH 
Figure 2.2 The structure of acylated ghrelin. Adapted from Kojima et al (2001) 
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The stomach is the principal site of ghrelin synthesis producing approximately 10 
times more of the hormone per gram of tissue than the next richest source, the 
duodenum (Kojima et ai, 1999). Patients who have undergone gastric bypass surgery 
have a decreased plasma ghrelin concentration and changes in ghrelin concentration 
diminish with food intake in these patients, providing evidence that the stomach is the 
main site of production (Cummings et ai, 2002). Research has also shown that ghrelin 
is secreted by the ARC of the hypothalamus (Kojima et ai, 1999), the pituitary 
(Korbonitis et ai, 200 I), kidney (Mori et ai, 2000), liver (Wang et ai, 2002), pancreas 
(Wierup et ai, 2002) and the small and large intestines (Date et ai, 2000). 
Ghrelin is secreted into blood vessels, circulating the whole body with one study 
showing normal fasting adult human plasma samples being 337.2 - 404.64 pg'mL,1 
(Kojima et ai, 2001) although values as high as 800 pg'mL,1 have been reported 
(Peeters et ai, 2005). The majority (80-98%) of ghrelin in plasma is des-acylated. 
(Broglio et ai, 2003) and the ratio has been shown to be 3:1 (Hosoda et ai, 2003). 
2.3.2 Growth hormone releasing activity of ghreIin 
Early research examined the effects of ghrelin on GH release smce ghrelin is 
stimulated by hypothalamic GH releasing hormone (GHRH). GH-secretagogues 
(GHS) are synthetic compounds that are potent stimulators of GH release working 
through the GHS-receptor (GHS-R). Ghrelin is the endogenous ligand (a molecular 
group that binds to another chemical entity to form a larger complex) for the GHS-R 
and stimulates GH secretion more potently than GHRH (Kojima et ai, 1999; De Vries 
et ai, 2002). Further studies only examined the orexigenic properties of ghrelin as 
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volunteers reported an increase in appetite as a side effect of the adrrrinistration of 
ghrelin (Wren et ai, 200Ib). 
2.3.3 Ghrelin, hunger and short-term energy regulation 
The most important role of ghrelin appears to be the stimulation' of hunger and 
regulation of energy homeostasis (Peeters et al 2005) and ghrelin is the first peripheral 
orexigenic signal to be discovered (Muccioli et al 2002). Immunohistochemical 
analysis reveals that ghrelin responsive neuronal cells can be found in a very limited 
region in the hypothalamic ARC (Bagnasco et ai, 2003; Kojima et ai, 1999). As 
described in section 2.3 the arcuate nucleus is the target site of the appetite-
stimulating peptides NPY and AgRP. Intracerebroventricular injection of ghrelin 
induces the expression of F os protein (a deoxyribonucleic acid binding protein that 
regulates transcription) in :t\1J>Y -containing neural cells, which increases the amount of 
NPY messenger ribonucleic acid (mRNA) in the ARC (Nakazato et ai, 2001). 
Intravenous injection of ghrelin also stimulates neurons that contain :t\1J>Y and/or 
AgRP (Cowley & Grove, 2004). Immunohistochemical analysis indicates that ghrelin 
neuron fibres directly protrude onto these neurons indicating that ghrelin increases 
. feeding activity by stimulating NPY and AgRP containing neurons in the 
hypothalamus to promote the secretion of NPY and AgRP peptides. The standard 
hormonal model of ghrelin action asserts that circulating ghrelin deriyed primarily 
from the stomach accesses the ARC through a leaky blood-brain barrier (Banks et ai, 
2002; Casanueva et ai, 2002). 
Administration of ghrelin by systematic infusion in order to achieve levels 2-3 fold 
higher than baseline has been shown to increase perceptions of hunger by 48% and 
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energy intake by 38% in humans (Wren et ai, 200Ia). Ghrelin has been shown to 
stimulate gastric motility and acid secretion, both of which increase in anticipation of 
meals (Asakawa, 2001). Research shows a dramatic preprandial rise and postprandial 
fall in circulating ghrelin (Cummings et ai, 2001) and healthy volunteers reported an 
intense feeling of hunger after ghrelin administration (Arvat et ai, 2000) confirming 
ghrelin is a meal initiator. Ghrelin's orexigenic actions are extremely rapid and short 
lived as required for a signal influencing meal related behaviour (Asakawa, 2001). 
2.3.4 Ghrelin and long-term energy regulation 
Ghrelin concentration correlates negatively with energy stores and displays 
compensatory changes in response to alterations of these stores (Cummings et ai, 
2005). In addition, ghrelin appears to be most sensitive to changes in body weight 
resulting from an overall energy deficit, independent of specific effects of reduced 
nutritional intake and/or physical exercise (Foster-Schubert et ai, 2005; Garcia et ai, 
2006; Leidy et al 2006). 
Evidence shows that ghrelin is involved in central energy balance regulation (Wren et 
ai, 2001a), but the full extent of its effects in humans is unknown. In rodents, 
continual ghrelin administration promotes adiposity due to both increased caloric 
intake and increased respiratory quotient (RQ) favouring fat deposition, resulting in 
weight gain (Tschop et ai, 2000). In humans, ghrelin secretion is suppressed by 
chronic over feeding and decreased concentrations of fasting ghrelin have been 
recorded in obese compared with age-matched lean subjects (Tschop et ai, 200Ia). 
This suggests that plasma ghrelin concentration may be down regulated in the obese 
as a possible consequence of chronic positive energy balance. Plasma ghrelin 
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concentrations have also been shown to be negatively correlated with body fat and are 
lower in Pima Indians (a population known for its susceptibility to obesity) compared 
with Caucasians (Ukkola and Poykko, 2002). 
Ravussin et al (2001) overfed twelve pairs of monozygotic twins by 351.5 MJ over a 
lOO-day period, whereas another seven pairs of monozygotic twins were subjected to 
a 221.8 MJ negative energy balance induced solely by exercise for 93 days. With 
overfeeding plasma ghrelin exhibited a non significant decrease of 205.7 ± 101.2 
pg'rnL- 1 (P = 0.18) while a non significant increase of 195.6 ± 114.6 pg·rnL-1 (P = 
0.17) was observed with negative energy balance. Baseline plasma ghrelin 
concentration was negatively correlated with body mass and body fatness, but there 
was no relationship between baseline plasma ghrelin concentrati.on and the magnitude 
of body weight change in both interventions providing evidence that ghrelin may not 
be involved in the aetiology of human obesity. In addition, the intraclass coefficient 
for twin resemblance (r = 0.75, P = 0.006) indicated that plasma ghrelin concentration 
is a familial trait i.e. plasma ghrelin concentration at baseline was more alike within 
pairs than between pairs of twins. This suggests that genetic differences among people 
could play a role in the production and/or clearance of ghrelin. 
Circulating concentrations of ghrelin are reduced in obese participants, so 
hyperproduction of ghrelin (hyperghrelinemia) does not appear to be responsible for 
overfeeding in the obese. In addition ghrelin null mice have normal bodyweight, food 
intake and appetite (Sun et ai, 2003). However, one study has shown that obese 
humans do not exhibit the decline in plasma ghrelin seen after a test meal in lean 
participants (English et ai, 2002). This lack of suppression following a meal could 
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lead to increased food consumption and weight gain predisposing to obesity, raising 
the tempting hypothesis that impaired ghrelin suppression may lead to an impaired 
satiety after eating. 
In contrast, increased ghrelin concentrations have been observed in patients with 
anorexia nervosa (Otto et aI, 2001). This was confirmed by Ariyasu et al (2001) who 
found that ghrelin levels were markedly elevated in anorexia nervosa patients 
compared with healthy participants fasting for 12 hours. Two anorexic patients 
showed a seven fold higher plasma ghrelin concentration compared with control 
participants. Weight loss causes plasma ghrelin concentration to increase (Tschop et 
aI, 2001 b) suggesting that ghrelin may contribute to the drive to eat that makes long 
term success with dieting so difficult. 
2.3.5 Regulation of ghrelin secretion 
Ghrelin secretion is predominantly controlled by feeding, peaking before food intake, 
with feeding and hyperglycaemia suppressing its release. This ultimately leads to 
enhanced satiety (Cumrnings et aI, 2001). In addition, temporal patterns of ghrelin and 
insulin surges are reciprocal. Figure 2.3 illustrates the ghrelin, insulin and hunger 
response to feeding. 
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Time (Hours) 
Ghrelin response to feeding. Adapted from Pinkney and WilIiams 
(2002). 
Yildiz et al (2004) measured circulating ghrelin for 24 hours in lean and obese 
participants and found significant ultradian (rhythms occurring in cycles more 
frequently than every 24 hours) fluctuations and an orderly pattern of release. There 
was a nocturnal rise that exceeded the meal associated increases in lean participants 
which was blunted in the obese suggesting this is a biological feature of human 
obesity. In lean participants, the highest ghrelin concentrations were recorded first 
thing in the morning, decreased after feeding, rising gradually throughout the day, 
increasihg and decreasing in response to further meals. 
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It is not clear what other factors are responsible for ghrelin regulation, but blood 
glucose levels may be critical, since ghrelin concentrations rise during 
hyperglycaemia (Toshinai et ai, 200 I) and both Tschop et al (2000) and Nakagawa et 
al (2002) have reported that oral or intravenous administration of glucose decreases 
plasma ghrelin concentration. Whilst decreases in plasma ghrelin concentration may 
be attributable in part to hyperglycaemia, plasma insulin levels also increase after 
glucose administration which could also contribute to the decrease. Saad et al (2002) 
found that insulin infusion decreases plasma ghrelin concentration which was 
confirmed by Flanagan et al (2003) who reported that hyperinsulinaemia suppressed 
ghrelin. 
Research also shows that the energy content but not the volume of a meal is 
responsible for the postprandial decrease of plasma ghrclin concentrations (Callahan 
et ai, 2004; Erdman et ai, 2004). Calorie for calorie the magnitude of suppression 
based on ingested macronutrients is Carbohydrate - Protein - Lipid (Cununings et ai, 
2005). In addition, Tschop et al (2000) found that gastric distension caused by water 
intake does not alter ghrelin concentration or influence its release. 
2.4 PYY 
PYY is another gut peptide hormone involved in hunger regul~tion as shown in figure 
2.1 
2.4.1 Structure, production and secretion 
Peptide YY is a 36 amino acid gastrointestinal hormone first isolated from porcine 
small intestine by Tatemoto (1980) and named PYY because of the presence of amino 
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acid terminal (Y) tyrosine and a carboxyl terminal tyrosine amide (Y). Studies have 
identified PYY rnRNA in the gastrointestinal tract, pancreas and the brainstem 
(Broome et ai, 1985; Ekblad and Sundler, 2002). The L cells found in the 
gastrointestinal tract are the major source of PYY, which exists in two endogenous 
forms PYYI-36 and PYY3-36. The latter is produced by the action of the enzyme 
dipeptidyl peptidase IV and is a truncated 34 amino acid peptide generated by the 
cleavage of two amino acids from the N terminus. The amino acid sequence ofPYYI_ 
36 and PYY 3-36 is as follows: 
PYYI-36: 
PYY3-36: 
yP AKPEAPGEDASPEELSRYY ASLRHYLNL VTRQRY 
--AKPEAPGEDASPEELSRYY ASLRHYLNL VTRQRY 
PYY shares a common tertiary structure with neuropeptide Y (NPY) and pancreatic 
polypeptide (PP) consisting of an a-helix and polyproline helix connected by a ~-tum 
resulting in a U-shaped peptide known as a PP fold (Glover et ai, 1983). The PP fold 
is important in the binding and activation of the six G protein-coupled receptor 
subtypes - Yl, Y2, Y3, Y4, Y5 and Y6 (Keire et ai, 2000). PYYI-36 binds to and 
activates at least four Y receptor subtypes (Yl, Y2, Y4 and Y5) whereas PYY3-36 is 
more selective for Y2 receptors (Ballentyne, 2006). 
Both PYYI-36 and PYY3-36 are stored in the gut mucosal endocrine cells and are 
secreted into the circulation following food intake (Grandt et ai, 1994). The 
percentage of the two forms in human blood differs depending on feeding status. In a 
fasted state the concentration ofPYYI_36 predominates over PYY3-36 (63% versus 37% 
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respectively) but after feeding the reverse is true (46% versus 54% respectively) 
(Grandt et ai, 1994). 
2.4.1 PYY, hunger and short term energy regulation 
Peripheral administration of PYY was first reported in 1993 to decrease hunger 
(Okada et ai, 1993). Peripheral administration of PYY3-36 at doses mimicking 
postprandial levels activates neurones in the ARC and markedly inhibits food intake 
in rodents and man. In particular human subjects have been shown to reduce food 
intake by 30% (Batterham et ai, 2002). Direct intra-ARC injection also reduces food 
intake in rats (Batterham et ai, 2002). 
After a meal PYY 3-36 is released into the circulation, and it is proposed that hunger is 
inhibited by PYY 3-36 acting directly on the arcuate nucleus via the Y2 receptor, a pre-
synaptic inhibitory autoreceptor. POMC neurons are under a tonic y-aminobutyric 
acid-mediated inhibition by NPY neurons, and thus decreased y-aminobutyric acid-
mediated tone, may lead to disinhibition of POMC neurons (Cowley et ai, 2001; 
Batterham et ai, 2002) and hence suppressed hunger. The binding of PYY 3-36 to the 
Y2 receptor leads to an inhibition of the NPY neurons and a possible reciprocal 
stimulation of the POMC neurons (Batterham et ai, 2002). Reduced l\TPY mRNA 
expression levels and increased POMC mRNA levels are observed after peripheral 
PYY 3-36 administration (Challis et ai, 2003). Evidence from these studies suggests 
. that PYY physiologically inhibits hunger in humans and suggests that it is important 
in the everyday regulation offood intake. 
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Sloth et al (2006) confirmed the anorectic effects of PYY3-36 infusion in lean and 
obese participants but noted feelings of nausea may confound subjective feelings of 
hunger. PYY3-36 caused increase thermeogeneis, lipolysis and increased postprandial 
glucose and insulin responses. Sloth et al (2006) also infused PYY 1-36 and found no 
effects of energy intake or hunger. 
2.4.2 PYY and long term energy regulation 
Obese individuals have a deficiency of PYY release, which is associated with reduced 
satiety which may reinforce obesity (Le Roux et ai, 2004). Obese persons have a 
lower fasting basal PYY and exhibit a diminished postprandial rise (Batterham et ai, 
2003). Batterham et al (2003) also found that energy intake during a buffet lunch 2 
hours after the infusion of PYY 3-36 was decreased by 30% in obese subjects and 31 % 
in lean subjects leading to a cumulative reduction in 24 hour food intake. Batterham et 
al (2006) confirmed previous findings of a significantly lower fasting PYY 
concentrations in obese compared with lean subjects. 
Chan et al (2006) found that complete fasting for 48 - 72 hours significantly decreases 
PYY concentrations in healthy participants. They also add that the fasting induced 
decrease in PYY concentrations is not mediated by falling leptin levels since 
restoration of leptin with exogenous recombinant human leptin does not alter the 
decline in pyy that is associated witb acute energy deprivation. 
Age does not impact on pyy levels. Macintosh et al (1999) studied PYY release 
following intra-duodenal infusion of lipid on pyy in seven younger (age 20 to 34 
years old) and eight older (age 65 to 75 years old) volunteers. Basal and lipid 
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stimulated PYY levels were nearly identical in the two age groups and therefore age 
does not appear to affect PYY metabolism. 
2~4.3 Regulation of PYY 
In response to food ingestion, plasma PYY3-36 concentrations rise within 15 minutes, 
peak at 60 minutes, plateau by approximately 90 minutes and remain elevated for up 
to 6 hours (Adrian et ai, 1985; McGowan and Bloom, 2004). Postprandial PYY 
concentrations increase in both lean and obese subjects (Batterham et ai, 2006). 
Batterham and Bloom (2003) suggest that PYY3-36 is released in proportion to calories 
ingested and regulates subsequent food intake by modulating the activity of the NPY 
and· POMC neurons in the ARC of the hypothalamus. PYY concentrations are 
influenced not only by energy intake but also by meal composition and higher 
concentrations are seen following fatty meals compared with meals containing high 
protein or carbohydrate (Adrian et ai, 1985; Un and Chey, 2003). This implies that 
due to a greater PYY release fatty meals should be eaten to suppress hunger but the 
downside of this is a greater energy intake so the effect of high fat meals on PYY, 
hunger, energy intake and subsequent energy intake on weight status remains to be 
elucidated. PYY release is also stimulated by gastric acid, cholecystokinin and 
infusion of bile acids into the ileum or colon, but not by gastric distension (Pedersen 
et ai, 1996). 
2.5 Exercise and hunger 
The role of exercise in reducing weight and preventing weight gain is widely accepted 
and it has been quoted that' exercise alone is an effective strategy for reducing obesity 
and related comorbidities' (Ross et ai, 2000). This is the direct result of energy 
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expenditure during exercise, but there is potential for exercise to help control weight 
by suppressing hunger and reducing energy intake in the immediate post -exercise 
period, a phenomenon which has been termed 'exercise induced anorexia' (Blundell 
et ai, 2003; King et ai, 1994). 
The inter-relationship between exercise and food intake is important because both are 
contributors to energy balance. The extra energy expended by exercise may stimulate 
hunger and increase energy intake to compensate for the energy used, possibly above 
and beyond that expended during exercise leading to positive energy balance. Though, 
contrary to widespread belief, there is no short-term increase in hunger and food 
intake after exercise (King and Blundell, 1995) and evidence suggests that an acute 
exercise-induced negative energy balance is not compensated by an increase in energy 
intake (Blundell et ai, 2003). Negative energy balances of:'S 4 MJ have been shown to 
be tolerable over periods of up to 16 days when performing exercise programmes. 
Although a subsequent increase in energy intake does eventually take place, evidence 
suggests that it only compensates for about 30% of the energy expended through 
exercise (Blundell et ai, 2003). 
Kissileff et al (1990) detected the suppression of feelings of hunger immediately 
following a vigorous bout of cycling (90W for 40 minutes). King et al (1994) assessed 
the differences between high and low intensity exercise with total energy expenditure 
remaining constant. Twelve healthy lean males either rested for -45 minutes, cycled 
at 70% VO, mal( for -30 minutes or cycled at 30% VO, max -60 minutes on the 
experimental day before being allowed to eat test foods ad libitum in their own time. 
Low intensity exercise did not produce any suppression of hunger either during nor 
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after the exercise session, but there was a significant suppression of hunger during and 
immediately after the high intensity exercise compared with the control session. 
Within 15 minutes of termination of the high intensity exercise session, subjective 
feelings of hunger had beguri to return to control values. Absolute food intake was not 
affected by either exercise protocol. 
If the suppression of hunger is short lived after single intense bouts of exercise this 
may only have a minor role to play in reducing food intake. Measuring food intake 
after exercise would be a better indicator of whether exercise is having an effect on 
energy intake than solely examining subjective feelings of hunger but this is beyond 
the scope of the studies in this thesis as the priority is to examine potential hormonal 
and metabolite changes that co-incide with any possible changes in hunger. 
King et al (1994) also report a second study with a similar research design except 
participants underwent two separate high intensity exercise sessions, one of short 
duration (mean time = 26 minutes) and the other long duration (mean time = 52 
minutes) and a resting control. The gross energy expenditure was significantly 
different and hunger was suppressed in both protocols, but the hunger suppression 
was greatest after the long duration session. Hunger values were not significantly 
different between any of the three treatments 10 minutes after the end of exercise. 
The findings of 'exercise induced anorexia' are mixed since Imbeault et al (1997) and 
Stubbs et al (2002a; 2002b) found no effect of exercise on hunger. Gender differences 
are also apparent. In lean male humans the feeling of hunger is suppressed by intense 
exercise (King et ai, 1994; King et ai, 1997b; King and Blundell, 1995) but whilst an 
27 
intense exercise session leads to increased palatability rating of foods in lean women, 
there is no suppression of hunger (King, 1996a). 
The mechanism through which intense exercise suppresses hunger is not understood, 
but Scheurink et al (1999) highlight that it could be due to an increase in blood lactate. 
Stress hormones such as corticotrophin releasing factor (CRF), adrenocorticotropic 
hormone (ACTH), cortisol and the catecholamines (all secreted in proportion to 
exercise intensity) could exert an anorexic effect (Borer, 2003). Growth Hormone is 
also secreted at increased exercise intensities and its releasing peptides, GHRH and 
ghrelin are associated with the stimulation and suppression of appetite (Borer, 2003). 
It is posited that the suppression of hunger may be the result of exercise induced 
changes to gut peptide hormones. The potential effect of exercise in suppressing 
hunger is not widely promoted because the evidence is conflicting and the causal 
mechanisms are not clear since the research evidence of how hunger related hormones 
respond to exercise is limited (0 'Connor et ai, 2006). Since exercise is a major 
component of the energy balance equation examining how hunger related hormones 
respond to exercise is of significant importance. 
2.6 Exercise and ghrelin 
The effect of acute exercise bouts on total plasma ghrelin concentrations are 
controversial with studies reporting no changes either during or post-exercise (Bums 
et ai, 2007; Dall et ai, 2002; Jiirimae et ai, 2007a; Kallio et ai, 2001; Kraemer et ai, 
2004a; Martins et ai, 2007; Pomerants et ai, 2006; Schmidt et ai, 2004; Takano et ai, 
2005), as well as increases (Christ et ai, 2006; Erdmann et ai, 2007; Jiirimae et ai, 
2007b; Sartorio et ai, 2008) and decreases (Ghanbari-Niaki, 2006; Kraemer et ai, 
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2004b; Toshinai et ai, 2007; Vestergaard et ai, 2007). A brief review of the studies 
follows: 
2.6.1 Effect of a single bout of exercise (acute response) 
The following studies have examined the ghrelin response to acute bouts of exercise. 
All have measured total ghrelin so there is no distinction between the changes in des-
acylated and acylated ghrelin. 
The first paper documenting the effects of exercise on ghrelin was by Kallio et al 
(200 I). They examined the ghrelin responses to cycling in 2 males and 7 females with 
the leucine 7 to proline 7 polymorphism (Leu71Pr07 genotype) compared with normal 
pair matched controls (Leu7lLeu7 genotype). The Leu7IPro7 genotype is associated 
with high blood lipid concentrations, accelerated atherosclerosis and increased birth 
weight. It was posited that this is due to increased NPY concentrations found in the 
Leu7IPro7 genotype but the mechanisms are unclear. Ghrelin was measured since it 
has been shown to stimulate NPY and participants cycled since this would stimulate 
increases in GH that have also been shown to stimulate ghrelin and NPY. The cycling 
protocol progressed for 8 minutes until a workload of 80% of V0 2 max was reached 
which was maintained for a further 12 minutes before being reduced to 20% V0 2 max 
for 10 minutes as a cool down. Plasma ghrelin concentration did not change 
significantly during the exercise study period in either group and was similar among 
both groups. Ghrelin concentrations were suppressed initially as a result of a standard 
meal fed two hours prior to exercise which may have masked an exercise effect 
highlighting the importance for participants to be fasted in the studies described in this 
thesis. 
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Since ghrelin is the endogenous ligand for the OHSR, Dall et al (2002) studied plasma 
ghrelin concentration during submaximal aerobic exercise in OH deficient adult males 
studied both with and without OH replacement as well as age matched healthy adults 
acting as a control. OH deficient males exercised on two occasions. On one occasion 
OH replacement had been discontinued from the evening before, but on the other 
occasion they received their evening OH in addition to an intravenous infusion of OH 
during exercise the following day. The age matched healthy participants exercised on 
one occasion without OH. Blood samples were taken for 3 hours prior to, during and 
for 2.75 hours after exercise to measure plasma ghrelin concentration. Exercise 
consisted of 45 minutes of cycling at 'lactate threshold' (approximately 62% of 
VO, m.x). Despite. exercise stimulating an increase in OH in healthy participants, 
plasma ghrelin concentration did not change significantly in any of the three trials 
before, during or after exercise. OH administration was associated with moderately 
reduced levels of ghrelin indicating that exercise induced OH release is not mediated 
via ghrelin. 
The studies by Kallio et al (2001) and DalI et al (2002) both used cycling as the mode 
of exercise. The exercise intensity was high yet there was no reported change in 
plasma ghrelin. Kraemer et al (2003) therefore examined the ghrelin response to high 
intensity intermittent running. Six male participants completed an intermittent 
treadmill running protocol consisting of 10 minutes at 60%, 10 minutes at 75%, 5 
minutes at 90% and 2 minutes at 100% of VO, max. Blood was sampled at 40 and 10 
minutes before exercise, after each exercise intensity and 4 times during a 1 hour 
recovery. Plasma ghrelin concentration changed significantly over time with a 
significant reduction from 100% VO, max to both 15 and 45 minutes post exercise. 
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When ghrelin concentrations were averaged for rest, exercise and recovery phases 
there was a significant decrease between exercise and recovery concentrations 
showing that high intensity running leads to a suppression of ghrelin. However the 
results are speculative since there was no control trial in the study and it is therefore 
difficult to ascertain whether the difference is the result of exercise or just by chance. 
Due to the lack of a control group, a second aerobic exercise study by Kraemer et al 
(2004a) examined 6 well trained males (mean V0 2 rnax 61.8 ± 2.6 mL·kg·l·min·l) who 
undertook the same intermittent treadmill run described previously (Kraemer et aI, 
2003) but who also completed a resting control trial one month later. Blood samples 
were taken at rest, during and for 1 hour post exercise. Plasma ghrelin concentration 
during exercise remained stable and was not different from the control trial. This was 
confirmed by subsequent area under the curve (AUC) analysis. The mean difference 
between ghrelin during exercise and control was small in that less than 1 % of the 
variance was explained by the trial factor. The stronger research design discredits the 
findings of Kraemer et al (2003) and shows that high intensity running does not affect 
plasma ghrelin. However the exercise protocol was intermittent in nature and a 
continuous bout of running or resistance exercise had not been examined. 
Kraemer et al (2004b) examined 9 males who completed two experimental resistance 
exercise trials. Participants performed the following resistance exercises in order: 
bench press, leg extension, military press and leg curl for four sets of 12 repetitions at 
80% of 10 rep max either concentrically or eccentrically at the same absolute 
workload. Participants rested for 90 seconds between all sets and exercises. A blood 
sample was taken at rest, immediately post exercise and 15 minutes thereafter. 
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Ghrelin decreased significantly during the concentric trial both from pre to 
immediately post exercise and from the 15 minutes after the completion of exercise. 
No cbange was observed in the eccentric trial. This suggests that concentric muscle 
actions performed during resistance exercise leads to suppressions of gbrelin but again 
there was no control group. In addition gbrelin had been shown to possess orexigenic 
properties (Cummings et ai, 2001) but it was not determined whether the magnitude 
of the small reduction in ghrelin concentration that occurred following the concentric 
trial would alter post exercise hunger or hunger feelings during exercise. 
The aim of Schmidt et aI's (2004) study was to determine the effect of exercise 
intensity on plasma ghrelin concentration. Eight healthy young male volunteers 
underwent treadmill exercise at 50% (10 minutes), 70% (10 minutes) and 90% (10 
minutes intermittent i.e. 30 seconds on and 30 seconds off) of VO 2 max on different 
days. Plasma ghrelin concentrations were comparable between the three different 
exercise days at baseline but were not influenced by exercise at any of the three 
workloads. Analysis of blood samples at baseline, 10 and 20 minutes during exercise 
and in the recovery period at 40, 60 and 80 minutes showed no significant change 
confirming the findings of Kraemer et al (2004a) that treadmill running has no effect 
on plasma ghrelin. Again there was no resting control group. 
Borer et al (2005) have only published preliminary findings but report that tw~ bouts 
of low intensity walking (40% VO 2 m.x) with a net energy expenditure of 800 kcal 
prior to meals did not effect hUnger ratings in a fed or fasted state and that exercise led 
to a significantly greater pre-meal plasma ghrelin concentration in the fasted state. 
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Takano et al (2005) highlight that heavy resistance exercise leads to a significant 
increase in GH which could potentially stimulate angiogenesis (capillary growth). 
Cardiac disease patients would benefit from such changes but it is unsuitable to apply 
heavy resistance loads due to the health risks yet low intensity resistance exercise with 
vascular occlusion has also been shown to lead to an increases in GH (Takarada et ai, 
2000). Takano et al (2005) therefore studied the hemodynamic and hormonal 
responses to a short-term low-intensity resistance exercise with a reduction of muscle 
blood flow. Eleven untrained men performed bilateral leg extension on two separate 
occasions with or without the reduction of muscle blood flow using a specially 
designed belt. Participants performed 30 repetitions at 20% of one repetition 
maximum, and after a 20-seconds rest, they performed three sets again until 
exhaustion. Plasma concentrations of ghrelin and GH were measured at baseline, 
immediately post, 10 and 30 minutes after exercise. As a result of vascular occlusion 
the arterial flow was reduced to about 30% of the control. Vascular occlusion 
significantly increased GH but did not alter plasma ghrelin during the exercise. This 
contradicts the findings of Kraemer et al (2004b) who found a significant suppression 
of ghrelin as a result of resistance exercise. The different ghrelin response is likely 
because the exercise intensity of the resistance exercise in the Kraemer et al (2004b) 
study was much greater. Exercise intensity therefore appears to be a determinant of 
plasma ghrelin response to resistance exercise. 
Zoladz et al (2005) posited that increases in piasma ghrelin concentration should be 
accompanied by decreases in heart rate during exercise so they compared incremental 
cycling starting at 30 Wand increasing by 30 W every 3 minutes until exhaustion in a 
fed state with a submaximal incremental test up to 150 W (I2 minutes) in a fasted 
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state. Despite a significant effect of overnight fast leading to a lower heart rate there 
was no difference pre exercise, dnring or post exercise ghrelin concentrations. 
There is a paucitY of data on the effect of meal composition on ghrelin so Christ et al 
(2006) investigated whether a short-term dietary intervention with high fat and low fat 
meals affects ghrelin and its modulators GR and insulin before and during aerobic 
exercise. Eleven healthy, endurance-trained male athletes were investigated twice in a 
randomized crossover de'sign following two types of diet. The low fat diet comprised 
0.5 g fat-kg-! body weight per day for 2.5 days whereas the high fat diet comprised of 
0.5 g fat'kg-! bodyweight per day for 1 day followed by 3.5 g fat·kg-! bodyweight per 
day for 1.5 days. The protein and eRO content was identical. After a standardised 
carbohydrate snack in the morning, metabolites and hormones were measured before 
and at regular intervals throughout a 3 hour aerobic exercise test on a cycle ergometer 
at 50% of W maJ(' Diet did not significantly affect GR concentrations during exercise 
but resulted in a significant increase in ghrelin after low fat compared with high fat 
diet. In addition pre exercise levels of ghrelin were not influenced by diet modality. 
These data suggest that acute negative energy balance induced by exercise elicits a 
hormonal response of ghrelin and the response is modulated by the preceding intake 
of fat. Since a non-exercise control experiment was not performed it is difficult to 
separate the effects of exercise and the pre exercise snack but the study demonstrates 
the importance of dietary control in the days preceding to the main trials in the studies 
described in this thesis. 
The aerobic studies described so far have failed to show suppressions of ghrelin 
during aerobic exercise. Both cycling and running have been examined at various 
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intensities. However the exercise protocols have been intermittent in nature and/or of 
short duration and thus whilst energy expenditures have not been reported these are 
assumed to be low. There was a need to examine continuous aerobic exercise of a 
longer duration for a greater energy expenditure. The author was involved in the study 
published by Burns et al (2007) in which 9 male and 9 female participants completed 
two 3 hour trials (exercise and control) on separate days in a randomized balanced 
design after overnight fasts. The exercise trial involved a 1 hour treadmill. run at 
73.5% of V0 2 max followed by 2 hours of rest to determine the effect of a prolonged, 
continuous high intensity bout of treadmill running as this had not been examined 
previously. The control trial consisted of 3 hours of rest. Blood samples were 
collected at 0, 0.5, I, \.5,2, and 3 hours and ghrelin concentrations were determined 
from plasma. In addition, despite its orexigenic properties, no study had yet to 
determine any associations between any observed changes in ghrelin and hunger 
responses so hunger was assessed following blood sampling using a IS-point scale. 
Hunger scores were significantly lower in the exercise trial compared with the control 
trial but plasma total ghrelin concentrations did not differ betwe.en trials. These 
findings indicate that treadmill running suppresses hunger but this effect is not 
mediated by changes in plasma total ghrelin concentration. However Burns et al 
(2007) comment that exercise may influence ghrelin concentrations in the ARC which 
cannot be measured and the responses of acylated and des-acyl ghrelin cannot be 
distinguished as all studies to date have measured total ghrelin. 
Ghanbari-Niaki (2006) examined the effects of free weight circuit resistance exercise 
on ghrelin, plasma glucose and GH. Fourteen volunteer male physical education 
students completed a single bout of circuit resistance training (10 exercises, three 
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circuits at 60% of 1 rep max). Blood samples were collected before, immediately after 
exercise and for 24 hours following the exercise protocol. GH and glucose showed a 
significant increase immediately after exercise but returned to pre exercise values over 
time. Plasma ghrelin decreased significantly immediately after the resistance exercise 
and increased significantly during the 24 hours following the exercise. This supports 
. the work of Kraemer et al (2004b) but contradicts the fmdings of Takano et al (2005). 
The findings have been mixed possibly because exercise intensity is a determinant of 
the ghrelin response to resistance exercise which warrants further studies to confirm 
these findings. 
Pomerants et al (2006) examined the changes in serum ghrelin concentrations during 
an acute aerobic cycle ergometer test in 60 boys at different stages of puberty. Boys 
were divided according to their pubertal status as group I (Tanner stage 1, n = 20), 
group II (Tanner stages 2 and 3, n = 20) and group 3 (Tanner stages 4 and 5, n = 20). 
Maximal oxygen consumption and individual ventilatory threshold of the participants 
were measured directly using increasing loads on a cycle ergometer followed by a 
second exercise test using a 30 minute constant load exercise on the same ergometer 
at the level of approximately 95% of the individual ventilatory threshold. Ghrelin was 
measured before, immediately after and after 30 minutes of recovery. At baseline, 
prepubertal children had significantly higher values for serum ghrelin compared to 
groups II and ill, but acute exercise' had no effect on ghrelin at different pubertal 
stages. 
Previous studies have examined the plasma ghrelin response to cycling and running 
exercise protocols so Jiirimae et al (2007a) investigated the effects of a single sculling 
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exercise performed above and below the individual 'anaerobic threshold ~ on total 
ghrelin concentration. Nine elite male rowers performed single scull rowing twice, 
below and above the individual 'anaerobic threshold' using a mean of 5 b.min- l . 
Ghrelin was measured before, immediately post exercise and after 30 minutes of 
recovery. Plasma ghrelin concentration did not increase significantly in either exercise 
trial but was approaching significance after 30 minutes of recovery (P = 0.051) when 
the constant load sculling was performed at the intensity above the individual 
'anaerobic threshold'. Similar to cycling and running, rowing does not significantly 
effect plasma ghrelin levels and the evidence is accumulating that aerobic exercise 
that is short duration has no effect on plasma ghrelin regardless of the mode or 
intensity. 
Jiirimae et al (2007b) evaluated the effects of maximal short-term ergometer rowing 
during a 6000 m all out test. It was hypothesized that maximal ergometer rowing 
would have an impact on plasma ghrelin as elite rowers present a relatively large body 
mass values and all extremities and trunk are involved in rowing compared with other 
endurance sports. Eight healthy well trained males performed a maximal 6000 m 
rowing ergometer test 2 hours after a standardised meal. Blood samples for the 
determination of plasma ghrelin were taken at baseline, immediately post exercise and 
30 minutes into recovery. Ghrelin was significantly increased immediately after 
exercise and decreased during the first 30 minutes of recovery. This contradicts the 
previous studies that have investigated the effects of short term exercise (up to 45 
minutes) on ghrelin concentrations after acute submaximal rowing (Jiirimae et ai, 
2007a), running (Jorgensen, 2003; Schmidt et al 2004), cycling (Dall et ai, 2002; 
Kallio et ai, 2001) and maximal running (Kraemer et ai, 2004b). The absence of any 
37 
significant change may be due to the relatively low energy expenditure considering 
Christ et al (2006) witnessed an increase after 3 hours of moderate intensity cycling. 
The response may also differ since participants were more sedentary in the previous 
studies highlighted and/or the exercise protocols used fewer muscle groups. 
Vestergaard et al (2007) looked at systemic ghrelin levels after exercise with and 
without concomitant GH administration to examine if plasma ghrelin is suppressed by 
the exercise-induced GH release. Twenty-nine elite athletes were studied after a 
maximal exercise test that was dependant on their sport. Blood samples were taken at 
baseline, immediately after the test and at 15, 30, 60, 90 and 120 minutes thereafter. 
In a double blind, placebo-controlled, parallel study, 32 healthy subjects were 
randomized to placebo, GH 0.1 IU/kg per day, or GH 0.2 IU/kg per day for 4 weeks. 
These participants performed a multi stage fitness test to assess maximum oxygen 
uptake at baseline and after 4 weeks. Total serum ghrelin levels were measured before 
and immediately after exercise and frequently thereafter. The findings of the study 
show ghrelin levels decrease significantly after acute exercise in elite athletes and 
healthy participants by 21 % and 34% respectively and that 4 weeks of high-dose GH 
suppresses ghrelin levels supporting the hypothesis that GH feedback inhibits ghrelin 
secretion. Ghrelin levels decreased significantly for up to 120 minutes after exercise 
in healthy participants but whether this is of physiological importance is unknown as 
there was no further analysis of subjective feelings of hunger, energy intake or 
macronutrient selection. 
Erdrnann et al (2007) examined the effects of both exercise intensity and duration on 
hunger sensations, food intake and the plasma ghrelin response. In Group A the effect 
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of exercise intensity was examined. Participants undertook three experimental trials 
being resting control, low intensity cycle ergometer exercise for 30 minutes at 50 W 
with an energy expenditure of85.6 kcal and high intensity cycle ergometer exercise at 
100 W for 30 minutes with an energy expenditure of 171.2 Kcal. During low intensity 
exercise ghrelin significantly increased compared with control but no differences were 
found in the high intensity trial. The postprandial ghrelin response to a standardised 
test meal showed no differences between the three trials. In Group B the effect of 
exercise duration was examined. Participants undertook 4 experimental trials 
including a resting control as well as cycling at 50 W for 30, 60 and 120 minutes with 
energy expenditures of 85.6, 171.2 and 342 kcal respectively. There was no difference 
in plasma 'ghrelin during exercise or postprandially between the four trials. The 
findings of both studies also show that low intensity exercise that is short duration 30-
60 minutes has no effect on energy intake or hunger sensations. However a 
prolongation of exercise to 120 minutes led to an increase in food intake. Since 
ghrelin levels were increased during the low intensity trial but there was no increase 
in energy intake it is unlikely that ghrelin mediates changes to hunger as there was no 
increase in plasma ghrelin in the 12.0 minute cycling trial yet a subsequent increase in 
food intake. 
Sartorio et al (2008) took two different groups of athletes to examine the ghrelin 
response to different training bouts. Group A athletes performed a 60-90 minutes 
training session at approximately 80% of V0 2 max on-the-field and ghrelin was 
measured immediately before and after. Group B athletes performed two consecutive 
30 minute cycling sessions at 80% of individual V0 2 max at different time intervals 
between bouts (2 arid 6 hours). In male athletes in Group A, ghrelin levels 
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significantly decreased after the training session while no significant changes were 
found in females. In Group B athletes no changes in ghrelin were observed. The 
fmdings show ghrelin responds to prolonged exercise bouts (60-90 minutes) in male 
athletes only, while repeated exercise bouts of lower duration (30 minute) does not 
change ghrelin concentrations. 
Table.2.1 is a summary table of studies examining the acute effects of exercise on 
ghrelin. 
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Table 2.1: Summary of research examining the acute effects of exercise on ghrelin. 
Study Participants Exercise Results and Conclusion 
Kallio et al 9 participants with Leu7/Pro7 genotype Cycling 30 min duration Ghrelin concentration did not change significantly during 
(2001) 2 male 7 female and 9 pair matched controls Workload increased by 20% VO, max every 2 the exercise study period from values at -5 minutes in either 
with Leu7/LeuPro genotype. minutes until 80% V02 max reached at 8minutes. group and was similar among both groups 
Worked for further 12 minutes before cooling 
down at 20% VOz max for 10 minutes 
Dall et al 8 healthy males and 8 hypopituitary males Cycling 45 minutes duration Plasma ghrelin levels did not change significantly with time 
(2002) with verified GH deficiency Workload equivalent to lactate threshold (62% in either trial. 
VO,max) 
No correlations were detected between gbrelin levels and 
parameters such as OH, age or body composition 
Kraemer et al 6 males Running 27 minutes duration Ghrelin concentration changed significantly over time with 
(2003) Intermittent treadmill protocol 10 minutes 60% a significant reduction from 100% VOz max to 15 and 45 
VO, max, 10 minutes 75% VO, max, 5 minutes minutes post exercise. There was a significant difference 
90% V02 max, 2 minutes 100% V02 max between exercise and recovery concentrations but no 
resting control group 
Kraemer et al 6 well trained males Running 27 minutes duration There was no difference in the in the ghrelin response to the 
(2004a) exercise and control trials. 
Intermittent treadmill protocol 10 minutes 60% 
VOz max. 10 minutes 75% V02 max, 5 minutes Ghrelin concentration during exercise remained stable 
90% V02 max, 2 minutes 100% VOz max 
Kraemer et al 9 males Resistance Ghrelin decreased significantly during the concentric trial 
(2004b) Bench press, leg extension, military press and leg both from pre to immediately post exercise and from the 15 
curl for four sets of 12 repetitions at 80% of 10 rep minutes after the completion of ~xercise. No change was 
max either concentrically or eccentrically at the observed in the eccentric trial 
same absolute workload. 90 second rest between 
sets 
Schmidt et al 8 young h~althy male volunteers Running 30 minutes duration Plasma ghrelin concentration remained unchanged at all 
(2004) Treadmill running at 50% (10 minutes), 70% (10 three workloads 
minutes) and 90% (10 minutes intermittent) VO, 
max on different days 
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Borer et al 10 overweight postmenopausal women Walking Preliminary findings: No effect on hunger in fed or fasted 
(2005) Treadmill walking 40% VO, max until a net state and exercise led to a significant greater pre-t;neal 
energy expenditure of 400 Kcal repeated in the plasma ghrelin concentration in the fasted state 
afternoon 
Takano et al 11 untrained men Resistance Vascular occlusion did not alter plasma ghrelin during the 
(2005) Bilateral leg extension on two separate occasions exercise 
with or without the reduction of muscle blood flow 
using a specially designed belt. 30 repetitions at 
20% of onc repetition maximum, and after 20-
seconds rest three sets again until exhaustion 
Zoldaz et al 8 healthy men Cycling 2 bouts on separate occasions No difference pre exercise, during or post exercise ghrelin 
(2005) I) Starting at 30 Wand increasing by 30 W every concentrations 
3 minutes until exhaustion in a fed state 2) a 
submaximal incremental test up to 150 W (12 
minutes) in a fasted state 
Christ et al 8 endurance trained males Cycling Significant increase in ghrelin 
(2006) 3 hours at 50% ofWmu 
Ghanbari- 14 males Resistance Plasma ghrelin decreased significantly immediately after 
Niaki (2006) Circuit resistance training (IO exercises, three the resistance exercise and increased significantly during 
circuits at 60% of I rep max) the 24 hours following the exercise 
Pomerants et 60 boys at different pubertal stages Cycling Acute exercise had no effect on ghrelin at different pubertal 
al (2006) 30 minute constant load exercise approximately stages 
95% of the individual ventilatory threshold 
Burns et al 9 males 9 females Running Hunger scores were significantly lower in the exercise trial 
(2007) 1 hour at 73.5% VO, max compared with the control trial but plasma total ghrelin 
concentrations did not differ between trials 
Jtirimae et al 9 elite male rowers Rowing Plasma ghrelin concentration did not increase significantly 
(2007a) Single scull rowing twice, below and above the in either exercise trial but was approaching significance 
individual 'anaerobic threshold' using a mean of 5 after 30 minutes of recovery 
b.min-1 during a graded exercise test for 30 
minutes 
J tirimae et al 8 elite male rowers Rowing Ghrelin was significantly increased immediately after 
(2007b) 6000m all out test exercise and decreased during the first 30 minutes of 
_recoyery 
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Vestergaard et 29 elite athletes and 32 healthy controls Max tests Ghrelin levels decrease significantly after acute exercise in 
al (2007) Elite athletes performed maximal tests that were elite athletes and healthy participants by 21% and 34% 
sport dependant and the controls performed the respectively. Ghrelin levels decreased significantly for up to 
multi stage fitness test 120 minutes after exercise in healthy controls 
Erdmarm et al Group A: 2 males 5 females Group A Cycling Group A: During low intensity exercise ghrelin 
(2007) 30 minutes at 50 W as well as 30 minutes at I.OOW significantly increased compared with control but no 
differences were found in the high intensity trial 
Group B: 2 males 5 females Group B Cycling Group B: There was no difference in plasma ghrelin during 
Cycling at 50 W for 30, 60 and 120 minutes with exercise o~ postprandially between the four trials 
energy expenditures of85.6, 171.2 and 342 kcal 
respectively 
Sartorio et al Group A: 19 males 18 females Group A: Training session In males ghrelin decreased significantly aaer training but 
(2008) 60-90 minutes training at 80% V02 max no significant differences were found in females 
Group B: 4 males Group B: Cycling No significant changes in ghrelin 
30 minute cycling 80% VO, max 
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2.6.2 Effect of repeated bouts (chronic response) 
Having examined the ghrelin response to acute bouts of exercise the review now 
discusses the literature on the ghrelin response to chronic exercise and therefore an 
accumulation of exercise bouts. 
Ravussin et al (2001) measured plasmaghrelin concentration in monozygotic twins. 
Twelve pairs of monozygotic twins were overfed by 84,000 kcal over a lOO-day 
period whereas another 7 pairs were submitted to a 53,000 kcal negative energy 
balance induced by exercise over a 93-day period. In response to the overfeeding 
plasma ghrelin exhibited a non significant decrease and a non significant increase 
with exercise induced negative energy balance.· Results do not therefore support that 
the physiological variability in ghrelin concentration has an impact on body weight 
regulation. A limitation of this study though is the small number of participants that 
actually completed the trials and details of the exercise induced negative energy 
balance in terms of mode,· frequency, duration and intensity were not provided. 
Morpurgo et al (2003) identified ghrelin concentration in fasting conditions and after 
a standard meal test in obese participants before and after a 3 week integrated body 
weight reduction programme which included an energy restricted diet and exercise 
training. At baseline, 10 obese participants showed significantly lower ghrelin levels 
than controls which were not modified by standard meal test whereas a significant 
reduction was observed in controls. After the 3-week programme, obese participants 
significantly reduced their weight and BMI, but no significant changes were found in 
both fasting serum ghrelin and in the ghrelin response to a test meaL Results suggest 
that weight loss -5% is not sufficient to normalise fasting ghrelin levels or to restore 
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the normal ghrelin suppressIOn after a meal in obese sUbjects. It is therefore 
speculated that a more prolonged period and/or increased weight reduction to achieve 
a new set point after weight loss is required. The exercise component of the study 
described above consisted of 30 minutes of cycle ergometer exercise at a constant 
work load of 60 W eliciting an average heart rate corresponding to 30-45% of 
\TO, max on 5 days per week and outdoor walking for 50-70 minutes at 45-60% of 
\TO, max on 2 days per week. Also, participants undertook 30 minutes of indoor 
activity 5 days per week consisting of light jogging, dynamic standing and floor 
exercises. Unfortunately due to the multi faceted nature of the study the individual 
influence of exercise cannot be determined. 
Leidy et al (2004) examined the effects of a 3-month energy deficit-imposing diet and 
exercise intervention on circulating ghrelin in normal weight, healthy women. 
Participants were regrouped after completion cif the intervention into three groups. 
One: 7· female controls who performed no exercise and consumed a weight 
maintenance diet. Two: 5 exercising women who remained weight stable .. Three: 10 
exercising women who lost weight. Exercise training occurred five times per week at 
70-80% of maximum heart rate and participants were fed a controlled diet. No 
significant differences were observed in plasma ghrelin between groups before the 
·intervention but ghrelin increased significantly over time in the weight loss group 
compared with the control and weight stable group. In addition changes in ghrelin 
were negatively correlated with changes in body weight. The findings suggest that 
ghrelin responds in a compensatory manner to changes in energy homeostas.is in 
healthy young women and highlights that the increase in ghrelin in the weight loss 
group was in response to the overall energy deficit created by the combination of 
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reduced food intake and exercise and not due to the endocrine or the metabolic effects 
of exercise. In addition the study shows that whilst ghrelin appears to be responsive to 
an energy deficit it is unclear what factors specifically modulate its secretion. 
Whilst it was not a major component of the study by Langenberg et al (2005) they 
measured serum ghrelin in 848 men and 665 women and found that those who 
exercised at least three times a week had lower levels of serum ghrelin than those who 
did not. This association was strengthened and became statistically significant after 
adjustment for BM!. 
Foster-Schubert et al (2005) randomised 173 sedentary, overweight, postmenopausal 
women to an aerobic exercise intervention or stretching control. Plasma ghrelin was 
measured at baseline, 3 and 12 months. Exercise resulted in weight loss which was 
associated with a progressive increase in ghrelin concentration in the presence of no 
significant change in energy intake. Ghrelin concentration increase was also 
dependant on the amount of weight loss since ghrelin levels increased in participants 
with more than a 3 kg weight loss but did not change in those without weight loss or 
when the weight loss was 0.5 - 3 kg. The findings support those of Leidy et al (2004) 
but it is still unclear as to the mechanisms which lead to an increase in ghrelin 
concentration and which components of body composition are detected by systems 
that regulate ghrelin. 
Bobbert et al (2005) examined 8 healthy women and 11 healthy men who were 
training for a marathon and measured the ghrelin response to running a marathon. 
Ghrelin was measured 6 weeks and 10 days before the marathon 2 days and 10 days 
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after and then 6 weeks later. Whilst there was a trend towards higher ghrelin levels 
after the marathon no significant differences were seen. The slightly increased ghrelin 
levels 2 days after the marathon are likely the result of a negative energy balance as 
observed in the previous studies (Leidy et ai, 2004; Foster-Schubert et ai, 2005). 
The aim of the study by Garcia et al (2006) was to investigate the relationship of 
plasma ghrelin concentrations to active weight loss and weight maintenance in obese 
participants. Obese Mexican-American women matched for age and BMI were 
randomized to a 12-month weight loss programme or a no intervention control. 
Interventions included diet, exercise, and orlistat. Fasting ghrelin concentrations were 
measured at baseline and 6 and 12 months. The weight loss group lost 8.5% of body 
weight after 6 months and maintained the new weight for the next 6 months. Ghrelin 
concentrations increased significantly at 6 months but returned to baseline at 12 
months. Baseline ghrelin concentrations were directly related to the degree of weight 
loss achieved after 12 months. Controls experienced no change in BMI or ghrelin 
levels. Consistent with previous results (Leidy et ai, 2004; Foster Schubert et al 2005), 
ghrelin rises in response to weight loss, perhaps as a counter regulatory mechanism. 
However, the present results indicate that ghrelin concentrations return to baseline 
with sustained weight maintenance, suggesting that its effects are unlikely to regulate 
long-term energy balance. 
A later study by Leidy et al (2007) examined whether chronic energy deficiency 
achieved with caloric restriction combined with exercise is associated with changes in 
the 24-hour profile of ghrelin. Twelve non-obese, non-exercising women (age 18 to 
24 years) were randomly assigned to a non-exercising control group or a diet and 
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exercise group. Repeated blood sampling over 24 hours to measure ghrelin occurred 
before and after the study. Significant increases in the following ghrelin features were 
found in only the deficit group: elevations in baseline, lunch peak, dinner peak, 
nocturnal rise and nocturnal peak. In addition there was a significantly larger dinner 
decline. The study i.s more informative than the previous research in that whilst 
elevation in ghrelin have been confirmed increases are seen throughout a 24 hour 
profile. 
Mackelvie et al (2007) investigated the effects of exercise on acylated ghrelin and 
des-acylated ghrelin concentrations and hunger in a tertiary care centre. Seventeen 
normal-weight and overweight male adolescents participated in 5 consecutive days of 
aerobic exercise for one hour per day. Pre exercise total and des-acylated ghrelin 
concentrations were significantly lower in overweight compared with normal weight 
boys but acylated ghrelin was similar. Exercise did not significantly affect fasting 
total ghrelin concentrations but there was a differential effect of exercise on both 
acylated and des-acylated ghrelin at fasting and in response to a test meal. Exercise 
significantly increased fasting acylated ghrelin and the response to a test meal 30, 60 
and 240 minutes later and this increase was greater in normal weight compared with 
overweight adolescents. In addition higher acylated ghrelin concentrations were 
correlated with an increase in markers of hunger. In normal weight boys exercise 
caused a decrease in des-acylated ghrelin concentrations but increased in overweight 
boys. Exercise differentially affects acylated and des-acylated ghrelin in normal 
weight and overweight male adolescents demonstrating the importance of measuring 
both types of ghrelin in future studies. 
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2.6.3 Exercise and ghrelin snmmary 
When examining the ghrelin response to exercise, studies indicate that a single session 
of aerobic exercise has no influence on ghrelin concentrations (Bums et ai, 2007; Dall 
et ai, 2002; Jiirimae et ai, 2007a; Kallio et ai, 2001; Kraemer et ai, 2004a, Martins et 
ai, 2007, Schmidt et ai, 2004; Zoladz, 2005) decreases (Kraemer et ai, 2003; 
Vestergaard, 2007) increases (Christ et ai, 2006; Jtirimae et ai, 2007b) or the findings 
are mixed depending on the duration and intensity of exercise (Erdmann et ai, 2007). 
With resistance exercise the findings are mixed with two studies showing a decrease 
in plasma ghrelin concentration (Kraemer et ai, 2004b; Ghanbari-Niaki, 2006) and 
one showing no change (Takano et ai, 2005). 
Research designs need improving as there is a tendency not to include a resting 
control trial and other metaboliles that may play a role in' the ghrelin responses to 
exercise such as glucose or insulin have not been measured in all studies. Previous 
studies finding no significant effect of acute exercise on total plasma ghrelin 
concentration have predominantly used cycling as the mode of exercise and the acute 
bouts have mostly been short in duration and/or intermittent in nature so there is a 
need to examine longer duration exercise protocols of varying mode. However, the 
main limitation of research concerning exercise and ghrelin is that the studies reported 
have measured total ghrelin, but acylation of ghrelin is thought to be essential for 
ghrelin to bind to the GHSR and to cross the blood brain barrier (Kojima et aI, 1999; 
Murphy et aI, 2006). In humans des-acylated ghrelin does not possess the pituitary 
and pancreatic activity of acylated ghrelin (Broglio et aI, 2003). Since acylated ghrelin 
is less stable than total ghrelin (Ho soda et ai, 2004) this creates practical difficulties in 
sample collection and processing. This may therefore be why to the author's 
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knowledge no published study has examined the effects of an acute bout of exercise 
on acylated ghrelin. 
Researchers have examined the role of ghrelin in hunger, energy balance and its 
relation to disorders including obesity in humans, because by suppressing ghrelin 
there is potential to suppress hunger and/or prevent a person from overeating. 
However, it may not be possible to cure obesity through the actions of ghrelin 
antagonists because plasma ghrelin concentrations have been shown to be decreased 
in obese individuals (Tschop et ai, 200Ib). Ghrelin antagonists could however play a 
role in prevention because a subset of obesity could be due to increased production or 
enhanced signalling through the GHSR pathway (Kojima et ai, 2001). The 
development of a pharmacologic ghrelin antagonist is possible, but the blockade of 
GH secretion by a GHSR antagonist could cause problems. As well as promoting 
growth, GH has other important metabolic actions and the anti-obesity effects of a 
pharmacologic ghrelin antagonist might therefore be offset by impaired secretion of 
growth hormone resulting in negative mood and poor quality of life (Pinkney & 
Williams, 2002). Until effective, non-harmful pharmacological ghrelin antagonists 
become available, exercise could be an important intervention for preventing obesity 
because of its potential action on plasma acylated ghrelin concentration without 
having a negative impact on the actions of GH. 
2.7 Exercise and PYY 
2.7.1 Effect of a single bout of exercise (acute response) 
To the authors knowledge only one study has examined the acute effect of exercise on 
PYY. Martins et al (2007) investigated the acute effects of exercise on the 
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postprandial levels of hunger-related honnones and metabolites, energy intake and 
subjective measures of hunger. PYY and ghrelin were measured in the fasting state 
and postprandially in 12 healthy, nonnal-weight volunteers (six males and six 
females) using a randomised crossover design. One hour after a standardised 
breakfast, participants either cycled for 60 minutes at 65% of their maximal heart rate 
or rested. Subjective hunger was assessed throughout the study using visual analogue 
scales and subsequent energy intake at a buffet meal was measured at the end (3 hours 
post-breakfast and 1 hour post-exercise). Exercise significantly increased mean PYY 
yet no significant effect of exercise was observed on postprandial levels of ghrelin. 
During the exercise period, hunger scores were significantly decreased, however, this 
effect disappeared in the post-exercise period. Exercise significantly increased 
subsequent absolute energy intake, but produced a significant decrease in relative 
energy intake after accounting for the energy expended during exercise. The study 
demonstrates that acute exercise, of moderate intensity, temporarily decreased hunger 
sensations and was able to produce a short-tenn negative energy balance. This impact 
on hunger and subsequent energy homeostasis was not explained by changes in 
postprandial levels of ghrelin however, 'exercise-induced anorexia' may potentially 
be linked to increased PYY. 
2.7.2 Effect of repeated bouts (chronic response) 
To the authors knowledge no published study has examined the effect of repeated 
bouts of exercise on PYY. 
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2.7.3 Exercise and PYY summary 
It is clear that there is a paucity of data on the effects of exercise on PYY. The author 
felt it necessary to include the measurement of pyy in chapter 8 to confirm the 
findings of Martins et al (2007) and examine the effects of resistance exercise. 
2.8 Summary 
The rise in overweight and obesity has prompted researchers to critically examine the 
physiological mechanisms involved in the regulation of short and long terni energy 
balance. The potential effect of exercise in suppressing hunger is not widely promoted 
because the evidence is conflicting and the causal mechanisms are not clear since the 
research evidence of how appetite related hormones respond to exercise is limited 
(O'Connor et ai, 2006). Despite a large body of research literature on the gut peptide 
hormones ghrelin and PYY, there is still a pauci~ of data on the effects of acute 
exercise on these hormones. To the authors knowledge no studies have examined the 
effect of prolonged continuous bouts of treadmill running or resistance exercise on 
plasma acylated ghrelin or total PYY concentrations. Since exercise is a major 
component of the energy balance equation, examining how hunger related hormones 
respond to exercise is of significant importance and therefore measuring the response 
of acylated ghrelin and total pYY to different modes, intensities and durations of 
exercise is the focus of this thesis. 
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CHAPTERll 
General Methods 
The following chapter describes the experimental procedures employed in the studies 
described in this thesis as many are common to each. All studies were conducted with the 
approval of Loughborough University's Ethical Advisory committee (Appendix A). 
3.1 Participants 
F or each of the studies described in this thesis, participants were recruited from within 
Loughborough University and the local area by word of mouth and/or poster advertising. 
Volunteers were given written information about the studies including the purpose of the 
studies and the potential risks and discomforts (Appendix B). After an opportunity to ask 
questions regarding the studies, volunteers signed a statement of informed consent 
(Appendix C) and then each underwent a confidential health screening process using a 
health screen questionnaire (Appendix D). Participants also completed a physical activity 
questionnaire (Appendix E) which examined their physical activity levels. Most of the 
volUnteers were sports science students studying at Loughborough University. All 
participants were physically active and most were involved in competitive sports such as 
soccer, rugby, tennis and hockey. Prior training status was not a prerequisite for any of 
the studies, but the physical demands of the studies ensured that all of the participants 
were reasonably fit. 
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To minimise risks participants were only recruited if they met the following criteria: 
• Were non-smoking 
o Were normally active 
• Were free of any known cardiovascular disease or abnormalities, acute illness or 
active chronic systematic disease 
o Were not taking any medi<;ation known to influence lipid or carbohydrate 
metabolism 
o Had no orthopaedic or muscular contraindications to treadmill runnmg or 
resistance exercise 
o Had no known dyslipidaemia 
• Had non-extreme dietary habits and were weight stable in the last 6 months 
o Had resting arterial blood pressure <140/90 mmHg 
• Had a BMI <30 kg-m-2 
o Not undertaking shift work at night 
3.2 Anthropometry 
Anthropometric measurements were conducted in all studies described in this thesis as 
follows: 
3.2.1 Height 
Height was measured to the nearest 0.1 cm using a wall-mounted stadiomete~ (Seca, 
Hamburg, Germany)_ Participants stood barefoot with their heels together against a 
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wooden back plate. Participants kept their arms loosely by their side. The head was 
placed in the Frankfort Plane i.e. a horizontal line between the lower orbits of the eyes 
and the external auditory meatus. The stadiometer head plate was lowered onto the top of 
the head and then the height was recorded. 
3.2.2 Weight 
Weight was measured to the nearest 0.0 I kg usmg a balance beam scale (Avery, 
Birmingham, U.K.). Participants wore light clothing, removed their shoes and jewellery 
and were told to remove anything from their pockets while being weighed. 
3.2.3 Body mass index 
Body mass index was calculated as weight in kilograms divided by the square of height 
in meters. 
3.2.4 Waist circumference 
Waist circumference was measured with an inelastic polyfibre tape measure 
(Hoechstmass Balzer GmbH, Sulzbach, Germany) placed directly on the skin while the 
participant stood balanced on both feet. The measurement was taken at the end of the 
expiration and was determined as the widest part of the torso between the xiphoid process 
of the sternum and the iliac crest. 
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3.2.5 Skinfold measurements 
Measurements of subcutaneous fat were perfonned to estimate total body fatness. 
Skinfold tbickness was measured using callipers (John Bull, British Indicators, West 
Sussex, U.K.). The measurements were taken at the following sites at tbe right hand side 
of tbe body witb the subject standing: 
1) Tricep 
2) Bicep 
3) Subscapular -
4) Suprailiac 
Vertical fold, on the posterior midline of tbe upper ann, 
halfway between the acromium and olecranon processes, witb 
the ann held freely to the side of the body. 
Vertical fold, of tbe anterior aspect of the ann over the belly 
of tbe bicep muscle, 1 cm above the level used to mark the 
tricep site. 
Diagonal fold (45 0 angle), 1 to 2 cm below tbe inferior angle 
of the scapula .. 
Diagonal fold, in line witb tbe natural angle of tbe iliac crest 
taken in tbe anterior axillary line immediately superior to tbe 
iliac crest. 
Each skinfold was lifted by the experimenter's left hand thumb and index finger. The 
skinfold callipers were placed 1 cm above tbe site of measurement. The measurement 
was taken after 1-2 seconds of calliper pressure while still pinching tbe skinfold. Each 
site was measured in triplicate. The skin was allowed to regain its normal texture and 
tbickness between measurements and tbe average of tbe three measurements for each site 
were calculated and used to represent tbe skinfold thickness for tbat site. The sum of the 
skinfolds was used to calculate body density using tbe predictive equations of Dumin and 
Womersley (1974) tben body fat percentage was estimated using tbe Siri equation (Siri, 
1956). 
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3·.3 Heart rate measurement 
Heart rate was measured during preliminary exercise tests and main trials (Chapters 4, 5, 
6,7,8) using short range telemetry (Polar A3, Polar Electro, Kempele, Finland). 
3.4 Ratings of perceived exertion 
Ratings of perceived exertion (RPE) were used to obtain each individual's perception of 
exercise intensity during preliminary exercise tests and main trials (Chapters 4, 5, 6, 7, 8) 
using the Borg Scale (Borg, 1973), with numbers ranging from 6 (no exertion at all) to 20 
(maximal exertion). 
3.5 Arterial blood pressure measurement 
Arterial blood pressure was measured during health screening by auscultation using a 
random-zero sphygmomanometer (Hawksley MK. n, Hawksley and Sons Ltd, Sussex, 
u.K.) according to the guidelines of the British Hypertension Society (Ramsay et aI, 
1999; Williams et aI, 2004). Participants were seated on a chair for 5 minutes before 
measurement. Two measurements were taken and the mean of these values recorded. 
3.6 Exercise tests 
For all studies participants completed aerobic exercise on a motorized treadmill 
(RUNRACE, Technogym, Gambettola, Italy). All participants were familiarised with 
treadmill running prior to testing. 
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3.6.1 Submaximal-incremental treadmill running test 
Participants completed a submaxirnal-incremental treadmill running test in each study to 
determine the relationship between running speed and oxygen consumption. The test was 
designed to exercise participants through a range of intensities from moderate to 
vigorous, but not maximum. The test was 16-minutes in duration and was continuous in 
nature but was divided into four, four minute stages. The initial running speed was set 
between 6 and 8 km/h depending upon each subject's fitness level. Treadmill speed was 
increased by I or 1.5 km/h at the end of each four min period depending upon each 
subject's fitness level. Expired air samples were collected into Douglas bags (Plysu 
Protection Systems, Milton Keynes, U.K.) for the final minute of each four minute stage 
for the determination of oxygen consumption and carbon dioxide production. Four 
minute stages were used to ensure that subjects were in steady state during expired air 
collection periods. Heart rate was monitored continuously throughout the test using short-
range telemetry (Polar A3, Kempele, Finland). Ratings of perceived exertion (Borg, 
1973) were assessed simultaneously with the expired air collections during the tests. At 
the end of the test the oxygen consumption at each stage was plotted against the running 
speed at each stage to illustrate the submaxirnal running speed-oxygen consumption 
relationship. 
Figure 3.1 shows a schematic representation of the submaximal-incremental treadmill 
running test protocol. 
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Figure 3.1 Schematic representation of the submaximal-incremental treadmill 
running test protocol. 
3.6.2 Maximum oxygen uptake test 
Participants were given 20 to 30 minutes to recover from the submaximal treadmill test 
before they embarked on the maximum oxygen uptake test Maximum oxygen uptake 
was measured directly using an incremental uphill protocol at a constant speed until the 
participants reached volitional fatigue (Taylor, 1955). The test was designed so that 
participants would reach volitional fatigue within 10 to 12 minutes as recommended by 
Taylor et al (1955). The initial incline of the treadmill was set at 3.5%. Thereafter 
. . 
treadmill gradient was increased by 2.5% every 3 minutes. Thus, treadmill incline was 
3.5% during minutes 0 to 3, 6% during minute 4 to 6, 8.5% during minute 7 to 9 and II % 
during minute 10 to 12. Expired air samples were collected into Douglas bags (Plysu 
Protection Systems, Milton Keynes, U.K.) between 1:45 and 2:45 minutes of each three 
minute stage and during the [mal minute of the test which occurred when participants 
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signaled that they could only continue for one more minute. Heart rate was monitored 
throughout these tests using short-range telemetry (Polar A3, Kempele, Finland). Ratings 
of perceived exertion (Borg, 1973) were assessed simultaneously with the expired air 
collections during each test. Strong verbal encouragement was given to participants 
tbroughout the test. 
At the end of the maximum oxygen uptake test oxygen consumption and carbon dioxide 
production were determined from each expired air sample and the highest value was 
accepted as the maximum oxygen uptake. Criteria used to confirm a true maximum value 
included two or more of the following: 1) heart rate within ± 10 b·min- I of age-predicted 
maximum heart rate, 2) a respiratory exchange ratio value:2: 1.15, 3) a plateau in oxygen 
consumption. 
Once maximum oxygen uptake was determined the oxygen consumption (mL·kg·1·min·1) 
required to elicit the desired percentage of maximum oxygen uptake for each of the 
treadmill runs could be calculated. This value was used together with the data obtained in 
the submaximal-incremental test to estimate the running speed required to elicit the 
desired percentage of maximum oxygen uptake. This running speed was used but was 
adjusted if necessary i.e. if participants could not maintain the 4esired intensity andlor to 
account for cardiovascular drift. 
Figure 3.2 shows a schematic representation of the maximal oxygen uptake test protocol. 
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Figure 3.2 Schematic representation of the maximal oxygen uptake test protoco!. 
3.7 Analysis of expired air samples 
Expired air-samples were collected into Douglas Bags (Plysu Protection Systems, Milton 
Keynes, U.K.). Oxygen consumption and carbon dioxide production were determined 
from these expired air samples using a paramagnetic oxygen analyzer and an infra-red 
carbon dioxide analyzer respectively (Series 1400; Servomex, Crowborough, East 
Sussex, U.K.). These analyzers were calibrated prior to analysis using gases of known 
concentration. Expired air volumes were measured using a dry gas meter (Harvard 
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Apparatus, Edenbridge, Kent, U.K.) and corrected to standard temperature and pressure 
(dry). The dry gas meter was calibrated regularly using a 3 litre calibration syringe 
(Series 5530, Hans Rudolph Inc, Kansas City, Missouri, USA). 
3.8 Calculation of energy expenditure 
For the aerobic trials oxygen consumption and carbon dioxide production values were 
used to calculate energy expenditure using indirect calorimetry (Frayn, 1983). Frayn 
(1983) notes that values of carbohydrate and fat oxidation calculated from standard 
formulas do not give true oxidation rates in the presence of metabolic processes such as 
gluconeogenesis or lipogenesis. In normal individuals it is reasonable to assume that rates 
of gluconeogenesis and lipogenesis are low, in which case standard formulas give almost 
true oxidation rates. 
3.9 Dietary and exercise control 
For one day prior to the first main trial in chapters 4, 5 and 6 participants weighed and 
recorded their food intake. Participants then replicated this food intake during the days 
prior to the one remaining trial (Chapter 4 and 5) or two remaining trials (Chapter 6). For 
more rigorous dietary control and after participant feedback that this would not be too 
inconvenient, participants weighed and recorded their food intake for two days prior to 
the first main trial in chapters 7 and 8 then replicated this food intake during the days 
prior to the two remaining trials. 
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Participants were asked to remain inactive and to avoid caffeine conswnption and alcohol 
consumption in the 24 hours prior to each main trial for all experimental studies. On the 
mornings of the main trials, participants arrived at the laboratory having fasted for a 
minimum of 10 hours (no food or drink except water). Sleep was not controlled for. 
3.10 Test meals 
In all of the experimental studies described in this thesis, participants consumed test 
meals. The timing, number, composition and energy content of the meals varied and 
therefore the test meals will be described in each experimental study chapter. 
3.11 Assessment of hunger 
In each study described in this thesis, throughout each main trial participants rated how 
hungry they felt using a 16-point ratings of perceived hunger scale (RPH) (Appendix F) 
that ranged from 0 'Not Hungry' to 15 'Very Hungry.' In addition a previously validated 
visual analogue scale (V AS) (Flint et ai, 2000) (Appendix F) was also used. To avoid 
bias all V AS were measured by independent researchers not associated with the studies 
and the data provided. 
3.12 Environmental temperature and humidity 
Environmental temperature and humidity were monitored during the main trials using a 
\ 
hand-held hygrometer (Omega RH85, Manchester, U.K.) in chapters 5, 6, 7 and 8. 
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3.13 Blood sample collection 
Prior to the start of all of the aerobic exercise and control trials, participants rested in a 
semi-supine position while a cannula (Venflon, Becton Dickinson, Helsinborg, Sweden) 
was inserted into an antecubital vein. Venous blood samples were subsequently collected 
into pre-cooled 4.9 or 9 mL potassium-ethlenediamine tetra-acetic acid (EDTA)-coated 
monovettes (Sarstedt, Leicester, u.K.) via a multi-adapter (Sarstedt, Leicester, U.K.). 
Patency of the cannula was maintained by flushing with a small amount of non-
heparinised saline (0.9% w/v Sodium Chloride, Baxter Healthcare Ltd, Norfolk, u.K.) 
after each collection. The saline waste remaining in the .connector tube after flushing was 
drawn off with a 2 mL syringe immediately before the next blood sample was collected. 
All blood samples were obtained with participants resting in a semi-supine position for 5 
minutes prior to collection except for samples collected during the aerobic exercise trials, 
where blood was collected while the participants straddled the treadmill. This took 
approximately I minute. For the resistance trial (Chapter 8), participants were 
venepunctured at 09:00 and at 09:45 since it was considered unwise for participants to 
undertake resistance exercise with a cannula inserted. At 10:30 a cannula was inserted 
and the remaining samples were extracted via this method as previously described. 
Blood collected into the EDT A monovettes were immediately spun at 4000 revolutions 
per minute (1681 g) for 10 minutes in a refrigerated centrifuge (Koolspin, Burkard, 
Hertfordshire, U.K.) at 4°C. The plasma supernatant of no less than 0.5 mL (to minimize 
any freeze drying effect) was then aliquoted into Eppendorf tubes (Sarstedt, Leicester, 
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U.K.). These were stored at _80°C for analysis of glucose and insulin (and total PYY in 
chapter 8) at a later date. 
Separate venous blood samples were drawn into 4.9 mL monovettes for the determination 
of plasma acylated ghrelin concentration. These monovettes contained EDTA and p-
hydroxymercuribenzoic acid (PHMB) to prevent the degradation of acylated ghrelin by 
protease. The monovettes were spun at 3500 revolutions per minute (1287 g) for 10 
minutes in a refrigerated centrifuge (GS-ISR Centrifuge, Beckman Coulter, Fullerton, 
U.S.A.) at 4°C. The supernatants were then aliquoted into storage tubes and lOO [!L of I 
M hydrochloric acid (HCL) was added per mL of plasma, Samples were then spun at 
3500 revolutions per minute (1287 g) for 5 minutes in a refrigerated centrifuge (GS-15R 
Centrifuge, Beckrnan Coulter, Fullerton, U.S.A.) at 4°C before being transferred into 
Eppendorf tubes (Sarstedt, Leicester, U.K.). The samples were then stored at _80°C for 
analysis later as soon as possible as storage in warm environments is not recomm~nded 
(Espelund et ai, 2003; Groschl et ai, 2002). 
At each acylated ghrelin blood sampling point, duplicate 20 [!L blood samples were 
collected into micropipettes for the measurement of haemoglobm concentration and 
triplicate blood samples were collected into heparinised micro haematocrit tubes for the 
detennination of haematocrit. 
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3.14 Blood Sample Analysis 
3.14.1 Estimation of changes in plasma volnme 
Haemoglobin concentration and haematocrit were used to calculate changes in plasma 
volume (Dill and Costill, 1974). Haemoglobin concentration was assayed in duplicate by 
a cyanmethaemoglobin method using an ultraviolet-visible spectrophotometer (CECIL 
CEIO 1\, Cecil Instruments Ltd., Cambridge, England). Haematocrit was determined in 
triplicate using a microlitre-haematocrit centrifuge (MIKRO, 20, Andreas Hettich GmbH 
and Co.KG, Tuttlingen, Germany). 
3.14.2 Glucose 
Plasma concentrations of glucose were determined by spectrophotometric assay using a 
commercially available kit (Randox Laboratories Ltd., County Antrim, U.K.) with the aid 
of an automated centrifugal analyzer (Cobas Mira Plus; Roche, Basel, Switzerland). 
3.14.3 Insulin 
For chapters 5 and 6, plasma insulin concentrations were determined by a solid-phase 1251 
radioimmunoassay available in a commercial kit (MP Biomedicals, Orangeburg, NY, 
U.S.A.) using an automated gamma counting system (Cobra n, Packard Instrument, 
Downers Grove, IL, U.S.A.). 
F or chapters 7 and 8 plasma insulin concentrations were determined by enzyme-linked 
Immuno sorbent assay using a commercially available kit (Mercodia, Sylveniusgatan, 
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Uppsala, Sweden) using a plate reader (Expert Plus, ASYS Atlantis, Eugendorf, Austria) 
to measure absorbance. 
3.14.4 Acylated ghrelin 
Plasma acylated ghrelin concentrations were determined by enzyme-linked immuno 
sorbent assay using a commercially available kit (SPI BIO, Montigny le BretollIleux, 
France supplied by Immuno Diagnostic Systems (IDS) using a plate reader (Expert Plus, 
ASYS Atlantis, Eugendorf, Austria) to measure absorbance. 
3.14.5 Total PYY 
Total PYY concentrations were determined by enzyme-linked immuno sorbent assay 
using a commercially available kit (Diagnostic System Laboratories, Texas, U.S.A.) 
using a plate reader (Expert Plus, ASYS Atlantis, Eugendorf, Austria) to measure 
absorbance. 
3.14.6 Precision of analysis 
To eliminate inter-assay variation, samples from each participant were analyzed in the 
same run. The within batch coefficients of variation for the assays were as follows: 
acylated ghrelin 4.5%, total PYY 1.2%, glucose 1.8% and insulin (radioimmunoassay 
8.2%; enzyme-linked immuno sorbent assay 4.0%). 
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3.15 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Science (SPSS) software 
version 12.0 for Windows (SPSS Inc, Chicago, IL, U.S.A.). Plasma acylated ghrelin, 
total PYY, hunger, glucose and insulin area under the concentration versus time curves 
were calculated using the trapezoidal rule. One-way ANOV A was used to assess 
differences between fasting and area under the curve values for acylated ghrelin, total 
PYY, hunger, glucose and insulin. Repeated measures, two-factor ANOVA was used to 
examine differences between trials over time. Where appropriate, post -hoc pair wise 
comparisons were performed using the Bonferroni method. The Pearson product moment 
correlation coefficient was used to examine relationships between variables. Statistical 
significance was accepted at the 5% level. Results are given as mean ± SEM unless 
otherwise stated. When a study has three trials, for graph clarity, error bars for one of the 
trials will not be shown. 
3.16 Feeding pilot study 
Due to the recent development of the kit by SPI Bro to measure acylated ghrelin, it was 
felt that a feeding pilot study was needed. The author collaborated with the kits provider 
(IDS) to make this possible. This served two purposes: 
I) Confirm the acylated ghrelin response to feeding 
2) Assess the kits reliability and validity 
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Procedures for the assay have been described previously. Despite the number of 
participants being low (n = 5) statistical analysis has been performed to provide evidence 
statements. 
3.16.1 Participants 
Five healthy Caucasian males mean (±SEM) age (26.4 ± 1.5 years), weight (77.2 ± 3.2 kg), 
Body Mass Index (25.2 ± l.2 kg·m·2), body fat (15.2 ± 2.9 %), volunteered to take part in the 
study. 
3.16.2 Main trials 
After standardising exercise and feeding and fasting overnight, participants undertook a 
feeding trial and a control trial on a separate occasion, in a random, crossover design with 
an interval of at least 7 days. For the feeding trial participants consumed a mixed meal at 
baseline and then rested for 3 hours, but were allowed to participate in sedentary 
behaviour which included reading and watching television. For the control trial 
participants undertook exactly the same protocol but were not fed. 
3.16.3 Test meal 
For the feeding trial participants consumed a 4186 kJ (1000 kcal) test meal at baseline 
consisting of95g of white bread, 90g of tuna, 15g of mayonnaise, 25g of potato crisps, a 
52g chocolate bar, 80g of green apple and 100g of orange juice based on a 70 kg person. 
The macronutrient content was 56% carbohydrate (149g), 15% protein (37g) and 29% fat 
(33g). The amount of each food stuff was adjusted for each participant based on their 
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bodyweight on the day of first trial and identical amounts were consumed on the second 
trial. Participants were encouraged to consume the meal within IS minutes and kept to 
the same start and finish times. 
Water was available ad libitum during both trials and the volume ingested and time of 
presentation was recorded. 
3.16.4 Blood sampling 
Venous blood samples were drawn from a cannula at baseline, 0.5, I, 1.5,2 and 3 hours 
as described in section 3.13 (page 51) 
3.16.5 Blood analysis 
Plasma samples were analysed for acylated ghrelin in duplicate by enzyme immuno 
sorbent assay as described in section 3.14.4 (page 54). Two plates were completed. 
3.16.6 Results 
3.16.6.1 Acylated ghrelin assay coefficient of variation 
Table 3.1 shows the coefficient of variation (CV) of the standards for plate I. 
Table 3.2 shows the coefficient of variation (CV) of the standards for plate 2. 
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Table 3.1 
Standards 
(pg-mL-1) 
1 (250) 
2 (125) 
3 (62.5) 
4 (31.3) 
5 (15.6) 
6 (7.81) 
7 (3.91) 
8 (1.96) 
Table 3.2 
Standards. 
(pg-mL-1) 
1 (250) 
2 (125) 
3 (62.5) 
4 (31.3) 
5 (15.6) 
6 (7.81) 
7 (3.91) 
8 (1.96) 
Acylated ghrelin standards percentage coefficient of variation (CV) for 
Plate 1. . 
Absorbence Absorbence Absorbence Mean SD CV 
1 2 3 Absorbence (%) 
2.308 2.313 2.321 2.314 0.006 0.280 
1.693 1.716 1.608 1.672 0.057 3.400 
0.785 0.774 0.782 0.780 0.006 0.778 
0.379 0.402 0.394 0.392 0.012 2.957 
0.201 0.234 0.204 0.213 0.018 8.648 
0.100 0.099. 0.075 0.091 0.014 15.442 
0.067 0.06 0.061 0.063 0.004 5.697 
0.061 0.029 0.035 0.042 0.017 41.172 
Acy1ated ghrelin standards percentage coefficient of variation (CV) for 
plate 2. 
Absorbence Absorbence Absorbence Mean SD CV 
1 2 3 Absorbence (%) 
2.345 2.344 2.339 2.343 0.003 0.139 
1.951 1.999 1.858 1.936 0.072 3.705 
0.944 0.974 0.984 0.967 0.021 2.165 
0.449 0.488 0.488 0.475 0.023 4.805 
0.242 0.217 0.219 0.226 0.014 6.232 
0.108 0.115 0.119 0.114 0.006 5.268 
0.07 0.066 0.068 0.068 0.002 2.848 
0.038 0.036 0.035 0.036 0.002 4.189 
All samples were measured in duplicate and the mean CV was 6.6%. 
3.16.6.2 Acy1ated ghrelin concentrations at baseline 
Participants 1 - 4 baseline values for both the control and feeding trial ranged from 45.8 -
107.1 pg·mL-1• However participant 5 displayed exceptionally high values for both the 
control and feeding trials (869.5 and 796.1 pg·mL-1) respectively. These values remained 
high for the remainder of the trial, skewing the data. All analyses will include data for 4 
(excluding participant 5) and 5 participants. 
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For 4 participants there was no difference (P = 0.333) in baseline acylated ghrelin 
concentration comparing the control (80.9 ± 12.8 pg·mL· I ) and feeding (68.9 ± .6 pg·mL· 
I) trial. For 5 subjects there was no difference (P = 0.174) in baseline acylated ghrelin 
concentration comparing the control (238.6 ± 11.4 pg·mL- I ) and feeding (214.4 ± 5.9 
pg·mL- I ) trial. 
3.16.6.3 Acylated ghrelin response to feeding 
For 5 participants (Figure 3.3) there was no main effect of trial (P = 0.140), no main 
effect of time (P = 0.269) and no trial x time interaction (P = 0.325) compared with 
control. Area under the curve values for acylated ghrelin confirm no difference (P = 
0.187) when comparing control versus feeding (678.1 ± 29.6 pg·mL I ·3h versus 596.0 ± 
15.4 pg·mL- I ·3h respectively). 
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Mean fasting plasma ghrelin concentrations (i.e. control trial concentration plus feeding 
trial concentration divided by two) were not significantly correlated with BMI, body 
mass, body fat percentage or waist circumference for 5 participants. This was expected 
due to the low sample size and therefore insufficient power to detect significant 
correlations 
For 4 participants acylated ghrelin (Figure 3.4) was lower after feeding: main effect of 
trial (P = 0.007), main effect of time (P = 0.112), trial x time interaction (P = 0.054) 
compared with control. Area under the curve values for acylated ghrelin confirm a 
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difference (P = 0.005) when comparing control versus feeding (258.7 ± 33.0 pg'mL-1'3h 
versus 126.0 ± 17.2 pg·mL·1·3h respectively). 
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Mean fasting plasma ghrelin concentrations (i.e. control trial concentration plus feeding 
trial concentration divided by two) were not significantly correlated with BM!, body 
mass, body fat percentage or waist circumference for 4 participants. 
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3.16.6.4 Discussion 
The aim of the pilot study was to test a recently developed assay and examine the 
postprandial acylated ghrelin response to a mixed meal compared with control. It was 
hypothesised that acylated ghrelin concentraiions would decrease post feeding and the 
findings of the study confirmed this was the case. 
For plate I the 1.96 pg'mL-1 had a very high CV of 41 %. This highlighted the need for 
extreme care whilst pippetting and improvements were seen with the CV's in plate 2. The 
low coefficient of variation for the majority of the standards demonstrates that the assay 
is reliable. 
All samples were measured in duplicate and a mean CV taken (6.6%). Unfortunately no 
samples were measured more than twice due to plate allocation, but the within batch 
coefficient for unknown samples was deemed acceptable compared with CV's published 
by researchers who were among the first to measure plasma total ghrelin: 
Cummings et al (2001): 8.7% 
Wren (200Ia): 8.9% 
Curnmings et al (2002): 6.9% 
Participant 5 displayed extremely high acylated ghrelin values. High ghrelin values of up 
to 800 pg'mL-1 have been reported previously by Peeters et al (2005) but this is for total 
ghrelin. Participant 5 showed acylated ghrelin values ranging from 704.6 - 1015.3 
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pg·mL-1• The reasons for this are unknown b~t participant 5 was dual heritage so ethnicity 
could be a factor and why this in turn may lead to hyperghrelinemia is unknown. 
Figure 3.2 shows the results for 5 participants in which participant 5's results skew the 
graph and distorts the statistical findings. It is therefore necessary to remove persons who 
display atypically high ghrelin levels from the data analysis. 
The finding that acylated ghrelin was suppressed post feeding yet increased slightly while 
fasting in 4 participants was assumed to be valid based on the findings found in the 
feeding literature on ghrelin (Erdmann et aI, 2003; Shiya et al 2002) and acylated ghrelin 
(AI Awar et aI, 2005; Lucidi et aI2004). 
Lucidi et al (2004) compared the effects of a mixed meal ingestion (meal study) or of 
additional 240 min fasting (control study) on plasma concentrations of acylated and total 
ghrelin in 6 healthy participants. Compared with control, meal intake significantly 
suppressed (nadir at 90 minutes) acylated and total ghrelin by 38 ± 3 and 40 ± 3% of 
basal values, respectively. 
The research of Al Awar (2005) confirmed the suppression of acylated ghrelin post 
feeding in a mixed meal in 11 healthy young women of normal body weight, but did not 
find a suppression with. an iso-energetic high fat meal. However, in the high fat 
intervention the low baseline values of acylated ghrelin compared with the balanced 
intervention may have masked the effects of the high fat meal. Tentolouris et al (2004) 
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failed to find suppressed acylated ghrelin after a high fat breakfast in lean females so the 
findings of a suppression of acylated ghrelin post high fat meals warrants confirmation. 
Having successfully measured a post feeding suppression of acylated ghrelin, studies 
measuring the acute effects of exercise on acylated ghrelin were undertaken. 
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CHAPTER IV 
The measurement of hunger during exercise using visual scales 
4.1 Introduction 
The inter-relationship between exercise and food intake is important because both are 
contributors to energy balance. Energy expended by exercise may stimulate hunger 
and increase energy intake to compensate for the energy used, possibly above and 
beyond that expended leading to positive energy balance (Blundell et aI, 2003). 
However, contrary to widespread belief, there is no short-term (a few hours after 
exercise) increase in hunger and food intake after exercise since only 19% of 
intervention studies show an increase in energy intake after exercise, 16% report a 
decrease whereas 65% report no change (Blundell and King, 1999). 
Katch et al (1979) found food consumption and body weight gain was less after low 
and high intensity exercise compared with control in rodents. Studies in humans have 
shown that exercise can influence hunger through the immediate suppression of 
hunger during and post exercise leading to a phenomenon termed 'exercise induced 
anorexia' (Blundell et aI, 2003; King et aI, 1994; King et aI, 1996b; Kissileff et al 
1990). However, the findings are mixed since other studies have reported no effect of 
exercise on hunger (Borer et aI, 2005; Pomerleau et aI, 2004; Stubbs et ai, 2002a, 
2002b). 
Kissileff et al (1990) detected the suppression of feelings of hunger immediately 
following a high intensity bout of cycling but not low intensity cyCling in non-obese 
women and demonstrated that food intake in a single meal is responsive to the effects. 
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of exercise in humans. These findings were confirmed by King et al (1994) who 
compared a low and high intensity bout of cycling and only reported 'exercise 
induced anorexia' in the high intensity trial. The findings of no 'exercise induced 
anorexia' in response to low intensity exercise were also reported by Borer et al 
(2005) who found no suppression of hunger in postmenopausal women during or after 
treadmill walking. The research evidence shows that exercise intensity is an 
important factor in the determination of 'exercise induced anorexia' . 
Through the authors involvement in a previous study (Burns et aI, 2007) problems 
were identified with the use of visual analogue scales (V AS) that measured hunger 
sensations published by Flint et al (2000) during exercise. As the participant needs to 
draw a vertical line on a horizontal scale, this was difficult while in motion during 
exercise. A number scale ranging from 0 'Not hungry' to 15 'Very Hungry' was 
therefore developed (See appendix F) so that participants only had to point to show 
how hungry they felt. There was no opportunity to test the validity of the scale so the 
main purpose of the present study was to examine whether the number scale was valid 
by comparing it with the previously published VAS (Flint et aI, 2000). 
Reviewers of the Burns et al (2007) paper suggested that 'exercise induced anorexia' is 
not the physiological response of exercise but merely distraction. The study would 
confirm if 'exercise induced anorexia' is the result of exercise by including a low 
intensity exercise bout and control trial. During low intensity exercise there is still 
distraction but any difference in hunger responses would show that there is an 
exercise intensity effect per se. 
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4.2 Methods 
4.2.1 Participants 
Twelve healthy Caucasians (6 males and 6 females) between the ages of 18 and 27 
from the population at Loughborough University volunteered to participate in the 
study. Table 4.1 shows the physical characteristics of participants. 
Table 4.1 Physical characteristics of participants. 
Characteristic 
Age (yr) 
Height (m) 
Weight (kg) 
Sum of Skinfolds (mm) 
BM! (kg·m2) 
Body Fat (%) 
Waist Circumference (cm) 
VO, max (mL·kg··1min- l ) 
Values are mean ± SEM (n = 12) 
4.2.2 Study design 
(Mean± SEM) 
20.7 ± 0.8 
1.72 ± 0.02 
66.5 ± 2.2 
45.9 ± 3.5 
22.6± 0.6 
19.7 ± 1.2 
75.1±1.4 
60.9 ± 2.7 
All experimental procedures were conducted in the Health and Paediatric Exercise 
Physiology Laboratory at Loughborough University. After being made aware of the 
protocol, health screened, then giving written consent to take part, anthropometric 
data was collected after which each participant undertook two preliminary exercise 
tests as follows: 1) submaximal-incremental treadmill running test, 2) maximum 
oxygen uptake (VO 2 m.x) treadmill running test. There was a 20 to 30 minute rest 
interval between the exercise tests. 
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During subsequent weeks participants undertook a high intensity exercise trial, a low 
intensity exercise trial and a non exercise control trial on separate occasions, in a 
random, crossover design with an interval of at least 7 days. 
The' day before the first main trial participants were asked to record their weighed 
food intake using a food record diary. The same food intake was then consumed the 
day prior to the next remaining trials. Participants were also asked to refrain from any 
form of vigorous activity and ingesting caffeine or alcohol 24 hours prior to the main 
trial. Participants were fasted for a minimum 10 hours, but were allowed to drink 
water ad libitum. Participants attended the laboratory between the hours of 08:00 and 
09:00 and were requested to use motorised transport where possible or ensure that 
activity prior to attending the laboratory was light. There was no control for menstrual 
cyCle phase among the female participants in this study. 
4.2.3 lVlain trials 
For the high and low intensity exercise trials participants ran on a level treadmill for 
60 minutes and results obtained from the submaximal-incremental treadmill running 
test and V0 2 max tests were used -to predict the running speed required to elicit a 
workloads of 75% and 40% V0 2 max. To ensure the speed was correct and adjust for 
cardiovascular drift, 60 second expired air samples were taken at 14-15,29-30,44-45 
and 59-60 minutes throughout the runs and analysed after each collection. Running 
speed was adjusted after each expired air collection if the oxygen consumption was 
above or below the predicted value or if the participant expressed that they were 
experiencing difficulties. On completion of the treadmill run, participants rested for a 
further 4 hours and were allowed to participate in sedentary behaviour which included 
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reading and watching television. For the control trial participants undertook exactly 
the same protocol but rested throughout. Participants were not devoid of time cues 
during the trials and a clock was on display in the laboratory throughout the trials. 
Figure 4.1 shows a schematic representation of the study protocol. 
R2 
Figure 4.1 Schematic representation of the main trial protocol 
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4.2.4 Subjective measurement of hunger 
On arrival, participants completed a ratings of perceived hunger (RPH) scale 
developed by Burns et al (2007) which ranged from 0 'Not Hungry' to 15 'Very 
Hungry'. Hunger measurements were recorded at baseline, 0.5,1,1.5,2,3,3.5,4, and 
5 hours. At the same sampling points participants also completed a hunger visual 
analogue scale (V AS) which has been deemed to be reliable and valid (Flint et al, 
2000) by placing a vertical mark on a 10 cm horizontal line ranging from 0 'Not at all 
hungry' to LOO 'Very Hungry.' Other visual analogue scales of this type that were 
completed included fullness, ranging from 0 'Not at all full' to 100 'Very full', desire 
to eat ranging from 0 'Very weak' to 100 'Very Strong' and how much can you eat 
ranging from 0 'None at all' to 100 'A large amount.' These scales were then 
measured by researchers not involved in the study to remove bias. 
4.2.5 Test meal 
Participants were fed a 4186 kJ (1000 kcal) test meal three hours after baseline 
measurements for all trials. The meal consisted cif 95g of white bread, 90g of tuna, 
15g of mayonnaise, 25g of potato crisps, a 52g chocolate bar, 80g of green apple and 
100g of orange juice based on a 70 kg person. The macronutrient content was 56% 
carbohydrate (149g), 15% protein (37g) and 29% fat (33g). The amount of each food 
stuff was adjusted for each participant based on their bodyweight on the day of their 
first trial and identical amounts were consumed on the second and third trials. 
Participants were encouraged to consume the meal within 15 minutes and kept to the 
same start and finish times. Water was available ad libitum during all trials and the 
volume ingested and time of presentation was recorded. 
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4.2.6 Oral temperature 
Oral temperature was measured at 0,0.5, I, 1.5,2,3,3.5,4 and 5 hours using a digital 
thermometer. 
4.2.7 Statistical analysis 
Data were analysed using the Statistical Package for the Social Science (SPSS) 
software version 12.0 for Windows (SPSS Inc, Chicago, IL, U.S.A.). One-way 
ANOV A was ~sed to assess differences in baseline hunger and weight and fluid 
intake for the three trials. Repeated measures ANOV A was performed to determine 
the differences between the effects of trial (high intensity versus low intensity versus 
control) and time (0,.0.5, 1, 1.5,2,3,3.5,4 and 5 hours) for hunger, fullness, desire to 
eat, how much you can eat and oral temperature and to assess whether there was any 
interaction effect (trial x time). The data for 0-15 hunger scale is discrete, but repeated 
measures ANOV A was used because there is no non-parametric equivalent. A 3 way 
repeated measures ANOVA was performed to determine the effect of gender (trial x 
time x gender). Post-hoc pair wise comparisons were made using the Bonferroni 
method. The Pearson product moment correlation coefficient was used to examine 
relationships between the number and VAS. Statistical significance was accepted at 
the 5% level. Results are given as mean ± SEM unless otherwise stated. 
4.3 Results 
4.3.1 Responses to treadmill running 
Table 4.2 shows the responses to treadmill running. 
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Table 4.2 Responses to treadmill running 
Exercise Trial 
Low Intensity High Intensity 
Mean Percentage V0 2 max 37± 1.0 71 ± 1.5 
(%) 
Mean respiratory exchange 
ratio 
Gross energy expenditure 
(kJ) 
Gross energy expenditure 
(kcal) 
Percentage energy 
contribution from fat (%) 
Percentage energy 
contribution from 
carbohydrate (%) 
Average heart rate (b·min- I ) 
MedianRPE 
0.83 ± 0.01 
. 1835 ± 101 
438 ± 34 
61 ± 4 
39 ±4 
112 ± 3 
10 
'very light' (range 9-10) 
Values are mean ± SEM (n = 12) 
4.3.2 Fluid consnmption and body mass 
·0.92 ± 0.01 
3488 ± 234 kJ 
834 ± 56 
29±4 
71 ±4 
177 ± 3 
16 
'hard' (range 15-16). 
There was a difference (One factor ANOVA, P = 0.002) in water consumption during 
the control trial (672 ± 112 mL) compared with the low intensity (800 ± 118 mL) and 
high intensity (1110 ± 119 mL) exercise trials. Post hoc analysis showed that all were 
significantly different from each other. Body mass did not differ (P = 0.262) between 
the control, low intensity and high intensity exercise trials at baseline (66.8 ± 2.2 kg 
versus 66.5 ± 2.2 kg versus 66.4 ± 2.2 kg respectively). 
4.3.3 Subjective ratings of hunger using the RPH and VAS scales 
There was no difference (One factor ANOVA, P = 0.780) in baseline hunger between 
the control, low intensity and high intensity exercise trials (7 ± 1 versus 6 ± 1 versus 
7 ± 1 respectively) when using the RPH. No difference was confirmed (One factor· 
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ANOVA, P = 0.900) in baseline hunger between the control, low intensity and high 
intensity exercise trials (49 ± 8 versus 47 ± 7 versus 51 ± 6 respectively) when using 
the V AS scale. 
Hunger scores were suppressed as a result of exercise; main effect of trial (P = 0.035) 
main effect of time (P < 0.0005), trial x time interaction (P < 0.0005) when using the 
RPH as shown in figure 4.2. Post hoc analysis revealed that differences were 
approaching significance in the high intensity compared with control (P = 0.066) but 
were significant in the high intensity compared with low intensity trials (P = 0.002). 
There was no difference in low intensity exercise compared with control. 
Similar trends were reported when using the VAS as shown in figure 4.2. Hunger was 
suppressed as a result of exercise main effect of trial (P = 0.012) main effect of time 
(P < 0.0005), trial x time interaction (P < 0.0005). Post hoc analysis revealed that 
differences were reaching significance in the high intensity compared with control (P 
= 0.065) but were significant in the high intensity compared with low intensity trials 
(P = 0.035). There was no difference in low intensity exercise compared with control. 
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Figure 4.2 
b,c 
-+- Control 
-a- Low Intensity 
-.- High Intensity 
1 2 3 4 5 
Time (Hours) 
b,c -+- Control 
b,c -a- Low Intensity 
a,b,c --.- High Intensity 
1 2 3 4 5 
Time (Hours) 
Subjective feeling of hunger using the RPH and V AS during control, 
low and high intensity exercise trials. Values are mean ± SEM, n = 12. 
The patterned rectangle indicates exercise during the exercise trials. 
The black rectangle represents consumption of the test meal. a Control 
different from low intensity exercise P < 0.05, b Control different from 
high intensity exercise P < 0.05, C Low intensity different from high 
intensity P < 0.05. 
4.3.4 Hunger and gender 
There was no effect of gender when using the RPH, main effect of trial x gender (P = 
0.617), time x gender (P = 0.583) or interaction (P = 0.612) as shown in figure 4.2. 
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Figure 4.3 
1 2 3 4 5 
Time (Hours) 
Subjective feeling of hunger using RPH during control, low and high 
intensity exercise trials by gender. Values are mean ± SEM, n = 6. The 
patterned rectangle indicates exercise during the exercise trials. The 
black rectangle represents consumption of the test meal. b Control 
different from high intensity exercise P < 0.05, C Low intensity 
different from high intensity P < 0.05. 
89 
4.3.5 Fullness 
Subjective feelings of fullness were higher as a result of exercise, main effect of trial 
(P = 0.031) main effect of time (P < 0.0005), and approaching significance for the 
trial x time interaction (P = 0.053) as shown in figure 4.3. However, post hoc analysis 
revealed there were only differences between trials at 1 hour. 
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Subjective feeling of fullness using VAS during control, low and high 
intensity exercise trials. Values are mean ± SEM, n = 12. The patterned 
rectangle indicates exercise during the exercise trials. The black 
rectangle represents consumption of the test meal. b Control different 
from high intensity exercise P < 0.05, C Low intensity different from 
high intensity P < 0.05. 
4.3.6 Desire to eat 
Subjective desire to eat was suppressed as a result of exercise main effect of trial (P "" 
0.06) main effect of time (P < 0.0005), trial x time interaction (P < 0.0005) as shown 
in figure 4.4. Post hoc analysis revealed that this was significant in the high intensity 
compared with control (P = 0.037) and in the high intensity compared with low 
90 
intensity trials (P = 0.028). There was no difference III low intensity exercise 
compared with control. 
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Time (Hours) 
Subjective desire to eat using a VAS during control, low and high 
intensity exercise trials. Values are mean ± SEM, n = 12. The patterned 
rectangle indicates exercise during the exercise trials. The black 
rectangle represents consumption of the test meal. a Control different 
from low intensity exercise P < 0.05, b Control different from high 
intensity exercise P < 0.05, C Low intensity different from high 
intensity P < 0.05. 
4.3.7 How much food' 
Subjective feelings of how much food could be eaten was suppressed as a result of 
exercise, main effect of trial (P = 0.001) main effect of time (P < 0.0005), trial x time 
interaction (P < 0.0005) as shown in figure 4.5. Post hoc analysis revealed that this 
was significant in the high intensity compared with control (P = 0.009) and in the high 
intensity compared with low intensity trials (P = 0.017). There was no difference in 
low intensity exercise compared with control. 
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b,c 
b,c 
-+- Control b,c 
-D- Low Intensity 
-.- High Intensity 
1 2 3 4 5 
Time (Hours) 
Subjective feelings of how much food could be eaten using a VAS 
during control, low and high intensity exercise trials. Values are mean 
± SEM, n = 12. The patterned rectangle indicates exercise during the 
exercise trials. The black rectangle represents consumption of the test 
meal. b Control different from high intensity exercise P < 0.05, C Low 
intensity different from high intensity P < 0.05. 
4.3.8 Oral temperature 
For the first hour ofthe trials oral temperature was lower as a result of exercise, main 
effect of trial (P = 0.01) main effect oftime (P < 0.0005), trial x time interaction (P = 
0.008). Post hoc analysis revealed that this was significant in the high intensity 
compared with control (P = 0.011) and in the low intensity compared with control (P 
= 0.014). There was no difference in low intensity exercise compared with bigh 
intensity exercise trials. 
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Oral temperature during control, low and high intensity exercise trials. 
Values are mean ± SEM, n = 12. The patterned rectangle indicates 
exercise during the exercise trials. The black rectangle represents 
consumption of the test meal. • Control different from low intensity 
exercise P < 0.05, b Control different from high intensity exercise P < 
0.05. 
4.3.9 Correlations between the RPH and VAS 
Results for appetite using the RPH and V AS were correlated at all time points for all 
trials. All were significant (P :S 0.001) and the r value ranged from 0.806 - 0.967 as 
shown in table 4.3. 
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Table 4.3 
Time (h) 
(n = 12) 
o 
0.5 
I 
1.5 
2 
3 
3.5 
4 
5 
Correlation coefficients between hunger values using the RPH and 
VAS. 
Control 
0.911 
0.957 
0.946 
0.956 
0.967 
0.908 
0.925 
0.839 
0.835 
Trial 
Low Intensity 
0.825 
0.908 
0.902 
0.878 
0.920 
0.806 
0.947 
0.875 
0.940 
High Intensity 
0.935 
0.875 
0.930 
0.875 
0.841 
0.819 
0.924 
0.942 
0.953 
4.4 Discussion 
The aim of the study was to confirm the existence of the phenomenon known as 
'exercise induced anorexia' as an exercise effect and not merely the result of 
distraction as well as test the validity of a ratings of perceived hunger scale. It was 
hypothesised that any reported hunger suppression would be greater in the high 
intensity exercise trial. The main finding of a significant hunger suppression in the 
high but not the low intensity exercise trial compared with control shows that that this 
is the case and exercise intensity is an important determinant of 'exercise induced 
anorexia'. Both the VAS and RPH show similar trends and correlational analysis 
confirms that the RPH scale is valid and should be used in the future. 
The present findings confirm previous research by Kissileff et al (1990) who detected 
the suppression of feelings of hunger immediately following a high intensity bout of 
exercise (cycling at 90W for 40 minutes) but not during a low intensity exercise bout 
(cycling 30W for 40 minutes). King et al (1994) assessed the differences between 
high and low intensity cycling but kept total energy expenditure constant. In 
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companson with current findings low intensity (30% V0 2 m",) cycling did not 
produce any 'exercise induced anorexia' whereas high intensity (70% V0 2 max) 
cycling did. Further support was provided in a second study which adopted a similar 
research design except that participants underwent two separate high intensity cycles, 
one of short duration (mean time = 26 minutes) and the other long duration (mean 
time = 52 minutes) and a resting control. The gross energy expenditure was 
significantly different and hunger was suppressed in both protocols, but suppression 
was greatest after the long duration session. 
Similar to the present study, Burns et al (2007) examined the hunger response to a 1 
hour high intensity (73.5 ± 0.8% V0 2 m.x) treadmill run using the RPH. There was a 
significant suppression of hunger during and after exercise, but the magnitude of the 
suppression was less. At 0.5 hours hunger had decreased by a mean of 2 points from 
baseline and was not suppressed any further by the end of exercise. In the present 
study hunger decreased by a mean of 4 points at 0.5 hours and 1 more point by the 
end of exercise. The greater magnitude of suppression in the present study is unknown 
as males and females were examined in both studies yet the energy expenditure (3747 
± 207 kJ) and intensity (73.5 ± 0.8% V0 2 max) was greater than that in the present 
study (3488 ± 234 kJ and 71 ± 1.5% V0 2 max respectively). This warrants further 
investigation. 
King et al (1994) have demonstrated in two studies that hunger values were not 
significantly different between any of the three treatments -15 minutes after the end 
of exercise and hunger had therefore begun to return to baseline values soon after the 
95 
termination of the exercise session. This contradicts the findings of the present study 
which showed significant differences at 30 minutes post exercise yet Burns et al 
(2007) and Thompson et al (1988) report that hunger is suppressed for up to 1 hour 
post exercise. This is possibly due to the greater energy expenditure but also during 
treadmill running there is greater gut movement than in stationery ergometer cycling. 
Based on the fmdings of previous research and the outcome of the present study it 
would seem that there is a threshold of energy expenditure before hunger is 
suppressed during and post exercise which is influenced by intensity, duration and 
mode of exercise. Further research is needed to identify this threshold and other 
modes of exercise such as resistance work needs to be examined. 
The reason for using two separate measures to assess hunger is because involvement 
in a previous study (Bums et ai, 2007) identified difficulties in the use of the V AS 
particularly during exercise. Participants struggled to make a vertical line when 
running and measuring the scales is a time consuming process ideally being 
conducted by persons blinded to the hypothesised outcomes of the study to avoid bias. 
A RPH scale was developed and has been used previously (Bums et ai, 2007) because 
the authors considered it to be more user friendly. The present study provided an 
opportunity to see whether it compared with previously published reliable and valid 
scales (Flint et ai, 2000) and it is clear from figure 4.1 that trends are similar. 
Correlational analysis confirms this is the case, since when results for hunger using 
the number and V AS scale were correlated at all time points for all trials, all were 
significant (P:::: 0.001) and the r value ranged from 0.806 - 0.967. In addition and as 
expected, both scales show a large suppression of hunger post feeding. 
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There was no difference in subjective feelings of fullness between the trials. This is 
possibly because the scale does not distinguish between feelings of fullness from food 
or water and water was available ad libitum throughout each trial. The fullness scale 
will not be used in future studies. 
The desire to eat and how much food you can eat scales are other markers of hunger 
and showed exactly the same responses as the hunger scale for all three trials. As the 
author felt that enough information was provided by the hunger scales only these 
would be used in future studies. 
In lean male humans, the feeling of hunger is suppressed by intense exercise (King et 
ai, 1994; King et ai, 1997; King and Blundell, 1995; Thompson et ai, 1988) but there 
are gender differences. An intense exercise session leads to increased palatabilitY 
rating of foods in lean women but there is no suppression of hunger (King, 1996a; 
Pomerleau et al 2004). There is a paucity of data and more studies are needed using 
female participants. Kissileff et al (1990) reported suppressed hunger in exercising 
women which contradicts the findings of Pomerleau et al (2004). Whilst the exercise 
intensities used in the present study were the same as that in Pomerleau et al (2004) 
study, contrasting results are likely because energy expenditure during the exercise 
trials was much lower (-1469 ± 46 kJ) compared with that in the present study 
(-3488 ± 234 kJ). Since the present study has shown that there is no difference 
between the hunger response to exercise in males and females, conflicting evidence 
warrants the need for further studies to confirm if this is the case. 
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During exercise core temperature increases and the extent of this change is greater in 
high intensity compared with low intensity exercise (Nielsen and Nielsen, 1962). 
Blundell and King (i 999) suggest that changes in core temperature may be a causal 
mechanism for suppression of hunger and hence its measurement in the present study. 
A variety of measures were considered for measuring core temperature including 
rectal and esophageal probes, tympanic membranes and core temperature pills. The 
author felt that rectal or esophageal probes would discourage people from 
volunteering, core temperature pills are expensive and during a test run, tympanic 
membranes were annoying and painful. Although it is not as accurate a predictor of 
core temperature as the other methods previously highlighted, a digital thermometer 
was used to measure oral temperature. The results were not as expected showing a 
significant lowering of oral temperature during exercise. This finding cannot be fully 
explained, but is possibly due to the drinking of cold water ad libitum which occurred 
more frequently during the exercise trials. Oral temperature was measured at 0.5 and 1 
h during exercise which took place on completion of the collection of an expired air 
sample. Having breathed through a mouthpiece it is commonplace for participants to 
drink water upon its removal, which may have affected the oral temperature reading 
and whether participants drank water prior to oral temperature measurements was not 
controlled for. 
The strength of the research design reinforces the validity of the study but there. are 
limitations. As the duration was fixed the extent to which 'exercise induced anorexia' 
is influenced by exercise intensity independently of energy expenditure cannot be 
distinguished. The author did not match the energy expenditure because when 
previous findings of 'exercise induced anorexia' were presented (Burns et ai, 2007) it 
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was questioned whether it is not the physiological influence of' exercise but the 
psychological distraction that causes subjective feelings of hunger suppression. A low 
intensity exercise trial was therefore included and since findings show that 'exercise 
induced anorexia' only occurred in the high intensity exercise trial, this provides 
evidence that exercise has the capacity to have a physiological influence and it is not 
merely psychological distraction. To determine an exercise intensity effect per se 
study 3 (Chapter 6) examined different exercise intensities but matched the energy 
expenditure. 
Due to the large energy deficit caused by exercise it was assumed that hunger would 
be higher towards the end of the five hour observation period for the remainder of the 
trial compared with control and greater in high compared with low intensity exercise. 
It is posited that as there was no short-term increase in hunger there would have been 
no increased energy intake to compensate for the energy used supporting the findings 
of (Blundell and King, 1999) However, this cannot be stated with confidence as 
subsequent energy intake and macronutrient selection was not examined, Subsequent 
energy intake and macronutrient food selection by the provision of buffet meals is an 
area of interest and warrants further investigation. 
In conclusion, high intensity exercise leads to 'exercise induced anorexia' supporting 
the findings of Burns et al (2007) and King et al (1994). There is a clear physiological 
role of exercise and suppressed subjective feelings of hunger is not merely the result 
of distraction. Responses are similar in males and females and exercise intensity is an 
important determinant of 'exercise induced anorexia'. In addition 'exercise induced 
anorexia' seems to be influenced by duration, energy expenditure and mode of 
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exercise. The RPH scale developed by Burns et al (2007) is valid and wi\1 continue to 
be used in future studies. Fina\1y, causal mechanismS for 'exercise induced anorexia' 
remain unclear and need to be studied. 
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CHAPTER V 
Exercise induced suppression of hunger coincides with decreased acylated 
ghrelin in humans 
5.1 Introduction 
Having confIrmed 'exercise induced anorexia' during and immediately after a bout of 
high intensity exercise, examining potential causal mechanisms was warranted. The 
mechanism through which intense exercise suppresses hunger is not understood, but 
Scheurink et al (1999) highlighted that it could be due to an increase in lactate since 
hunger and food intake has been shown to decrease in monkeys when lactate is 
infused in the portal vein. Stress hormones such as corticotrophin releasing factor 
(CRF), adrenocorticotropic hormone (ACTH), cortisol and the catecholamines (all 
secreted in proportion to exercise intensity) could exert an anorexic effect (Borer, 
2003). Growth Hormone (GH) is also secreted at increased exercise intensities and its 
releasing peptides, Growth Hormone Releasing Hormone and ghrelin are associated 
, 
with the stimulation and suppression of hunger (Borer, 2003). 
The potential effect of exercise in suppressing hunger is not widely promoted because 
the evidence is conflicting and the causal mechanisms are not clear since the research 
evidence of how hunger related hormones respond to exercise is limited (O'Connor et 
aI, 2006). It is posited that the suppression of hunger may be the result of exercise 
induced changes to gut peptide hormones. 
Ghrelin is a 28-amino acid peptide hormone which stimulates the release of growth 
hormone from the pituitary (Kojima et aI, 1999). Ghrelin is secreted primarily from 
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cells within the stomach (fundus) but ghrelin is synthesized and secreted in many 
other tissues including the small intestine, pancreas, hypothalamus, cardiomyocytes, 
chondrocytes and placenta (Carninos et a12005; Kojima and Kangawa, 2005). Plasma 
ghrelin concentrations rise prior to meals and decrease following meals suggesting 
that ghrelin is orexigenic (appetite stimulating) (Cummings e.t ai, 2005; Cummings et 
al 2002). This suggestion is supported by the fmdings that intracerebroventricular 
ghrelin administration stimulates feeding in rats (Nakazato et ai, 2001, Wren et ai, 
2001a) and intravenous ghrelin infusion increases food intake in humans (Druce et ai, 
2005, Wren et ai, 2001b). 
Several studies have investigated the influence of high intensity aerobic exercise bouts 
on plasma ghrelin concentration (Bums et ai, 2007; Dall et ai, 2002; Jiirimae et ai, 
2007; Kallio et ai, 2001; Kraemer et ai, 2004a; Schrnidt et ai, 2004; Vestergaard et ai, 
2007). Most of these studies indicate that a single session of aerobic exercise has no 
influence on ghrelin concentrations (Bums et ai, 2007; Dall et ai, 2002; Jiirimae et ai, 
2007; Kallio et ai, 2001; Kraemer et ai, 2004a; Schmidt et ai, 2004) although one 
study reported that serum ghrelin levels are suppressed for up to an hour after the 
cessation of exercise (Vestergaard et ai, 2007). In contrast, one study has reported that 
plasma ghrelin concentrations are increased during three hours of moderate intensity 
exercise but it is uncertain whether this is a true effect of exercise because this study 
did not include a control trial (Christ et ai, 2006). Furthermore, fasting ghrelin 
concentrations appear to be unaffected by exercise training in the absence of 
concurrent weight loss (Leidy et ai, 2004). This indicates that ghrelin may be a sensor 
of negative energy balance as suggested previously (Ravussin et ai, 2001). 
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A limitation of research concerning exercise and ghrelin is that all of the studies 
performed so far have measured total ghrelin (Burns et ai, 2007; Dall et ai, 2002; 
Jiirimaeet ai, 2007; Kallio et ai, 2001; Kraemer et ai, 2004a; Schmidt et aI, 2004; 
Vestergaard et ai, 2007). Ghrelin exists in des-acylated (non-acylated) and acylated 
forms with the majority (80 to 90%) being non-acylated (Ghigo et ai, 2005; Hosoda et 
ai, 2004). Acylation is thought to be essential for ghrelin to bind to the growth-
hormone-secretagogue receptor and to cross the blood brain barrier (Kojima et ai, 
1999; Murphy and Bloom, 2006). In humans des-acylated ghrelin does not possess the 
pituitary and pancreatic activity of acylated ghrelin (Broglio et ai, 2003). Therefore, 
des-acylated ghrelin is not considered to 'be important for appetite regulation although 
it may have other functions such as inhibiting cell proliferation (Cassoni et ai, 200 I) 
and stimulating adipogenesis (Thompson et ai, 2004). 
Relatively few studies have measured acylated ghrelin. Acylated ghrelin is less stable 
than total ghrelin (Hosoda et ai, 2004) creating practical difficulties in sample 
collection and processing. Due to its short half life the sample needs to be processed 
immediately placing extra demands on resources. Two studies have shown that 
acylated ghrelin is suppressed after mixed meals providing evidence that 
macronutrient composition may affect the extent of this suppression (AI Alwar et ai, 
2005; El Khoury et ai, 2006). Three studies have simultaneously measured acylated 
and total ghrelin responses to food consumption (Blom et ai, 2006; Lucidi et aI, 2004; 
Hosoda et ai, 2004). These studies have confirmed that acylated ghrelin is suppressed 
after food intake and one of these studies found that acylated ghrelin responds more 
rapidly and dynamically than total ghrelin in response to glucose ingestion (Hosoda et 
ai, 2004). In view oftrus latter fmding and bearing in mind that hunger is suppressed 
, 
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following exercise (King and Blundell, 1995; King et ai, 1994) and that ghrelin is 
thought t6 be such a strong determinant of hunger, the author decided to re-investigate 
the influence of exercise on ghrelin by specifically measuring acylated ghrelin. 
The primary purpose of the present study was to determine plasma acylated ghrelin 
concentrations during and following an intense bout of treadmill running. It was 
hypothesized that intense treadmill running would cause a temporary suppression of 
hunger and that this would be associated with reduced concentrations of plasma 
acylated ghrelin. The acylated ghrelin response to feeding was also assessed since 
limited information is available in this regard. Finally, concentrations of plasma 
glucose and insulin were measured during and after exercise and feeding because 
glucose and insulin have suppressive effects on concentrations of total ghrelin and are 
therefore important for ghrelin regulation (Flanagan et ai, 2003; Murdolo et ai, 2003; 
Shiya et ai, 2002). 
5.2 Methods 
5.2.1 Participants 
Nine healthy Caucasian males aged 19 to 25 years from the population at 
Loughborough University volunteered to participate in the study. Table 5.1 shows the 
physical characteristics of participants. 
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Table 5.1 Physical characteristics of participants. 
Characteristic 
Age (yr) 
Height (m) 
Weight (kg) 
Sum of Skinfolds (mm) 
BM! (kg·m·2) 
Body Fat (%) 
Waist Circumference (cm) 
VO, max (ml·kg··!min·!) 
Values are mean ± SEM (n = 9) . 
5.2.2 Study design 
(Mean + SEM) 
21.2±0.7 
1.81 ± 0.02 
72.6 ± 2.0 
31.1 ± 2.4 
.22.2± 0.7 
14.2 ±1.0 
78.3 ± 1.7 
63.3 ± 2.0 
All experimental procedures were conducted in the Health and Paediatric Exercise 
Physiology Laboratory at Loughborough University. After being made aware of the 
protocol, -health screened, then giving written consent to take part, anthropometric 
data was collected after which each participant undertook two preliminary exercise 
tests as follows: 1) sub maximal-incremental treadmill running test, 2) maximum 
/ 
oxygen uptake (VO, max) treadmill running test. There was a 20 to 30 minute rest 
interval between the exercise tests. 
During subsequent weeks participants undertook two mam trials (exercise and 
control) and these were performed in a randomized order with an interval of at least 7 
days. The day before the first main trial participants were asked to record their 
weighed food intake using a food record diary. The same food intake was then 
consumed the day prior to the next remaining trials. Participants were also asked to 
refrain from any form of vigorous activity and ingesting caffeine or alcohol 24 hours 
prior to the main trial. Participants were fasted for a minimum of 10 hours, but were 
allowed to drink water ad libitum. Participants attended the laboratory between the 
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hours of . 08:00 and 09:00 and were requested to use motorised transport where 
possible or ensure that activity prior to attending the laboratory was light. 
5.2.3 rYIain trials 
Participants were given at least one week tci recover from the preliminary exercise 
tests before embarking on the main trials. Each main trial began in the morning and 
lasted for nine hours. At the start of the exercise trial participants ran on the treadmill 
for 60 minutes at a running speed predicted to elicit 75% of maximum oxygen uptake. 
One minute expired air samples were collected at 14-15, 29-30, 44-45 and 59-60 
minutes during the run. Running speed was adjusted after each expired air collection 
if the oxygen consumption was above or below the predicted value or if the subject 
expressed that they were experiencing difficulties. After the run, participants rested 
for 8 hours (sitting reading, writing, working at a computer or watching television). 
For the control trial participants undertook exactly the same protocol but rested 
throughout. Participants were not devoid oftime cues during the trials and a clock was 
on display in the laboratory throughout the trials. Due to participants being aware of 
the study protocol there may have been anticipatory changes. 
Figure 5.1 shows a schematic representation of the study protocol. 
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Figure 5.1 Schematic representation of the main trial protocol 
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5.2.4 Subjective measurement of huuger 
On arrival, participants completed an RPH scale compiled by Burns et al (2007) 
which ranged from 0 'Not Hungry' to 15 'Very Hungry'. Hunger measurements were 
recorded at baseline, 0.5, 1, 1.5,2,3,3.5,4,5,6,7,8, and 9 hours. 
5.2.5 Test meal 
Participants were fed a 4201 kJ (1004 kcal) test meal three hours from baseline 
measurements for both trials. The meal consisted of 77g of white bread, 12g of butter, 
12g of mayonnaise, 33g of cheddar cheese, 30g of potato crisps, a 52g chocolate bar, 
150g of whole milk and 7g of milk shake powder based on a 70 kg person. The 
macronutrient content was 38% carbohydrate (l03g), 10% protein (24g) and 52% fat 
(57g). The amount of each food stuff was adj'usted for each participant based on their 
bodyweight on the day of first trial and identical amounts were consumed on the 
second triaL Participants were encouraged to consume the meal within 15 minutes and 
kept to the same start and finish times on both trials. Water was available ad libitum 
during trials and the volume and time of ingestion were recorded. 
5.2.6 Environmental temperature and humidity 
Environmental temperature and humidity were monitored during the main trials using 
a hand-held hygrometer (Omega RH85, Manchester, U.K.). 
5.2.7 Blood sampling 
Prior to the start of each trial subjects rested in a semi-supine position while a cannula 
was inserted into an antecubital vein. Venous blood samples were subsequently 
collected into pre-cooled 9 mL EDTA monovettes at baseline, 0.5, 1, 1.5,2,3,3.5,4, 
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5, 6, 7, 8, and 9 hours. During the exercise trial at 0.5 hours, blood was collected 
while the participants straddled the treadmill which took approximately 1 minute. All 
other blood samples were collected whilst subjects lay in a semi-supine position. The 
EDTA monovettes were spun at 1681 g (4000 rpm) for 10 minutes in a refrigerated 
centrifuge at 4°C. The plasma supematant was then aliquoted into Eppendorf tubes. 
These were stored at -20°C for analysis of glucose and insulin later. 
Separate venous blood samples were drawn into 4.9 mL monovettes at baseline, 0.5, 
1, 3, 4 and 9 hours for the determination of plasma acylated ghrelin concentration. 
These monovettes contained EDTA and p-hydroxymercuribenzoic acid (PHMB) to 
prevent the degradation of acylated ghrelin by protease. The monovettes were spun at 
1287 g (3500 rpm) for 10 minutes in a refrigerated centrifuge at 4°C. The supematants 
were then aliquoted into storage tubes and 100 ilL of 1 M hydrochloric acid (HCL) 
was added per mL of plasma. Samples were then spun at 1287 g (3500 rpm) for 5 
minutes in a refrigerated centrifuge at 4°C before being transferred into Eppendorf 
tubes. The samples were then stored at _20°C for analysis later. 
At each blood sampling point, duplicate 20 ilL blood samples were collected into 
micropipettes for the measurement of haemoglobin concentration and triplicate blood 
samples were collected into heparinised micro haematocrit tubes for the determination 
of haematocrit. 
5.2.8 Blood biochemistry 
Plasma acylated ghrelin concentrations were determined by enzyme immunoassay . 
. 
Plasma glucose concentrations were determined by enzyrnatic, colorimetric methods. 
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Plasma insulin concentrations were determined by radioimmunoassay. To eliminate 
. inter-assay variation, samples from each participant were analyzed in the same run. 
The within batch coefficients of variation for the assays were as follows: acylated 
ghrelin 6.6%, insulin 7.4% and glucose 1.8%. 
5.2.9 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Science (SPSS) 
software version 12.0 for Windows (SPSS Inc, Chicago, IL, U.S.). Plasma acylated 
ghrelin, glucose and insulin area under the concentration versus time curves were 
- calculated using the trapezoidal rule. Area under the curve (AUC) values for hunger 
versus time were also assessed using the same method. Student's I-tests for correlated 
data were used to assess differences between fasting and area under the curve values 
for acylated ghrelin, glucose and insulin on the control and exercise trials. Repeated 
measures, two-factor ANOVA was used to examine differences between the two trials 
over time for acylated ghrelin, glucose, insulin, hunger, body mass and plasma 
volume change. Post-hoc pair wise comparisons were performed using the Bonferroni 
method. The Pearson product moment correlation coefficient was used to examine 
relationships between variables. Statistical significance was accepted at the 5% level. 
Adjustment of values for changes in plasma volume did not alter the statistical 
findings and hence for simplicity the unadjusted values are reported. Results are given 
as mean ± SEM unless otherwise stated. 
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5.3 Results 
5.3.1 Responses to treadmill running 
The mean percentage of maximum oxygen uptake elicited during exercise was 72 ± 
2.0% and the mean respiratory exchange ratio was 0.94 ± 0.01. Gross energy 
expenditure during exercise was 3915 ± 207 kJ (935 ± 50 kcal) with 15 ± 4% of 
energy provided from fat and 85 ± 4% of energy provided from carbohydrate. 
Average heart rate during exercise was 179 ± 2 b·min·1 and median rating of 
perceived exertion (RPE) was 15 i.e. 'hard' (range 15-16). 
5.3.2 Body mass and fluid consumption 
Two-factor ANOVA revealed a main effect of trial (P < 0.009) and a significant 
interaction (P < 0.039) for body mass. On the control trial body mass was 72.7 ± 2.3 
. kg at the start of the trial and 72.9 ± 2.4 kg at the end of the trial. On the exercise trial 
body mass was 72.3 ± 2.3 kg at the start of the trial and 72.1 ± 2.3 kg at the end of the 
trial. Bonferroni post hoc tests revealed that body mass at the end of the exercise trial 
was significantly (P < 0.003) lower than body mass at the end of the control trial. 
There was a trend (Student's I-test, P = 0.061) for water consumption to be higher 
during the exercise trial (2168 ± 335 mL) compared with the control trial (1468 ± 114 
mL). 
5.3.3 Temperature and humidity 
There was no difference (Student's I-test, P = 0.502) in environmental temperature 
between the control and the exercise trials (26.2 ± 0.8 compared with 25.6 ± 1.0 °C 
respectively). Likewise there. was no difference (Student'st-test, P = 0.960) in 
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humidity between the control and the exercise trials (39.4 ± 3.1 compared with 49.2 ± 
4.1 % respectively). 
5.3.4 Hunger 
Two-factor ANOVA revealed a main effect of time (P < 0.0005) and a trial x time 
interaction effect (P = 0.001) for hunger indicating that responses differed over time 
between the exercise and control trials. Post hoc analysis indicated between trial 
differences at 0.5, 1 and 7 hours but after adjusting for multiple comparisons using the 
Bonferroni method the only difference to remain significant (P = 0.003) was that at 7 
hours (Figure 5.2). 
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Subjective feelings of hunger using the RPH scale during the exercise 
and control trials. Values are mean ± SEM, n = 9. The diagonal 
patterned rectangle indicates the treadmill run. The black rectangle 
indicates consumption of the test meal. a Control different from 
exercise P < 0.05. 
Between trial differences in hunger ratings were also evaluated using ADC values for 
\ 
the three hours prior to the meal (0 to 3 hours), the three hours after the meal (3 to 6 
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hours), the six hours after the meal (3 to 9 hours) and the full nine hours. A significant 
difference was found over the first three hours: 32 versus 24 (mean values) for the 
control and exercise trials respectively (Student's I-test, P = 0.013). The difference 
between AUC values for the six hours after the meal (11:00 to 17:00) approached 
significance: 44 versus 50 (mean values) for the control and exercise trials 
respectively (Student's I-test, P = 0.056). 
5.3.5 Acylated ghrelin 
Fasting plasma acylated ghrelin concentrations did not differ significantly between the 
control and exercise trials: control 150.3 ± 56.4, exercise 137.5 ± 46.8 pg.rnL-1 (P < 
0.274). Two-factor ANOVA revealed a main effect of trial (P = 0.022), a main effect 
of time (P = 0.048) and a trial x time interaction (P = 0.043) for acylated ghrelin 
concentrations. Post hoc analysis indicated between trial differences at 0.5, 1 and 9 
hours but after adjusting for multiple comparisons using the Bonferroni method the 
only difference to remain significant (P < 0.001) was that at 0.5 hours (Figure 5.3). 
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Time (Hours) 
Plasma acylated ghrelin concentration during the exercise and control 
trials. Values are mean ± SEM, n = 9. The diagonal patterned rectangle 
indicates the treadmill run. The black rectangle indicates consumption 
of the test meal. a Control different from exercise P < 0.05. 
Total area under the concentration versus time curve for plasma acylated ghrelin was 
lower on the exercise trial compared with the control trial: 917.1 ± 342.2 compared 
with 1400.9 ± 521.0 pg'mL-1'9 hours for the exercise and control trials respectively 
(Student's I-test, P = 0.033). The plasma acylated ghrelin AUC value was also lower 
for the first three hours of the exercise trial in comparison with the same time period 
in the control trial: 316.6 ± 135.1 compared with 509.6 ± 185.6 pg'mL-1'3 hours for 
exercise and control respectively (Student's I-test, P = 0.021). In terms of percentage 
change area under the acylated ghrelin concentration versus time curve was 38% 
lower over the first three hours of the exercise trial and 35% lower over the full nine 
hours of the exercise trial compared with the control trial (Figure 5.4). 
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Total area under the concentration versus time curve (AUC) for plasma 
acylated ghrelin (mean ± SEM, n = 9). Values are for the first three 
hours of the trial (pg'mL-1'3 hours) and for the full nine hours of the 
trial (pg'mL-1'9 hours). a Control different from exercise P < 0.05. 
Fasting plasma acylated ghrelin concentrations were not significantly correlated with 
BMI, body mass, waist circumference, maximum oxygen uptake, fasting hunger, 
fasting plasma insulin concentrations or fasting plasma glucose concentrations. 
5.3.6 Glucose 
Fasting plasma glucose concentrations did not differ significantly (Student's t-test, P 
= 0.613) between trials (control 5.4 ± 0.1 mmolrl, exercise 5.3 ± 0.1 mmoIT1). 
Two-factor ANOyA revealed a main effect of trial (P = 0.013), a main effect oftime 
(P < 0.0005) and a trial x time interaction (P = 0.021) for plasma glucose (Figure 5.5). 
Post hoc analysis indicated between trial differences at 0.5, I and 4 hours but after 
adjusting for multiple comparisons using the Bonferroni method none of these 
remained significant (Figure 5.5). 
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Plasma glucose concentration during the exercise and control trials. 
Values are mean ± SEM, n = 9. The diagonal patterned rectangle 
indicates the treadmill run. The black rectangle indicates consumption 
of the test meal. 
Total area under the concentration versus time curve for plasma glucose was higher 
on the exercise trial compared with the control trial: 50.6 ± 1.0 compared with 47.3 ± 
0.8 mmol·L· 1·9 hours for the exercise and control trials respectively (Student's (-test, P 
= 0.015). The glucose ADC value was also higher for the one-hour exercise bout in 
comparison with the same time period in the control trial: 6.5 ± 0.5 compared with 5.3 
± 0.1 mmol-L·1·1 hour for exercise and control respectively (Student's (-test, P = 
0.038). 
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5.3.7 Insnlin 
Fasting plasma insulin concentrations did not differ significantly (Student's t-test, P = 
0.980) between trials (control 208.4 ± 20.1 pmol·L-1, exercise 207.7 ± 34.0 pmol·L-\ 
Two-factor ANOVA revealed a main effect of time (P < 0.0005) for plasma insulin 
but there was no effect for trial and no interaction effect (Figure 5.6). 
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Plasma insulin concentration during the exercise and control .trials. 
Values are mean ± SEM, n = 9. The diagonal patterned rectangle 
indicates the treadmill run. The black rectangle indicates consumption 
of the test meal. 
Total area under the concentration versus time curve for plasma insulin showed no 
difference on the exercise trial compared with the control trial: 3889.5 ± 405.5 
compared with 4339.7 ± 608.1 pmol·L-1·9 hours for the exercise and control trials 
respectively (Student's t-test, P = 0.377). The plasma insulin AUC value also showed 
no difference for the one-hour exercise bout in comparison with the same time period 
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in the control trial: 183.6 ± 22.8 compared with 191.8 ± 24.9 pmol'L-1'1 hour for 
exercise and control respectively (Student's i-test, P = 0.690). 
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5.4 Discussion 
To the author's knowledge, the present study is the first to examine plasma acylated 
ghrelin concentrations during exercise. The novel finding arising from this study is 
that there is a suppression of plasma acylated ghrelin during running. These findings 
suggest that acylated ghrelin responds differently to an exercise stimulus compared 
with total ghrelin, although a limitation of the study with regard to this latter finding is 
that total ghrelin concentrations were not measured due to cost implications. The 
present study also indicates that hunger is suppressed during exercise and to some 
extent in the immediate post-exercise period. 
Although the present study is the first to examine plasma acylated ghrelin during 
exercise, several previous studies have investigated the response of plasma total 
ghrelin to exercise (Bums et ai, 2007; Dall et ai, 2002; Jiirimae et ai, 20.07; Kallio et 
ai, 2001; Kraemer et ai, 2004a; Schmidt et ai, 2004). The findings of most of these 
studies indicate plasma total ghrelin concentrations are unaffected by a single session 
of exercise although one study has reported that serum total ghrelin levels are 
suppressed for up to an hour after the cessation of exercise (Vestergaard et ai, 2007) 
while another has reported that plasma total ghrelin concentrations are elevated during 
prolonged (three hours) moderate intensity exercise (Christ et ai, 2006). We did not 
measure plasma total ghrelin in the present study but in a previous study using a 
similar exercise protocol we found no change in plasma total ghrelin concentration 
during or after exercise (Bums et ai, 2007). 
It is possible that previous studies failed to detect changes in ghrelin because they 
measured total ghrelin and not acylated ghrelin. Hosoda and colleagues (2004) have 
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reported that acylated ghrelin responds more quickly than total ghrelin in response to 
glucose ingestion and more dynamically i.e. the percentage changes in acylated 
ghrelin are greater than those for total ghrelin in response to glucose ingestion. It is 
possible that the same applies during exercise. It is known that splanchnic blood flow 
is reduced during intense exercise (Rowell, 1974) and this would reduce oxygen 
delivery to the stomach and intestines. It is possible that this reduced oxygen delivery 
interferes in some way with the secretion of ghrelin, altering the ratio of total to 
acylated ghrelin but there is no evidence to support this and the suggestion is highly 
speculative. 
The finding that there is a suppression of hunger during· and to some extent after 
exercise is consistent with results from previous studies that have monitored 
subjective hunger ratings following vigorous exercise (above 60% of maximum 
oxygen uptake) (Blundell et ai, 2003; King and Blundell, 1995; King et ai, 1994). As 
in previous studies the suppression of hunger was short lived and hunger ratings had 
returned to control values within two hours of the cessation of exercise. 
In addition to the decline in acylated ghrelin concentrations during exercise, acylated 
ghrelin concentrations declined after feeding in both the control and exercise trials. 
This is consistent with data from studies examining the response to feeding of both 
acylated plasma ghrelin (AI Alwar et aI, 2005; Blom et aI, 2005; El Khoury et ai, 
2006; Hosoda et ai, 2004; Lucidi et aI, 2004) and total plasma ghrelin (Blom et aI, 
2005; Curnmings et aI, 2002; Cummings et,al, 2001; Hosoda et aI, 2004; Lucidi et aI, 
2004). Macronutrient composition may influence the extent to which feeding 
suppresses ghrelin. There is evidence to suggest that carbohydrate has a greater 
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suppressive effect on plasma acylated ghrelin than protein or fat (El Khoury et ai, 
2006) and at least two studies have reported that plasma acylated ghrelin 
concentrations are not suppressed significantly after high fat meals (AI Alwar, 2005; 
Tentolouris et ai, 2004). Our findings conflict with these latter findings since the meal 
employed in the present study was high in fat. However, this meal was also high in 
energy content (4200 kJ for an individual with a body mass of 70 kg) and this has 
been shown to impact on the suppression of total ghrelin (Callahan et ai, 2004). 
Moreover high fat meals have been shown to suppress total serum ghrelin 
concentrations (poppitt et ai, 2006). Considering the similarity in the response of 
acylated and total ghrelin to feeding, it is difficult to understand why there is a 
divergent response to exercise i.e. no change in total ghrelin but a reduction in 
acylated ghrelin. The findings suggest that the mechanism by which exercise alters 
acylated ghrelin may differ from that by which feeding alters acylated ghrclin. This is 
feasible because factors other than feeding, such as circadian rhythms and body 
composition, have been demonstrated to influence total plasma ghrelin concentration 
(English et ai, 2002; Natalucci et ai, 2005). 
The mechanisms by which feeding suppresses ghrelin concentration are thought to 
involve post gastric feedback. Intravenous infusion of insulin suppresses plasma total 
ghrelin concentrations in humans (Flanagan et ai, 2003) as does intravenous infusion 
of glucose (Shiya et ai, 2002). In individuals with type I diabetes meal intake 
suppresses total plasma ghrelin concentrations when insulin is administered but not in 
the absence of insulin (Murdolo et ai, 2003). Moreover, at least one study has shown 
an inverse correlation between the percentage decrease in plasma total ghrelin 
concentration and the percentage increase in plasma insulin and glucose concentration 
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after meals (Blom et ai, 2005). In the present study the area under the curve values for 
plasma glucose concentration were elevated during the one hour run compared with 
the same time period during the control trial. This is consistent with the fIndings of 
previous studies which also demonstrate an increase in plasma glucose during 
exercise particularly in trained participants (Kjaer et ai, 1986; Kraemer et ai, 2002). 
This may in part explain the lower area under the curve values for plasma acylated 
ghrelin during the exercise trial. Plasma insulin concentrations were not elevated 
during exercise in the present study, in line with previous fIndings (Kjaer et ai, 1986; 
Kraemer et ai, 2002), and are therefore unlikely to contribute to the suppression of 
acylated ghrelin during exercise. 
In the present study there was a tendency for higher hunger ratings over the last fIve 
hours of the exercise trial compared with the control trial. This is probably because 
participants were in energy defIcit during the exercise trial compared with the control 
trial. Previous research has demonstrated an increase in energy intake after an acute 
bout of exercise (Pomerleau et ai, 2004) and after a one-week period of exercise 
training (Stubbs et ai, 2002a). This is not a universal fInding since one study has 
reported no increase in energy intake over a two day period following acute bouts of 
exercise (King et ai, 1997). Although there was a transient reduction in hunger after 
exercise in the present study, it is likely that hunger was elevated later in the day due 
to the 3915 kJ (930 kcal) energy expenditure resulting from the run. However, the 
nine hour values for plasma acylated ghrelin concentration do not support the notion 
that hunger was elevated at the end of the exercise trial. In fact, acylated ghrelin 
concentrations at nine hours suggest that hunger was still suppressed on the exercise 
122 
trial compared with the control trial. This apparent contradiction reqUIres further 
study. 
The present study had several limitations. Firstly the participants were young and well 
trained and therefore the findings may not apply to older subjects or to untrained 
participants. Secondly the low sample size may have limited the power to detect 
significant relationships between acylated ghrelin and other variables. Thirdly, 
acylated ghrelin was measured at only six time points over the nine hour observation 
period. More frequent measurements of acylated ghrelin would provide a clearer 
picture of the responses to exercise and feeding. Finally, total ghrelin concentration 
was not measured, limiting our ability to determine the extent of variation between the 
responses of acylated ghrelin and total ghrelin to exercise and feeding. 
In conclusion, this study demonstrates that plasma acylated ghrelin concentration is 
reduced during an acute bout of treadmill running and this lends support for the role 
of acylated ghrelin in hunger suppression during and immediately after exercise. 
Further research is required to determine the influence of other modes, durations and 
intensities of exercise on plasma acylated ghrelin concentration and to documen( 
acylated ghrelin responses to exercise in different subject groups e.g. older, untrained 
and obese participants. Such research could have important implications regarding the 
role of exercise in weight management. 
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CHAPTER VI 
The effect of exercise intensity on plasma acylated ghrelin 
6.1 Introduction 
Several studies have investigated the influence of high intensity aerobic exercise bouts on 
plasma ghrelin concentration (Burns et ai, 2007; Dall et ai, 2002; Jiirimae et ai, 2007; 
Kallio et ai, 2001; Kraemer et ai, 2004a; Schmidt et ai, 2004; Vestergaard et ai, 2007). 
Most of these studies indicate that a single session of aerobic exercise has no influence on 
ghrelin concentrations (Burns et ai, 2007; Dall et ai, 2002; JUrimae et ai, 2007; Kallio et 
ai, 200 I; Kraemer et ai, 2004a; Schmidt et ai, 2004) although one study reported that 
serum ghrelin levels are suppressed for up to an hour after the cessation of exercise 
(Vestergaard et ai, 2007). In contrast, one study has reported that plasma ghrelin 
concentrations are increased during three hours of moderate intensity exercise but it is 
uncertain whether this is a true effect of exercise because this study did not include a 
control trial (Christ et ai, 2006). The study presented in the previous chapter found 
suppressed acylated ghrelin as a result of high intensity treadmill running but to the 
author's knowledge no study has reported the effects of low intensity exercise on ghrelin 
or acylated ghrelin. 
Chronic high intensity exercise suppressed food intake and associated weight gain in 
male rats more than low intensity exercise of the same expenditure (Katch et al, 1979). 
King et al (1994) found suppressed hunger was associated with high but not low intensity 
cycling. Thompson et al (1988) also inferred that exercise intensity is an important 
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variable mediating exercise effects on hunger as they found that hunger was briefly 
suppressed as a result of high intensity cycling compared to low intensity cycling and 
control. Causal mechanisms were not identified in the papers described but the results of 
the previous study (Chapter 5) suggest that acylated ghrelin is suppressed during and for 
a short period after a high intensity bout of treadmill running which coincides with 
suppressed hunger. An exercise induced effect on acylated ghrelin needs confirmation 
and there is a paucity data on how soon acylated ghrelin responds to an exercise stimulus. 
In the previous study the first blood sample was taken 30 minutes after the initiation of 
exercise so measurement of acylated ghrelin soon after exercise begins is warranted. 
Similar to Katch et al (1979), King et al (1994) and Thompson et al (1988) the author has 
also demonstrated that exercise intensity is a determinant of 'exercise induced anorexia' 
// 
as suppressed feelings of hunger were seen in the high but not the low intensity exercise 
trial in the study described in Chapter 4. However the energy expenditure in the high 
intensity exercise trial was much greater, so a true exercise intensity affect could not be 
., 
determined. Energy expenditure was therefore controlled for in the present study. 
To the author's knowledge, no study has examined the influence of exercise intensity on 
plasma acylated ghrelin or its response soon after the initiation of exercise. Therefore, the 
purpose of the present study was to determine if acylated ghrelin concentrations are 
suppressed ·during and following a low and high intensity bout of treadmill running 
keeping the energy expenditure constant. Since associations between suppressed acylated 
ghrelin and 'exercise induced anorexia' have been demonstrated previously it was 
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hypothesized that intense treadmill running would be associated with a greater reduced 
concentration of plasma acylated ghrelin compared with low intensity exercise and that 
exercise would cause a temporary suppression of hunger which would again be greater in 
the high intensity exercise trial. 
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6.2 Methods 
6.2.1 Participants 
Nine healthy males aged 20 to 25 years from the population at Loughborough University 
volunteered to participate in the study. Table 6.1 shows the physical characteristics of the 
participants. 
Table 6.1 Physical characteristics ofparticipants. 
Characteristic 
Age (yr) 
Height (m) 
Weight (kg) 
Sum of Skin folds (mm) 
BM! (kg·m·2) 
Body Fat (%) 
Waist Circumference (cm) 
VO, max (ml·kg··1min· l ) 
Values are mean ± SEM (n = 9) 
6.2.2 Study design 
(Mean + SEM) 
21.4± 0.6 
1.80 ± 0.02 
78.3 ± 3.2 
33.1 ± 1.7 
24.5 ± 0.7 
15.3 ± 0.8 
77.7 ± 1.7 
58.2 ± 1.6 
All experimental procedures were conducted in the Health and Paediatric Exercise 
Physiology Laboratory at Loughborough University. After being made aware of the 
protocol, health screened, then giving written consent to take part, anthropometric data 
was collected after which each participant undertook two preliminary exercise tests as 
follows: I) submaximal-incremental treadmill running test, 2) maximum oxygen uptake 
(VO, max) treadmill running test. There was a 20 to 30 minute rest interval between the 
exercise tests. 
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During subsequent weeks participants undertook three main trials (low intensity exercise, 
high intensity exercise and control) and these were performed in a randomized order with 
an interval of at least 7 days. 
The day before the first main trial participants were asked to record their weighed food 
intake using a food record diary. The same food intake was then consumed the day prior 
to the next remaining trials. Participants were also asked to refrain from any form of 
vigorous activity and ingesting caffeine or alcohol 24 hours prior to the main trials. 
Participants were fasted for a minimum 10 hours, but were allowed to drink water ad 
libitum. Participants attended the laboratory between the hours of 08:00 and 09:00 and 
were requested to use motorised transport where possible or ensure that activity prior to 
attending the laboratory was light. 
6.2.3 Main trials 
Participants were given at least one week to recover from the preliminary exercise tests 
before embarking on the main trials. Each main trial began in the morning and lasted for 
four hours. At the start of the low intensity exercise trial participants ran on the treadmill 
at a running speed predicted to elicit 50% of maximum oxygen uptake until a gross 
energy expenditure of 2510 kJ (600 kcal) was achieved. A 600 kcal energy expenditure 
was selected as analysis of results from previous studies showed that at this energy 
. expenditure participants would be running for around one hour in the low intensity 
exercise trial and for 0.5 hours in the high intensity exercise trials. At the start of the high 
intensity exercise trial participants ran on the treadmill at a running speed predicted to 
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elicit 75% of maximum oxygen uptake until a gross energy expenditure of 2510 kJ (600 
kcal) was achieved. 
One minute expired air samples were collected frequently during the runs. Running speed 
was adjusted after each expired air collection if the oxygen consumption was above or 
below the predicted value or if the participants expressed that they were experiencing 
difficulties. After the runs, participants rested until 4 hours (sitting reading, writing, 
working at a computer or watching television). For the control trial participants 
undertook exactly the same protocol but rested throughout. Participants were not devoid 
of time cues during the trials and a clock was on display in the laboratory throughout the 
trials. 
Figure 6.1 shows a schematic representation of the study protocol. 
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Figure 6.1 Schematic representation of the main trial protocol 
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6.2.4 Subjective measurement o"f hunger 
On arrival, participants completed an RPH scale compiled by Burns et al (2007) which 
ranged from 0 'Not Hungry' to 15 'Very Hungry'. Hunger measurements were recorded 
at baseline, 0.5, 1, 1.5,2,2.5,3 3.5, and 4 hours. 
6.2.5 Test meal 
Participants were fed a 4186 kJ (1000 kcal) test meal three hours from baseline 
measurements for all trials. The meal consisted of95g of white bread, 90g of tuna, 15g of 
mayounaise, 52g of chocolate bar, 2Sg of potato crisps, 80g of green apple and lOOg of 
orange juice based on a 70 kg person. The macronutrient content was 56% carbohydrate 
(l49g), 15% protein (37g) and 29% fat (33g). The amount of each food stuff was 
adjusted for each participant based on their bodyweight on the day .of first trial and 
identical amounts were consumed on the remaining trials. Participants were encouraged 
to consume the meal within 15 minutes and kept to the same start and finish times on 
both trials. Water was available ad libitum during trials and the volume and time of 
ingestion were recorded. 
6.2.6 Environmental temperature and humidity 
Environmental temperature and humidity were monitored during the main trials using a 
hand-held hygrometer (Omega RH85, Manchester, U.K.). 
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6.2.7 Blood sampling 
Prior to the start of each trial participants rested in a semi-supine position while a cannula 
was inserted into an antecubital vein. Venous blood samples were subsequently collected 
into pre-cooled 4.9 mL EDTA monovettes at baseline, 0.5, I, \.5,2, 3, 3.5 and 4 hours. 
During the exercise trials, if the participants were still running and a blood sample was 
due to be taken, blood was collected while the participants straddled the treadmill, which 
took approximately I minute. All other blood samples were collected whilst subjects lay 
in a semi-supine position. The EDTA monovettes were spun at 1681 g for to minutes in a 
refrigerated centrifuge at 4°C. The plasma supernatant was then aliquoted into Eppendorf 
tubes. These were stored at -20°C for analysis of glucose and insulin later. 
Separate venous blood samples were drawn into 4.9 mL monovettes at baseline, 5 
minutes, 0.5, I, 3, 3.5 and 4 hours for the determination of plasma acylated ghrelin 
concentration. These monovettes contained EDTA and p-hydroxymercuribenzoic acid 
(PHMB) to prevent the degradation of acylated ghrelin by protease. The monovettes were 
spun at 1287 g for 10 minutes in a refrigerated centrifuge at 4°C. The supernatants were 
then aliquoted into storage tubes and 100 ilL of I M hydrochloric acid (HCL) was added 
per mL of plasma. Samples were then spun at 1287 g for 5 minutes in a refrigerated 
centrifuge at 4°C before being transferred into Eppendorf tubes. The samples were then 
stored at -20°C for analysis later. 
At each blood sampling point, duplicate 20 ilL blood samples were collected into 
micropipettes for the measurement of haemoglobin concentration and triplicate blood 
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samples were collected into heparinised micro haematocrit tubes for the determination of 
haematocrit. 
6.2.8 Blood biochemistry 
Plasma acylated gbrelin concentrations were determined by enzyme immunoassay. 
Plasma glucose concentrations were determined by enzymatic, colorimetric methods. 
Plasma insulin concentrations were determined by radioinununoassay. To eliminate inter-
assay variation, samples from each participant were analyzed in the same run. The within 
batch coefficients of variation for the assays were as follows: acylated ghrelin 7.0%, 
insulin 8.9% and glucose 1.4%. 
6.2.9 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Science (SPSS) software 
version 12.0 for Windows (SPSS Inc, Chicago, IL, V.S.). Plasma acylated gbrelin, 
glucose and insulin area under the concentration versus time curves were calculated using 
the trapezoidal rule. One-way ANOV A was used to assess differences in baseline hunger, 
acylated gbrelin, weight and fluid intake for the three trials. Repeated measures ANOVA 
was performed to determine the differences between the effects of trial (high intensity 
versus low intensity versus control) and time (0, 0.5, I, 1.5,2,3, 3.5 and 4 hours) for 
hunger, acylated gbrelin, glucose, insulin, temperature and humidity and to assess 
whether there was any interaction effect (trial x time). The data for the RPH is discrete, 
but repeated measures ANOV A was used because there is no non-parametric equivalent. 
Post-hoc pair wise comparisons were performed using the Bonferroni method. The 
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Pearson product moment correlation coefficient was used to examine relationships 
between variables. Statistical significance was accepted at the 5% level. Adjustment of 
values for changes in plasma volume did not alter the statistical findings and hence for 
simplicity the unadjusted values are reported. Results are given as mean ± SEM unless 
otherwise stated. 
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6.3 Results 
6.3.1 Responses to treadmill running 
Table 6.2 shows the responses to treadmill running. 
Table 6.2 Responses to treadmill running. 
Exercise Trial 
Low Intensity High Intensity 
Mean Percentage V0 2 max 52 ± 1.0 75 ± 1.0 
(%) 
Mean respiratory exchange 
ratio 
Gross energy expenditure 
(kJ) 
Gross energy expenditure 
(kcal) 
Percentage energy 
contribution from fat (%) 
Percentage energy 
contribution from 
carbohydrate (%) 
Duration of the run 
(minutes) 
Average heart rate 
(b'min- I ) 
Median RPE 
0.90 ± 0.01 
2580± 51 
617 ± 12 
32 ±3 
68 ± 3 
55 ± 2 
136 ± 5 
12 
0.96 ± 0.01 
2504 ± 55 
599 ± 13 
11 ± 3 
89 ±3 
36 ±2 
164 ± 6 
14 
'fairly light' (range 11-12) 'fairly hard' (range 13-14). 
Values are mean ± SEM (n = 9) 
There was no significant difference in gross energy expenditure between the two trials (P 
= 0.376). 
6.3.2 Body mass and fluid consumption 
Two-factor ANOVA revealed changes in body weight were not significant. On the 
control trial body mass was 78.8 ± 3.4 kg at the start of the trial and 79.2 ± 3.6 kg at the 
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end of the trial. On the low intensity exercise trial body mass was 78.8 ± 4.1 kg at the 
start of the trial and 78.4 ± 4.0 kg at the end of the trial. On the high intensity exercise 
trial body mass was 78.9 ± 3.6 kg at the start of the trial and 78.9 ± 3.7 kg at the end of 
the trial. Water consumption was higher during the exercise triais compared with control 
(One-factor ANOVA, P = 0.012). When performing the Bonferroni method differences 
lay between the control (610 ± 104 mL) and high intensity exercise trial (883 ±103 mL). 
6.3.3 Temperature and humidity 
There was no significant difference in environmental temperature between the control, 
low intensity and high intensity exercise trials (22.7 ± 0.1 versus 22.7 ± 0.3 versus 22.6 ± 
0.2 QC respectively). However there was a significant trial x time interaction, with 
humidity between the control, low intensity and high intensity exercise trials (30.7 ± 1.7 
versus 34.0 ± 1.8 versus 35.3 ± 1.1 % respectively). However post hoc analysis indicated 
no significant between trial differences after adjusting for multiple comparisons using the 
Bonferroni method. 
6.3.4 Hunger 
There was a significant effect of time (P < 0.0005) but no trial (P = 0.742) or trial x time 
interaction (P = 0.239) for hunger (Figure 6.2). This indicates that exercise did not 
stimulate' exercise induced anorexia. ' 
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Subj ective feelings of hunger using the RPH scale during the low 
intensity, high intensity and control trials. Values are mean ± SEM, n = 9. 
The checked rectangle indicates the low intensity treadmill run. The 
diagonal patterned rectangle indicates the high intensity treadmill run. The 
black rectangle indicates consumption of the test meal. 
Between trial differences in hunger ratings were also evaluated using AUC values for the 
first hour of the trial (0 to 1 hours), the three hours prior to the meal (0 to 3 hours), and 
the full 4 hours. One-factor ANOV A confirmed no difference between the control, low 
and high intensity exercise trials for the first hour: 7 versus 6 versus 6 (mean values) 
respectively (P = 0.276). The difference between AUC values for the three hours prior to 
the meal and full four hours were also not significant. 
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6.3.5 Acylated ghrelin 
One of the participants displayed exceptionally high acylated values throughout the trials 
ranging from 74 to 1489 pg·mL-1• The participants values were deemed to be an outlier 
and distorted the statistical findings so were removed from the data analysis. 
Fasting plasma acylated ghrelin concentrations did not differ (P = 0.473) between the 
control, low and high intensity exercise trials (67.2 ± 10.5 versus 67.7 ± 8.6 versus 78.9 ± 
14.0 pg·mL-1 respectively). Two-factor ANOVA revealed no effect of trial (P = 0.747), 
but a main effect of time (P < 0.0005) and a trial x time interaction (P = 0.024) for 
acylated ghrelin concentrations. At 0.5 hours plasma acylated ghrelin was lower on the 
high intensity exercise trial compared with the low intensity and control trials: 42.7 ± 
11.2 versus 59.3 ± 9.5 versus 63.2 ± 9.7 pg·mL- 1 (Figure 6.3). Post hoc analysis indicated 
this was approaching significance (P = 0.065). 
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Between trial differences for acylated ghrelin were also evaluated using AUC values for 
the first hour of the trial (0 to I hours), the three hours prior to the meal (0 to 3 hours), 
and the full 4 hours. One-factor ANOV A confirmed no difference between the control, 
low and high intensity exercise trials for the first hour: 66.3 ± 9.7 versus 61.3 ± 9.4 
versus 54.7 ± 11.5 pg'mL-1'1 hour respectively (P = 0.559). The difference between AUC 
values for the three hours prior to the meal and full fours hours were also not significant 
(Figure 6.4). 
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Figure 6.4 Total area under the concentration versus time curve (AUC) for plasma 
acylated ghrelin (mean ± SEM, n = 9). Values are for the first hour of the 
trial (pg'mL-\'1 hours), first three hours of the trial (pg'mL-\'3 hours) and 
for the full four hours of the trial (pg·mL-\·4 hours). 
Fasting plasma acylated ghrelin concentrations were not significantly correlated with 
BMI, body mass, waist circumference, maximum oxygen uptake, fasting hunger, fasting 
plasma insulin concentrations or fasting plasma glucose. concentrations. 
6.3.6 Glucose 
Fasting plasma glucose concentrations did not differ significantly (P = 0.451) between 
control, low and high intensity exercise trials (5.3 ± 0.2 versus 5.5 ± 0.2 versus 5.6 ± 0.4 
mmol'L-\ respectively). Two-factor ANOVA revealed a main effect of trial (p = 0.045), a 
main effect of time (P < 0.0005) but no trial x time interaction (P = 0.181) for plasma 
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glucose (Figure 6.5). Post hoc analysis identified trial differences were between the high 
intensity and low intensity exercise trial (P = 0.023). 
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Total area under the concentration versus time curve for plasma glucose confirmed that 
values were higher during the high intensity exercise trial compared with the low 
intensity exercise and control trials (22.1 ± 0.7 versus 20.9 ± 0.7 versus 20.9 ± 0.7 
mmol'L,I A hours respectively, P = 0.05) for the 4 hours of the trial. Post hoc analysis 
showed that differences were between the low and high intensity exercise trials (P = 
0.004). 
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6.3.7 Insulin 
Fasting plasma insulin concentrations did not differ significantly (P = 0.218) between 
control, low and high intensity exercise trials (144.3 ± 18.0 versus 188.6 ± 23.7 versus 
. 174.8 ± 17.2 pmol'L-1 respectively). Two-factor ANOV A revealed a main effect of time 
(P < 0.0005) but no effect of trial (P = 0.998) and no trial x time interaction (P = 0.559) 
for plasma insulin (Figure 6.6). 
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Between trial differences for insulin were also evaluated using AUC values for the first 
hour of the trial (0 to 1 hours), the 3 hours prior to the meal (0 to 3 hours), and the full 4 
hours. One-factor ANOV A confirmed no difference between the control, low and high 
intensity exercise trials for the first hour: 159.7 ± 16.0 versus 135.5 ± 12.0 versus 203.7 ± 
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38.0 pmol-L-1'1 hours respectively (P = 0.279). The difference between AUC values for 
the 3 hours prior to the meal and full 4 hours were also not significant. 
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6.4 Discussion 
To the author's knowledge, the present study is the fIrst to examine the transient effect of 
exercise intensity on plasma acylated ghrelin concentrations during exercise. The novel 
fInding arising from this study is that there is a suppression of plasma acylated ghrelin 
during high but not low intensity running. 
At 0.5 hours plasma acylated ghrelin was lower on the high intensity exercise trial 
compared with the low intensity and control trials (42.7 ± 11.2 versus 59.3 ± 9.5 versus 
63.2 ± 9.7 pg·mL·! P = 0.065). The fIndings therefore confIrm those of chapter 5 that 
acylated ghrelin is suppressed in response to high intensity treadmill running. The 
fIndings also show that exercise intensity is a determinant of the acylated ghrelin 
response to exercise as there was no signifIcant suppression of acylated ghrelin during the 
low intensity exercise trial even when the energy expenditure was kept constant. 
To keep the energy expenditure matched the durations differed so that participants were 
running for 55 ± 2 minutes during the low intensity trial and for 36 ± 2 minutes for the 
high intensity exercise trial and the statistical fmdings show no signifIcant suppression of 
acylated ghrelin during the low intensity trial. It is possible that acylated ghrelin is not 
suppressed during low intensity exercise compared with high intensity exercise due to a 
lower rate of energy expenditure, less gut upheaval and no signifIcant increase in plasma 
glucose that was demonstrated in the high intensity trial. 
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A plasma acylated ghrelin measurement was taken at 5 minutes to examine if acylated 
ghrelin would respond to an exercise stimulus within this time. Although there is a trend 
for a decline in both the low and high intensity exercise trials (Figure 6.3) this was not 
significant. No previous study has measured acylated ghrelin so soon after the initiation 
of exercise so the findings need confinnation. However, the author felt that in subsequent 
studies acylated ghrelin should be measured at other time points due to the restricted 
number of plasma acylated ghrelin samples that can be assayed. 
Acylated ghrelin values reported are similar to that reported in chapter 5 apart from one 
of the participants whose acylated ghrelin data was removed from the analysis due to 
extremely high values. His fasting acylated ghrelin concentration during the control trial 
was 584 pg°mL'! which is not a result of measurement error as values were high 
throughout all trials. Atypically high acylated ghrelin values have been reported 
previously in Chapter 2. The reasons for this are unclear but it is interesting to note that 
both participants were dual heritage and/or ethnic minority. High total ghrelin values 
have been reported previously (Peeters et ai, 2005) but to the author's knowledge no 
study has previously reported atypically high acylated ghrelin values or given reasons for 
high ghrelin values per se in lean participants without genetic defects. 
In addition to the decline in acylated ghrelin concentrations during exercise, acylated 
ghrelin concentrations declined after feeding. This is consistent with data from studies 
examining the response to meals of both acylated plasma ghrelin (AI Alwar et ai, 2005; 
Hosoda et ai, 2004; Lucidi et ai, 2004) and total plasma ghrelin (Blom et ai, 2005; 
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Cummings et ai, 2002, Lucidi et ai, 2004) and the study presented in chapter 5. The 
present study measured acylated ghrelin 30 minutes after the initiation of feeding and 
found a 12% suppression in the control trial, a 7% suppression in the low intensity trial 
and 2% reduction in the high intensity trial. The study described in Chapter 5 used a high 
fat test meal fed at 3 hours in which the macronutrient content was (38% CHO, 10% 
protein and 52% fat) providing 4201 kJ (1004 kcal) based on a 70 kg person. This led to a 
30% decline in plasma acylated ghrelin concentration I hour after the meal in the control 
trial and a 27% decline in the exercise trial. In the present study a mixed meal was fed at 
3 hours in which the macronutrient content was 56% CHO, 15% protein and 29% fat 
providing 4186 kJ (1000 kcal) based on a 70 kg person. This led to a 44% decline in 
plasma acylated ghrelin concentration 1 hour after the meal in the control trial, a 42% 
decline in the low intensity exercise trial and a 39% decline in the high intensity exercise 
trial. Whilst analysis of acylated ghrelin's feeding response to varying meal composition 
in two different participant groups is highly speculative, meal composition could affect 
the suppression of acylated ghrelin which has been shown by Al Awar et al (2005) who 
found that a mixed meal led to a greater acylated ghrelin suppression than an iso-
energetic high fat meal. 
Another key finding from the present study was the failure of the exercise stimulus to 
suppress hunger during and following both high and low intensity treadmill running. This 
is consistent with results from previous studies thaf have monitored subjective hunger 
ratings (King et ai, 1996a; Pomerleau et al 2004), but contradicts other work where the 
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high intensity exercise bout was above 60% of maximum oxygen uptake (Blundell et ai, 
2003; King and Blundell, 1995; King et ai, 1994, Thompson et ai, 1988). 
Thompson et al (1988) assigned 16 males aged 19 to 29 years to undertake low intensity 
cycling at 35% VO, max, high intensity cycling at 68% VO, max and a resting control 
matching the energy expenditure at 4.1 kcal'kg- I bodyweight. The mean body weight of 
participants was 75.9 kg so the predicted energy expenditure for each trial was 311 kcal 
and participants were cycling for a mean of 57.5 minutes for the low intensity exercise 
trial and a mean of 28.7 minutes for the high intensity exercise trial. There was a brief 
suppression of hunger immediately after high but not low intensity exercise or control. 
The duration of exercise is similar to that undertaken in the present study, but the energy 
expenditure is nearly half. It is therefore surprising that the high intensity exercise trial in 
the present study did not suppress hunger considering participant characteristics are also 
similar. 
King et al (1994) also examined the effect of exercise intensity keeping the total energy 
expenditure constant in twelve lean males aged 21-27 years. In the high intensity exercise 
trial participants cycled at 70% VO, max for a mean time of 27 minutes with a mean 
energy expenditure of 340 kcal. For the low intensity exercise trial participants cycled at 
30% VO, max for a mean time of 63 minutes with a mean energy expenditure of 340 kcal. 
A resting control was also undertaken where participants rested througliout. Similar to 
. Thompson et al (1988) low intensity exercise did not produce any suppression of hunger 
either during or after the exercise session whereas high intensity exercise did. These 
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findings contradict those of the present study despite the exercise intensity being similar. 
However the exercise challenge was greater in the present study due to a larger energy 
expenditure and considering that cycling is weight supported it is posited that there was 
greater gastro intestinal upheaval during treadmill running. 
The fmding of no 'exercise induced anorexia' during high intensity rurmmg was 
unexpected considering that acylated ghrelin was suppressed in the high intensity 
exercise trial which contradicts the association found between the suppression of acylated 
ghrelin and 'exercise induced anorexia' seen in chapter 5. Participants undertaking high 
intensity treadmill rurming in the study described in chapter 5 and in the present study 
were still running at 0.5 hours and the exercise intensity was similar (74.0 ± 1.5 % 
VO,max present study versus 71.9 ± 2.1 % VO,max Chapter 5). In the present study, 
from baseline to 0.5 hours there was a mean decline of plasma acylated ghrelin 
concentration of 42% yet in chapter 5 the decline was only 30% which was temporarily 
associated with 'exercise induced anorexia.' Baseline hunger values reported in chapter 5 
were higher than that in the present study and may have therefore been more susceptible 
to change. An exercise intensity and energy expenditure threshold for acylated ghrelin 
cannot be stated with confidence at this time as more work is needed. 
The mechanism by which exercise suppresses acylated ghrelin concentration is uncertain. 
Growth hormone is secreted at increased exercise intensities and its releasing peptides 
GHRH are associated with changes in acylated ghrelin (Borer, 2003). It is impossible to 
ascertain links between changes in acylated ghrelin and GH in the present study as GH 
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was not measured. Future studies should therefore consider the measurement of GH but 
this is not feasible with the remaining studies ofthis thesis due to the cost implications. 
The finding of a significant increase in plasma glucose during the high intensity treadmill 
running confirms the findings described in chapter 5 and since there was no significant 
increase in plasma glucose during low intensity exercise and no suppression of acylated 
ghrelin the exercise induced increase in glucose during high intensity treadmill running 
could be a mechanism for acylated ghrelin suppression during exercise. However figure 
6.5 shows that post feeding there were similar increases in glucose which coincided with 
similar suppressions of acylated ghrelin (Figure 6.3) in all three trials. Therefore the 
mechanism by which exercise influences the relationship between glucose and ghrelin 
may differ from the mechanism by which feeding alters the relationship between glucose 
and ghrelin. The finding of no significant difference in plasma insulin concentration 
between the trials confirms the findings of the study described in chapter 5 and therefore 
changes in insulin cannot be responsible for the exercise induced changes to acylated 
ghrelin. 
In conclusion, this study demonstrates that plasma acylated ghrelin concentration IS 
reduced during an acute bout of high intensity but not low intensity treadmill running. 
Exercise intensity is therefore a key determinant of the acylated ghrelin response to 
exercise. Trends show that acylated ghrelin responds within 5 minutes to an exercise 
stimulus but this needs confirmation. Increases in glucose concentration during high 
intensity treadmill running is temporarily associated with a decline in acylated ghrelin but 
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the mechanism by which exercise alters acylated ghrelin may differ from that by which 
feeding alters acylated ghrelin as similar increases in glucose were seen in all three trials 
post feeding. Findings of no 'exercise induced anorexia' were surprising and contradict 
previous findings of previous studies presented in this thesis. 
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CHAPTERVll 
The effect of exercise duration on acylated ghrelin 
7.1 Introduction 
The fmdings of the studies presented in this thesis so far indicate that acylated ghrelin 
is suppressed during high intensity treadmill running (Chapters 5 and 6) and exercise 
intensity is a determinant as no suppression was seen in a low intensity exercise trial 
(Chapter 6). The author has also demonstrated that exercise intensity is a determinant 
of 'exercise induced anorexia' as suppressed feelings of hunger were seen in a high 
but not a low intensity exercise trial (Chapter 4) and high intensity trial compared 
with control (Chapter 5). However no 'exercise induced anorexia' was seen in either 
high or low intensity exercise trials (Chapter 6) which was surprising since there was 
a suppression of acylated ghrelin in the high intensity exercise trial and associations 
between the suppression of acylated ghrelin and 'exercise induced anorexia' have 
been shown previously (Chapter 5). It was posited that despite a suppression of 
acylated ghrelin sUbjective feelings of hunger were not suppressed post exercise as the 
energy expenditure was only 600 kcal since the duration of the high intensity exercise 
was only short. 
The effect of exercise duration on 'exercise induced anorexia' has been examined 
previously. King et al (1994) recruited twelve participants who undertook two high 
intensity cycling bouts of short duration (mean time 25.9 minutes; mean 77% 
V0 2 m.x), long duration (mean time 51.8 minutes; mean 74% V0 2 mu) and a resting 
control. Compared with control hunger was suppressed during both the short and long 
duration exercise sessions and remained suppressed immediately post exercise but 
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returned to baseline values after 10 minutes. As expected the hunger suppression was 
greatest after the long duration exercise session showing that exercise duration is a 
determinant of the extent of 'exercise induced anorexia'. Potential changes to 
hormones and metabolites could not be identified since blood samples were not taken 
so these responses need to be examined. 
Despite numerous studies examining the exercise response to ghrelin (Bums et aI, 
2007; Dall et aI, 2002; Jiirimae et aI, 2007; Kallio et aI, 2001; Kraemer et aI, 2004; 
Schmidt et aI, 2004; Vestergaard et aI, 2007) and accumulating evidence of the 
plasma acylated ghrelin response to exercise as a result of the work presented in this 
thesis, to the author's knowledge no study has examined the effect of exercise 
duration on plasma acylated ghrelin whilst keeping the exercise intensity constant. As 
suppressions of acylated ghrelin had been shown previously with high intensity 
exercise (Chapter 5 and Chapter 6) the intensity of the exercise would be kept high in 
the present study. In both Chapters 5 and 6 a target exercise intensity of75% V0 2 max 
was set so it was decided that a target exercise intensity of 70% V0 2 max would be set 
in the present study to examine if a lowering of the exercise challenge would result in 
a different acylated ghrelin response. In chapters 5 participants ran for 60 minutes and 
a mean time of 36 minutes in the high intensity trial in chapter 6, so short duration 
exercise was set at 45 minutes and long duration exercise was set at 90 minutes. 
It had been drawn to the author's attention that chan~es in self reported ,E.unger ratings 
. . 
may not reflect a decrease oI-increase-in~ger because other factors affecting 
~'-
hunger sensations such as feelings of nausea which have been found after long 
duration vigorous exercise (Halvorsen and Ritland, 1992) may influence responses. 
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To confirm if any feelings of-nausea were influencing subjective feelings of hunger a 
nausea V AS was compiled and implemented. 
The findings presented in this thesis suggest a threshold of exercise intensity, duration 
and energy expenditure which when reached, exercise will stimulate changes in gut 
peptide hormones which could influence subjective feelings of hunger. Evidence is 
accumulating on the effects of exercise intensity and energy expenditure on acylated 
ghrelin but to the author's knowledge, no study has examined the influence of 
exercise duration on plasma acylated ghrelin. Therefore, the purpose of the present 
study was to determine if acylated ghrelin concentrations are suppressed during and 
following a short and long duration bout of high intensity treadmill running. It was 
hypothesized that the longer duration treadmill running would be associated with a 
greater reduced concentration of plasma acylated ghrelin compared with the short 
duration exercise and that exercise would cause a temporary suppression of hunger 
which would again be greater in the long duration trial. The inclusion of a na~sea 
VAS would confirm if feelings of sickness confound any suppressions of hunger seen 
during exercise. 
\ 
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7.2 Methods 
7.2.1 Participants 
Nine healthy males aged 20 to 28 years from the population at Loughborough 
University volunteered to participate in the study. Table 7.1 shows the physical 
characteristics of participants. 
Table 7.1 Physical characteristics of participants. 
Characteristic 
Age (yr) 
Height (m) 
Weight (kg) 
Sum of Skinfolds (mm) 
BMI (kg·m·2) 
Body Fat (%) 
Waist Circumference (cm) 
V0 2 max (mL·kg··[min·[) 
Values are mean ± SEM (n = 9) 
7.2.2 Study design 
(Mean± SEM) 
23.2 ± 0.7 
1.78 ± 0.01 
72.0 ± 1.6 
26.1 ± 1.3 
22.8 ± 0.4 
12.0 ± 0.7 
76.7 ± 0.6 
63.4 ± 1.7 
All experimental procedures were conducted in the Health and Paediatric Exercise 
Physiology Laboratory at Loughborough University. After being made aware of the 
protocol, health screened, then giving written consent to take part, anthropometric 
data was collected after which each participant undertook two preliminary exercise 
tests as follows: I) submaximal-incremental treadmill running test, 2) maximum 
oxygen uptake (V0 2 m.x) treadmill running test. There was a 20 to 30 minute rest 
interval between the exercise tests. 
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During subsequent weeks participants undertook three main trials (short duration 
exercise, long duration exercise and control) and these were performed in a 
randomized order with an interval of at least 7 days. 
For two days before the first mam trial participants were asked to record their 
weighed food intake using a food record diary. The same food intake was then 
consumed for the two days prior to the next remaining trials. Participants were also 
asked to refrain from any form of vigorous activity and ingesting caffeine or alcohol 
24 hours prior to the main trial. Participants were fasted for a minimum 10 hours, but 
were allowed to drink water ad libitum. Participants attended the laboratory between 
the hours of 08:00 and 09:00 and were requested to use motorised transpoli where 
possible or ensure that activity prior to attending the laboratory was light. 
7.2.3 Main trials 
Participants were given at least one week to recover from the preliminary exercise 
tests before embarking on the main trials. Each main trial began in the morning and 
lasted for 9 hours. At the start of the short duration exercise trial participants ran on 
the treadmill at a running speed predicted to elicit 70% of maximum oxygen uptake 
for 45 minutes. After the run, participants rested for 8.25 hours (sitting reading, 
writing, working at a computer or watching television). At the start of the long 
duration exercise trial participants ran on the treadmill at a running speed predicted to 
elicit 70% of maximum oxygen uptake for 90 minutes. After the run, participants 
rested for 7.5 hours (sitting reading, \\'Titing, working at a computer or watching 
television). For the control trial participants undertook exactly the same protocol but 
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rested throughout (9 hours). Participants were not devoid of time cues during the trials 
and a clock was on display in the laboratory throughout the trials. 
One minute expired air samples were collected frequently during the runs. Running 
speed was adjusted after each expired air collection if the oxygen consumption was 
above or below the predicted value or' if the subject expressed that they were 
experiencing difficulties. 
Figure 7.1 shows a schematic representation of the study protocol. 
159 
Figure 7.1 Schematic representation of the main trial protocol 
- ,--
Exercise 70% M M 
V02max for 45 min, E E 
90 min or rest A A 
L L 
I I I I I I I 
Baseline 2 3 4 5 6 7 R 9 
I I i i i Time (h) i i i 
i i i i i r T i i i i i i 
tttttt 
l' i i i i i i i i i i i i i i i i i i i I 
Key: . 
er Acylated Ghrelin, Insulin haematoclit and haemoglobin i Visual Analogue Scales, Temperature and Humidity 
I' Glucose t Samples of Expired Air 
157 
7.2.4 Subjective measurement of hunger and nausea 
On arrival, participants completed an RPH scale compiled by Bums et al (2007) 
which ranged from 0 'Not Hungry' to 15 'Very Hungry'. Hunger measurements were 
recorded at baseline, 0.5, 0.75, 1, 1.5,2,2.5,3 3.5,4,4.5,5,5.5,6,6.5,7,7.5,8,8.5 
and 9 hours. At the same sampling points participants also completed a nausea V AS 
by placing a vertical mark on a 10 cm horizontal line ranging from 0 'Not at all 
nauseous' to 100 'Very nauseous.' 
7.2.5 Test meal 
Participants were fed two 3230 kJ (772 kcal) test meals at 2 and 6 hours from baseline' 
measurements for all trials. Each meal consisted of 77g of white bread, 33g of 
cheddar cheese, 12g of mayonnaise, 12g butter, 30g of potato crisps, 7g of milks hake 
powder and 150g of whole milk based on a 70 kg person. The macronutrient content 
was 33% carbohydrate, 11% protein and 56% fat. The amount of each food stuff was 
adjusted for each participant based on their bodyweight on the day of first trial and 
identical amounts were consumed on the remainiog trials. Participants were 
encouraged to consume the meal within 15 minutes and kept to the same start and 
fmish times on both trials. Water was available ad libitum during trials and the 
volume and time of ingestion were recorded. 
7.2.6 Environmental temperature and humidity 
Environmental temperature and humidity were monitored during the main trials using 
a hand-held hygrometer (Omega RH85, Manchester, U.K.). 
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7.2.7 Blood sampling 
Prior to the start of each trial participants rested in a semi-supine position while a 
cannula was inserted into an antecubital vein. Venous blood samples were 
subsequently collected into pre-cooled 9 mL EDTA monovettes at baseline, 0.75, 1.5, 
2, 2.5, 3, 4, 5, 6, 6.5, 7, 8 and 9 hours. During the exercise trials, when participants 
were still running and a blood sample was due to be taken, blood was collected while 
the participants straddled the treadmill, which took approximately 1 minute. All other 
blood samples were collected whilst participants lay in a semi-supine position. The 
EDTA monovettes were spun at 4000 revs.min·! (1681 g) for 10 minutes in a 
refrigerated centrifuge at 4°C. The plasma supernatant was then aliquoted into 
Eppendorf tubes. These were stored at _80°C for analysis of glucose and insulin later. 
Separate venous blood samples were drawn into 4.9 mL monovettes at baseline, 0.75, 
1.5, 2, 3, 6, 7 and 9 hours for the determination of plasma acylated ghrelin 
concentration. These monovettes contained EDTA and p-hydroxymercuribenzoic acid 
(PHMB) to prevent the degradation of acylated ghrelin by protease. The monovettes 
were spun at 3500 revs.min·! (1287 g) for 10 minutes in a refrigerated centrifuge at 
4°C. The supernatants were then aliquoted into storage tubes and 100 fLL of 1 M 
hydrochloric acid (HCL) was added per mL of plasma. Samples were then spun at 
3500 revs.min·! (1287 g) for 5 min in a refrigerated centrifuge at 4°C before being 
transferred into Eppendorf tubes. The samples were then stored at -80°C for analysis 
later. 
At each acylated ghrelin blood sampling point, duplicate 20 fLL blood samples were 
collected into micropipettes for the measurement of haemoglobin concentration and 
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triplicate blood samples were collected into heparinised micro haematocrit tubes for 
the determination of haematocrit. 
7.2.8 Blood biochemistry 
Plasma acylated ghrelin concentrations were determined by enzyme immunoassay. 
Plasma glucose concentrations were determined· by enzymatic, colorimetric methods. 
Plasma insulin concentrations were determined by enzyme immunoassay. To 
eliminate inter-assay variation, samples from each participant were analyzed in the 
same run. The within batch coefficients of variation for the assays were as follows: 
acylated ghrelin 2.2%, insulin 4.73% and glucose 0.6%. 
7.2.9 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Science (SPSS) 
software version 12.0 for Windows (SPSS lnc, Chicago, lL, U.S.). Plasma acylated 
ghrelin, glucose and insulin area under the concentration versus time curves were 
calculated using the trapezoidal rule. One-factor ANOVA was used to assess 
differences in baseline hunger, nausea, acylated ghrelin, weight and fluid intake for 
the three trials. Repeated measures, two-factor ANOVA was used to examine 
differences between the three trials over time for acylated ghrelin, glucose, insulin, 
hunger, body mass and plasma volume change. Post-hoc pair wise comparisons were 
performed using the Bonferroni method. The Pearson product moment correlation 
coefficient was used to examine relationships between variables. Statistical 
significance was accepted at the 5% level. There was no statistically significant 
change in plasma volume and hence for simplicity the unadjusted values are reported. 
Results are given as mean ± SEM unless otherwise stated. 
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7.3 Results 
7.3.1 Responses to treadmill running 
Table 7.2 shows the responses to treadmill running. 
Table 7.2 Responses to treadmill running. 
Exercise Trial 
Short Duration Long Duration 
Mean Percentage \TO 2 max 
(%) 
Mean respiratory exchange 
ratio 
Gross energy expenditure 
(kJ) 
Gross energy expenditure 
(kcal) 
Percentage energy 
contribution from fat (%) 
Percentage energy 
contribution from 
carbohydrate (%) 
Average heart rate 
(b'min- I ) 
Median RPE 
70.1 ± 0.7 69.7 ± 0.7 
0.93 ± 0.02 0.89 ± 0.04 
2918 ± 110 5949±2l8 
697 ± 26 1422 ± 52 
24± 3 33±9 
76 ± 3 67±9 
169 ±4 169 ± 4 
13 14 
'fairly hard' (range 13-14) 'fairly hard' (range 13-14). 
Values are mean ± SEM (n = 9) 
There was no significant difference in exercise intensity between the two trials (P = 
0.630). 
7.3.2 Body mass and fluid consumption 
Two-factor ANOV A revealed changes in body weight which were not significant. On 
the control trial body mass was 71.9 ± 1.7 kg at the start of the trial and 72.2 ± 1.7 kg 
at the end of the trial. On the short duration exercise trial body mass was 72.0 ± 1.8 kg 
at the start of the trial and 72.0 ± 1.2 kg at the end of the trial. On the long duration 
exercise trial body mass was 72.0 ± 1.7 kg at the start of the trial and 71.7 ± 1.8 kg at 
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the end of the trial. There was a trend (One-factor ANOVA, P = 0.001) for water 
consumption to be higher during the exercise trials compared with control. \¥hen 
performing the Bonferroni method differences lie between the control (1433 ± 237 
mL) and long duration exercise trial (2348 ± 315 mL) (P = 0.001) as well as the long 
duration exercise trial and short duration exercise trial (1532 ± ~40 mL) (P = 0.048). 
7.3.3 Temperature and humidity 
There was no significant difference III environmental temperature between the 
control, short duration and long duration exercise trials (23.9 ± 0.3 versus 23.7 ± 0.3 
versus 24.4 ± 0.5 °C respectively). Likewise there was no significant difference in 
humidity between the control, short duration and long duration exercise trials (42.3 ± 
1.6 versus 40.3 ± 0.9 versus 39.1 ± 1.9 % respectively). 
7.3.4 Hunger 
Fasting hunger did not differ (P = 0.943) between the control, short and long duration 
exercise trials (7 ± 1 versus 7 ± 1 versus 7 ± 1 mean values respectively). Two-factor 
ANOVA revealed a main effect of trial (P = 0.039), time (P < 0.0005) and a trial x 
time interaction effect (P < 0.0005) for hunger indicating that responses differed over 
time between the exercise and control trials. Post hoc analysis indicated between trial 
differences between the control and short duration trial (P = 0.003). Post hoc analysis 
indicated between trial differences between control and short duration at 0.5, 0.75, 1, 
1.5, and 2 hours (Figure 7.2). There were further between trial differences between 
the control and long duration exercise trial at 0.5, 0.75, 1, 1.5 and 2 hours (Figure 
7.2). At 2 hours the difference between short duration arid long duration exercise was 
approaching significance (P = 0.052). 
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-+-Control 
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-0-- Short Duration 
--.r.-- Long Duration 
2 3 4 5 6 7 8 9 
Time (Hours) 
Subjective feelings of hunger using the RPH scale during the short 
duration, long duration exercise and control trials. Values are mean ± 
SEM, n = 9. The checked rectangle indicates the short duration 
treadmill run. The diagonal patterned rectangle indicates the long 
duration treadmill run. The black rectangles indicate consumption of 
the test meals. a Control different from short duration exercise P < 
0.05, b Control different from long duration exercise P < 0.05. 
Between trial differences in hunger ratings were also evaluated using AUC values for 
the first 0.75 hour of the trial (0 to 0.75 hours), the first 1.5 hours of the trial (0 to 1.5 
hours), and the full 9 hours. One-factor ANOVA confirmed a difference between the 
control and short duration exercise trial for the first 0.75 hours: 6 versus 4 (mean 
values) respectively (P = 0.006) as well as between control and long duration 
exercise: 6 versus 4 (mean values) respectively (P = 0.018). One-factor ANOVA 
confirmed a difference between the control and short duration exercise trial for the 
first 1.5 hours: 14 versus 9 (mean values) respectively (P < 0.0005) as well as 
between control and long duration exercise: 14 versus 7 (mean values) respectively (P 
= 0.004). One-factor ANOVA confmned a difference between the control and short 
. " IO~ 
duration exercise trial for the full 9 hours: 66 versus 50 (mean values) respectively (P 
= 0.011) but there was no difference between control and long duration (P = 0.141) 
and short duration and long duration exercise (P = 1.00). 
7.3.5 Nausea 
Fasting nausea did not differ (P = 0.512) between the control, short and long duration 
exercise trials (12 ± 4 versus 11 ± 4 versus 13 ± 3 mean values respectively). Two-
factor ANOV A revealed no significant effect of trial, time or trial x time interaction 
(Figure 7.3) but time was approaching significance (P = 0.078). The data was 
examined further using a planned contrast using the Helmert statistical test to examine 
the difference between control and both runs and the difference between runs. There 
was so significant difference between the control and both runs (P = 0.133) and 
between short and long duration runs (P = 0.460) . 
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Subjective feelings of nausea using a VAS during the short duration, 
long duration exercise and control trials. Values are mean ± SEM, n = 
9. The checked rectangle indicates the short duration treadmill run. The 
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diagonal patterned rectangle indicates the long duration treadmill run. 
The black rectangles indicate consumption of the test meals. 
Between trial differences in nausea ratings were also evaluated using ADC values for 
the first 0.75 hour of the trial (0 to 0.75 hours), the first 1.5 hours of the trial (0 to 1.5 
hours), and the full 9 hours. One-factor ANOVA confirmed no differences between 
the control, short duration and long duration exercise trial for the first 0.75 hours: 8 
versus 11 versus 12 (mean values) respectively (P = 0.163). One-factor ANOVA 
confirmed no differences between the control, short duration and long duration 
exercise trial forthe first 1.5 hours": 15 versus 24 versus 32 (mean values) respectively 
(P = 0.071). One-factor ANOVA confirmed no differences between the control, short 
duration and long duration exercise trials for the full 9 hours: 95 versus 118 versus 
129 (mean values) respectively (P = 0.198). 
A repeated measures ANOV A was also undertaken for the first 1.5 hours. There was 
no significant effect of trial or trial x time but these were approaching significance (P 
= 0.76 and P = 0.64 respectively). The main effect of time was significant (P = 0.006) 
so a planned contrast using the Helmert statistical test to examine the effect of control 
versus runs with a 'repeated on time' analysis to examine differences over time. There 
was a significant difference between control and both runs (P = 0.016) but no 
difference between runs (P = 0.3 71). There was a significant trial x time interaction (P 
= 0.009) so changes over time were examined between 0-0.5, 0.5-0.75, 0.75-1 and 1-
1.5 hours and there was a significant (P = 0.017) increase in nausea between 0.5 and 
0.75 hours showing that nausea did increase during the run. 
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7.3.6 Acylated ghrelin 
Fasting plasma acylated ghrelin concentrations did not differ (P = 0.775) between the 
control, short and long duration exercise trials (158.6 ± 46.6 versus 162.9 ± 46.8 
versus 153.4 ± 42.7 pg·mL-1 respectively). Two-factor ANOVA revealed a main effect 
of trial (P = 0.00 I), a main effect of time that was approaching significance (P = 
0.063) but no trial x time interaction (P = 0.097) for acylated ghrelin concentrations 
(Figure 7.4). Post hoc analysis indicated between trial differences between the control 
and short duration trial (P = 0.041) and between the control and long duration trial (P 
= 0.005). Post hoc analysis indicated between trial differences between control and 
short duration at 0.75 hours (Figure 7.2). There were further between trial differences 
between the control and long duration exercise trial at 0.75 and 1.5 hours and 
differences that were approaching significance at 3 (P = 0.077) and 6 (P = 0.070) 
hours (Figure 7.2). At 1.5 hours the difference between short duration and long 
duration exercise was significant. 
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Acylated ghrelin concentration during the short duration, long duration 
exercise and control trials. Values are mean ± SEM, n = 9. The 
checked rectangle indicates the short duration treadmill run. The 
diagonal patterned rectangle indicates the long duration treadmill run. 
The hlack rectangles indicate consumption of the test meals. a Control 
different from short duration exercise P < 0.05, b Control different 
from long duration exercise P < 0.05. C Short different from long 
duration exercise P < 0.05. 
Between trial differences for acylated ghrelin were also evaluated using AUC values 
for the first 0.75 hour of the trial (0 to 0.75 hours), the first 1.5 hours of the trial (0 to 
1.5 hours), and the full 9 hours. One-factor ANOVA confinued a difference between 
the control and long duration exercise trial for the first 0.75 hours: 123.3 ± 30.0 versus 
95.4 ± 26.1 pg·mL-1·0.75 hours respectively (P = 0.032). One-factor ANOVA 
confmned a difference between the control and long duration exercise trial for the 
first 1.5 hours: 248.3 ± 57.9 versus l70.6± 52.6 pg·mL-1·1.5 hours respectively (P = 
0.004). One-factor ~OVA confmned a difference between the control and short 
duration exercise trial for the full 9 hours: 1360.4 ± 279.8 versus 968_9 ± 196.9 
pg·mL-1·9 hours respectively (P = 0.024) as well as between the control and long 
167 
duration exercise trial for the full 9 hours: 1360.4 ± 279.8 versus 961.9 ± 218.3 
pg'mL- I '9 hours respectively (P = 0.018) (Figure 7.5) .. 
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Total area under the concentration versus time curve (AUC) for plasma 
acylated ghrelin (mean ± SEM, n = 9). Values are for the first 0.75 
hours of the trial (pg·mL- I ·0.75 hours), for the first 1.5 hours of the trial 
(pg·mL- I .l.5 hours) and for the full 9 hours of the trial (pg'mL- I '9 
hours). a Control different from short duration exercise P < 0.05, b 
Control different from long duration exercise P < 0.05. 
Fasting plasma acylated ghrelin concentrations were not significantly correlated with 
BMI, body mass, waist circumference, maximum oxygen uptake, fasting hunger, 
fasting plasma insulin concentrations or fasting plasma glucose concenirations. 
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7.3.7 Glucose 
Fasting plasma glucose concentrations did not differ significantly (P = 0.946) 
between control, short duration and long duration exercise trials (5.0 ± 0.1 versus 5.1 
± 0.1 versus 5.1 ± 0.2 mrnol'L-1 respectively). Two-factor ANOVA revealed no main 
effect of trial (P = 0.084), a main effect of time (P < 0.0005) and a trial x time 
interaction (P = 0.017) for plasma glucose (Figure 7.6). Post hoc analysis indicated 
between trial differences between control and short duration at 0.75 hours (Figure 
7.6). There were further trial differences between the control and long duration 
exercise trial at 0.75 hours and a difference that was approaching significance at 3 
hours (P = 0.077) (Figure 7.6). There was no significant differences between the short 
duration and long duration exercise. 
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Plasma glucose concentration during the short duration, long duration 
exercise and control trials. Values are mean ± SEM, n = 9. The 
checked rectangle indicates the short duration treadmill run. The 
diagonal patterned rectangle indicates the long duration treadmill run. 
The black rectangles indicate consumption of the test meals. a Control 
different from short duration exercise P < 0.05, b Control different 
from long duration exercise P < 0.05. 
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Between trial differences for plasma glucose were also evaluated using ADC values 
for the first 0.75 hour of the trial (0 to 0.75 hours), the first 1.5 hours of the trial (0 to 
1.5 hours), and the full 9 hours. One-factor ANOVA confmned a difference between 
the control and short duration exercise trial for the fust 0.75 hours: 3.7 ± 0.1 versus 
4.2 ± 0.1 mrnol·L-1·0.75 hours respectively (P = 0.045) and between the control a.,.,d 
long duration exercise trial: 3.7 ± 0.1 versus 4.0 ± 0.1 mrnol·L-1·0.75 hours 
respectively (P = 0.045). One-factor ANOVA confirmed no differences between the 
control, short and long duration exercise trials for the first 1.5 hours: 7.4 ± 0.1 versus 
8.0 ± 0.2 versus 7.7 ± 0.2 mmol·L-1·1.5 hours respectively (P = 0.059). One-factor· 
ANOV A confirmed no difference between the control, short and long duration 
exercise trials for the full 9 hours: 43.1 ± 0.7 versus 45.3 ± 0.6 versus 45.2 ± 0.6 
mrnol·L-1·9 hours respectively (P = 0.151). 
7.3.8 Insulin 
Fasting plasma insulin concentrations did not differ significaptly (P = 0.834) between 
control, short duration and long duration exercise trials (26.55 ± 5.42 versus 24.1 ± 
4.85 versus 24.35 ± 7.35 pmol·L-1 respectively). Two-factor ANOVA revealed a main 
effect of time (P < 0.0005) but no effect of trial (P = 0.461) and no trial x time 
interaction (P = 0.440) for plasma insulin (Figure 7.7). Post hoc analysis indicated 
between trial differences between control and short duration at 0.75 hours (Figure 
7.7). There were further between trial differences between the short and long duration 
exercise trial at 2 hours (Figure 7.7). There were no differences between control and 
long duration exercise. 
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Plasma insulin concentration during the short duration, long duration 
exercise and control trials. Values are mean ± SEM, n = 9. The 
checked rectangle indicates the short duration treadmill run. The 
diagonal patterned rectangle indicates the long duration treadmill run. 
The black rectangles indicate consumption of the test meals. a Control 
different from short duration exercise P < 0.05, C Short different from 
long duration exercise P < 0.05. 
Between trial differences for plasma insulin were also evaluated using AUC values 
for the first 0.75 hour of the trial (0 to 0.75 hours), the first 1.5 hours of the trial (0 to 
1.5 hours), and the full nine. hours. One-factor ANOVA showed a difference between 
the control and short duration exercise trial for the first 0.75 hours: 18.8 ± 3.0 versus 
28.1 ± 4.4 pg·mL-1·0.75 hours respectively (P = 0.044). One-factor ANOVA showed a 
difference between the short and long duration exercise trials for the first 1.5 hours: 
53.9 ± 8.4 versus 29.7 ± 5.7 pg·mL-1·1.5 hours respectively (P = 0.036) and a 
difference between the control trial and short duration trial that was approaching 
'significance: 34.7 ± 5.6 versus 53.9 ± 8.4 pg·mL-1·1.5 hours respectively (P = 0.055) 
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One-factor ANOVA confirmed no difference between the control, short and long 
duration exercise trials for the full 9 hours: 679.6 ± 90.7 versus 671.8 ± 80.2 versus 
616.5 ± 81.4 pg·mL"I·9 hours respectively (P = 0.799). 
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7.4 Discussion 
To the author's knowledge, the present study is the first to examine the effect of 
exercise duration on plasma acylated ghrelin concentrations during exercise. The 
novel fIDding arising from this study is that there is a suppression of plasma acylated 
ghrelin during both short and long duration exercise and the suppression occurs whilst 
exercise is ongoing. 
At 0.75 hours plasma acylated ghrelin was lower on the short and long duration 
exercise trials compared with control. (94.8 ± 43.2 versus 100.9 ± 38.2 versus 170.2 ± 
46.3 pg·mL- t respectively). The findings therefore confirm those of chapter 5 and 6 
that acylated ghrelin is modestly suppressed in response to high intensity treadmill 
rurming even though the exercise intensity was slightly lower at 70% V0 2 max. In the 
short duration exercise trial participants ceased exercise at 0.75 hours at which point 
plasma acylated ghrelin values began to return to baseline and were approaching 
control values at 1.5 hours (142.9 ± 42.4 versus 163.3 ± 40.8 pg·mL- t respectively). 
However, in the long duration exercise trial participants remained exercising for a 
further 0.75 hours and plasma acylated ghrelin concentration remained suppressed. 
The findings therefore show that exercise duration is a determinant of the extent of the 
acylated ghrelin response to exercise when the exercise intensity is kept constant. 
Findillgs also show that the suppression of acylated ghrelin plateaus after 0.75 hours 
during the long duration treadmill run. Whilst acylated ghrelin values remain 
suppressed there is no further decline and values remain similar at 0.75 and 1.5 hours 
(100.9 ± 38.2 versus 99.6 ± 44.6 pg·mL- t respectively). This shows that depending on 
the exercise stimulus, acylated ghrelin declines to a point after which if there is no 
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change to the exercise intensity there will be no change in the acylated ghrelin 
response. All the previous studies in this thesis measuring acylated ghrelin have 
shown that values begin to return to baseline upon the cessation of exercise so it is 
assumed that if the exercise intensity was reduced but participants continued to 
exercise, acylated ghrelin concentration would remain suppressed but values would 
begin to return to baseline. It is also posited that an increase in exercise intensity 
would result in a greater suppression of acylated ghrelin but this is highly speculative 
and warrants further investigation as a plateau of acylated ghrelin suppression may 
exist after which no increase in exercise intensity, duration or expenditure will 
increase the suppression of acylated ghrelin further. 
Acylated ghrelin values reported are similar to that reported in chapters 5 and 6 and 
no participant displayed atypically high acylated ghrelin values. It has been suggested 
in chapter 6 that participants who are of ethnic origin have a tendency to display 
higher acylated ghrelin values possibly due to genetic differences and this IS 
supported by the findings of the present study as all participants were Caucasian. 
In addition to the decline in acylated ghrelin concentrations during exercise, acylated 
ghrelin concentrations declined after feeding. The present study used two test meals 
fed at 2 and 6 hours and acylated ghrelin was measured 1 hour after the initiation of 
feeding. One hour after the initiation of the first test meal there was a 32% 
suppression in the control trial, a 39% suppression in the short duration trial and a 
35% suppression in the long duration trial. One hour after the initiation of second test 
meal there was a 36% suppression in the control trial, a 40% suppression in the short 
duration trial and a 35% suppression in the long duration trial. As a result of exercise 
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plasma acylated ghrelin concentrations are lower than resting control values but 
exercise does not seem to affect the acylated ghrelin response to meals. 
The study described in Chapter 5 used a high fat test meal fed at 3 hours in which the 
macronutrient content was 38% CRO, 10% protein and 52% fat providing 4201 kJ 
(1004 kcal) based on a 70 kg person. This led to a 30% decline in plasma acylated 
ghrelin concentration I hour after the meal in the control trial and a 27% decline in 
the exercise trial. The macronutrient content of each test meal in the present study was 
33% CRO, 11% protein and 56% fat providing 3230 kJ (772 kcal). Despite a lower 
energy content of the test meals employed in the present study the percentage of fat is 
greater which co-incides with declines in plasma acylated ghrelin concentration that 
are greater than that reported in chapter 5. This provides further evidence that meal 
composition could affect the suppression of acylated ghrelin .. 
Another key finding from the present study is that both short and long duration 
exercise lead to 'exercise induced anorexia' and the suppression of subjective feelings 
of hunger is present whilst exercise is ongoing. This is consistent with the findings of 
King et al (1994) who also found that compared with control, hunger was suppressed 
during both short and long duration exercise sessions and occurred whilst exercise 
was ongoing. Findings therefore provide further evidence that exercise duration is a 
determinant of the extent of 'exercise induced anorexia.' King et al (1994) used a 
different VAS making comparisons difficult but trends are similar. In both studies 
hunger declines during exercise and begins to return to baseline values post exercise 
yet 'exercise induced anorexia' is not short lived in the present study. Whereas King 
et al (1994) reported that feelings of hunger had returned to baseline values within 10-
15 minutes after the cessation of exercise in the present study hunger had not returned 
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to baseline 1.25 hours after short duration exercise or for 0.5 hours after long duration 
exercise. Unfortunately the time it would have taken for values to return to baseline 
cannot be assessed as a test meal was given. Whilst the exercise intensity was lower in 
the present study the more prolonged 'exercise induced anorexia' reported in the 
present study is likely because treadmill running as opposed to cycling was used for a 
longer duration, greater energy expenditure and greater gut upheaval. The exercise 
challenge in the present studies short duration trial was greater than that of the long 
duration trial in King et al (1994) since participants were exercising for a mean 51.8 
± 2.4 minutes with a gross energy expenditure of 541 ± 52 kcal whereas the short 
duration trial in the present study was 45 minutes with a gross energy expenditure of 
697 ± 26 kcal. 
It had been drawn to the author's attention that suppressed feelings of hunger may not 
be a result of exercise per se but due to other sensations such as feelings of nausea 
which have been found after long duration vigorous exercise (Halvorsen and Ritland, 
1992). To confirm if any feelings of nausea were influencing subjective feelings of 
hunger, a nausea V AS was compiled and implemented and the findings show that 
there is a significant increase in nausea during exercise. The finding of a significant 
difference of nausea in the presence of a significant hunger suppression shows that 
during exercise, 'exercise induced anorexia' may be confounded by feelings of 
nausea. 
In terms of causal mechanisms the findings confirm those of chapter 5 that suppressed 
acylated ghrelin is temporarily associated with 'exercise induced anorexia'. It cannot 
be stated with confidence that suppressed acylated ghrelin is the sole mechanism for 
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'exercise induced anorexia' since no association was seen in chapter 6 and since 
hunger regulation is complex involving the interplay of many other gut peptide 
ho=ones more work is needed particularly for the ho=one PYY as to the authors 
knowledge there is only one published study. Likewise the mechanism in which 
acylated ghrelin is suppressed is not fully understood but the finding of a significant 
increase in plasma glucose during both the long and short duration treadmill runs 
confi=s the findings described in chapter 5 and 6. Increase in glucose concentrations 
during high intensity treadmill running could therefore be a mechanism for acylated 
ghrelin suppression. However, figure 7.6 shows that post feeding there were similar 
increases in glucose which coincided with similar suppressions of acylated ghrelin in 
all three trials providing further evidence that the mechanism by which exercise alters 
acylated ghrelin may differ from that by which feeding alters acylated ghrelin as 
discussed previously in chapter 6. 
The finding of a significant increase in plasma insulin concentration during the short 
duration trial at 0.75 hours is perplexing considering that participants were wo"rking at 
similar exercise intensities and energy expenditures as in the long duration trial. 
Regardless a suppression of acylated ghrelin has arisen with an increase in insulin 
during the short duration trial and no increase in the long duration trial confi=ing the 
findings of chapters 5 and 6 that is likely that changes in insulin cannot be responsible 
for the exercise induced changes to acy lated ghrelin. 
In conclusion, this study demonstrates that plasma acylated ghrelin concentration is 
reduced during an acute bout of high intensity short and long duration treadmill 
running and is more prolonged in the long duration exercise trial. Suppressions of 
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acylated ghrelin co-incide with 'exercise induced anorexia' which agam IS more 
prolonged in the long duration exercise trial and the effect may not be short lived as 
hunger was suppressed for some time after exercise. Exercise duration is therefore a 
key determinant of the acylated ghrelin and hunger response to exercise. Whilst 
associations have been seen causal mechanisms cannot be stated with confidence as 
the fmdings are mixed and more work is needed. Finally, suppressed hunger may be 
confounded by associated feelings of nausea. 
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CHAPTER VIII 
Effects of resistance and aerobic exercise on total PYY and acylated ghrelin 
8.1 Introduction 
The majority of studies examining the effect of exercise on ghreI.in have used aerobic 
exercise Prot9cols using cycling (Dall et aI, 2002; Kallio et aI, 2001; Schmidt et aI, 
2004; Vestergaard et aI, 2007), rowing (Jiirimae et aI, 2007) or treadmill running 
(Bums et aI, 2007; Kraemer et aI, 2004a) including the studies reported in chapters 5, 
6 and 7 which have measured acylated ghrelin. However there is some evidence that 
hormonal responses may vary depending on the mode of exercise (Kraemer and 
Castracane, 2007) and few studies have looked at resistance exercise. Kraemer et al 
(2004b) found a reduction in ghrelin following concentric muscle contractions which 
was supported by Ghanbari-Niaki (2006) who found that ghrelin decreased 
significantly after three circuits of 10 resistance exercises at 60% of 1 rep max. 
However, Takano et al (2005) found no change with short term low intensity 
resistance exercise so the findings are mixed and need confirmation. To the author's 
knowledge the influence of resistance exercise on acylated ghrelin has not been 
examined. 
Despite a growing evidence base on the influence of exercise on total and acylated 
ghrelin research measuring other gut peptide hormones is scarce. PYY is a 36 amino 
acid hormone secreted from endocrine L-cells of the distal ileum and colon (Bottcher 
et ai, 1984). It exists in two endogenous fonns, PYYI-J6 and PYYJ-36. Increased 
concentrations of PYY3-J6 inhibits food intake by altering central nervous system 
appetite circuits within the arcuate nucleus of the hypo thalamus or area postrema 
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(Batterham and Bloom 2003). PYY is a potent inhibitor of food intake and increased 
concentrations leads to reduced food intake. 
To the author's knowledge only one study has examined the effects of exercise on 
PYY. Martins et al (2007) showed an increase in total PYY with intermittent 
moderate intensity cycling. This coincided with suppressed hunger suggesting that 
exercise induced changes to total PYY also leads to 'exercise induced anorexia'. 
There appears to be no evidence on the effects of treadmill running or resistance 
exercise on PYY. Therefore, the primary purpose of the present study was to 
determine plasma acylated ghrelin and total PYY concentrations during and following 
treadmill running and resistance exercise to see if there are any associations between 
subjective feelings of hunger and the exercise induced response of these gut peptide 
hormones. It was hypothesized that exercise would cause a temporary suppression of 
hunger and that this would co-incide with reduced concentrations of plasma acylated 
ghrelin and increased concentrations of total PYY. 
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8.2 Methods 
8.2.1 Participants 
Twelve healthy Caucasian males aged 19 to 23 years from the population at 
Loughborough University volunteered to participate in the study. Table 8.1 shows the 
physical characteristics of participants. 
Table 8.1 Physical characteristics of participants. 
Characteristic 
Age (yr) 
Height (m) 
Weight (kg) 
Sum of Skin folds (mm) 
BMI (kg·m·2) 
Body Fat (%) 
Waist Circumference (cm) 
V0 2 max (mL·kg··1min- l ) 
Values are mean ± SEM (n = 12) 
(Mean± SEM) 
21.2±0.3 
1.79 ± 0.02 
74.4 ± 2.4 
29.2 ± 1.7 
23.2 ± 0.4 
13.5 ± 0.8 
78.6 ± 1.1 
62.0 ± 1.8 
The physical characteristics of the subjects (mean ± SEM) were as follows: age 21.2 ± 
0.3 years, height 1.79 ± 0.02 m, body mass 74.4 ± 2.4 kg, BMI 23.2 ± 0.4 kg'm-2, 
waist circumference 78.6 ± 1.1 cm, maximum oxygen uptake 62.0 ± 1.8 rnL'kg-I'min-1 
(4.58 ± 0.13 L·min-I). 
8.2.2 Study design 
All experimental procedures were conducted in the Health and Paediatric Exercise 
Physiology Laboratory at Loughborough University. After being made aware of the 
protocol, health screened, then giving written consent to take part, anthropometric 
data was collected after which each participant undertook two preliminary exercise 
tests in one session as follows: 1) submaximal-incremental treadmill running test, 2) 
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maximum 'oxygen uptake (VO 2 max) treadmill running test. There was a 30 minute rest 
interval between the exercise tests. Participants also undertook a 12 rep max 
resistance test and resistance familiaristaion prior to starting the main trials on 
separate days with an interval of at least 3 days. 
During subsequent weeks participants undertook three main trials (aerobic exercise, 
resistance exercise and control)' and these were peIformed in a randomized order with 
an interval of at least 7 days. For two days before the first main trial participants were 
asked to record their weighed food intake using a food record diary. The same food 
intake was then consumed for the two days prior to the next remaining trials. 
Participants were also asked to refrain from any form of vigorous activity and 
ingesting caffeine or alcohol 24 hours prior to the main trials. Participants were fasted 
for a minimum 10 hours, but were allowed to drink water ad libitum. Participants 
attended the laboratory between the hours of 08:00 and 09:00 and were requested to 
use motorised transport where possible or ensure that activity prior to attending the 
laboratory was light. 
8.2.3 12-repetition maximal test 
The l2-repetition maximal test was completed for each of the 10 resistance exercises 
employed in the study. The order in which each resistance exercise was performed 
was the same for each participant i.e. squat, dumbbell lateral raise, bench press, 
upright row, lunges, bicep curl, barbell pullover, seated shoulder press, tricep 
extension and bent over row. The 12-repetition maximal values were determined by 
trial and error by adding or removing weights after each attempt, as required. 
Participants were allowed to take as long as they felt necessary to recover from each 
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attempt. 
8.2.4 Resistance familiarisation session 
On a separate visit participants undertook the 90 minute resistance exercise session to 
ensure completion of 3 sets of each resistance exercise at 80% of 12 rep max and 
confirm fatigue from overload by the end. This was verified by visual inspection and 
verbal feedback from the participants and adjustments were made if necessary. 
8.2.5 Main trials 
Participants were given at least one week to recover from the preliminary exercise 
sessions before embarking on the main trials. Each main trial began in the morning 
and lasted for 8 hours. 
8.2.5.1 Aerobic trial 
At the start of the aerobic exercise trial participants ran on the treadmill for 60 
minutes at a running speed predicted to elicit 70% of maximum oxygen uptake. One 
minute expired air samples were collected at 14-15, 29-30, 44-45 and 59-60 minutes 
during the run. Running speed was adjusted after each expired air collection if the 
oxygen consumption was above or below the predicted value or if the subject 
expressed that they were experiencing difficulties. After the run, participants rested 
for 7 hours (sitting reading, writing, working at a computer or watching television). 
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8.2.5.2 Resistance trial 
At the start of the resistance trial participants completed a free weight session for 90 
minutes performing three sets of 12 repetitions of 10 different weight lifting exercises 
at 80% of 12 repetition max. Three sets of 12 repetitions was used to maximise total 
energy expenditure and increase the likelihood of an exercise effect. Pilot work for a 
previous study (Bums et ai, 2006) revealed that a higher exercise intensity would have 
prevented most participants from completing the session. Participants were given 3 
minutes in which to complete each set. On completion of the 12 repetitions, 
participants rested for the remainder of the 3 minutes. An expired air sample was 
taken for 3 minutes during the third set for each exercise. Thus the whole exercise 
session lasted for 90 minutes (10 exercises x3 sets x 3min). Exercises were completed 
in the order described for the preliminary resistance sessions. All sets for one exercise 
were completed before moving onto the next exercise. After the resistance session, 
participants rested for 6.5 hours (sitting reading, writing, working at a computer or 
watching television). 
8.2.5.3 Control trial 
For the control trial participants undertook exactly the same protocol but rested 
throughout. 
Participants were not devoid of time cues during the trials and a clock was on display 
in the laboratory throughout the trials. 
Figure 8.1 shows a schematic representation of the study protocol. 
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Figure 8.1 Schematic representation of the main trial protocol 
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8.2.6 Calculation of energy expenditure 
For the aerobic trial oxygen consumption and carbon dioxide production values were 
used to calculate energy expenditure using indirect calorimetry (Frayn, 1983). The 
short duration intermittent nature of weight lifting invalidates the typical assumptions 
of indirect caliorimetry because the respiratory exchange ratio is consistently equal to 
or greater than 1.0. Energy expenditure was calculated as being 5.047 kcal (21.1 kJ) 
per liter of oxygen (McArdle, 2001). This reflects the assumption that that energy was 
derived from carbohydrate rather than fat and assumes no protein contribution to 
energy provision during the exercise. This assumption may not be entirely valid and 
as no attempt was made to quantifY the' energy contribution from anaerobic sources, 
this would lead to underestimations of the energy expended during exercise. 
8.2.7 Subjective measurement of hunger and nausea 
On arrival, participants completed an RPH compiled by Burns et al (2007) which 
ranged from 0 'Not Hungry' to IS 'Very Hungry'. Hunger measurements were 
recorded at baseline, 0.5, 0.75, I, 1.5,2,2.5,3,3.5,4,4.5,5,5.5,6,6.5,7,7.5 and 8 
hours. At the same sampling points participants also completed a nausea V AS by 
placing a vertical mark on a 10 cm horizontal line ranging from 0 'Not at all 
nauseous' to 100 'Very nauseous.' 
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8.2.8 Test meal 
Participants were fed a 3230 kJ (772 kcal) test meal at 2 hours and another at 5 hours. 
Each meal consisted of77g of white bread, 12g of butter, 12g of mayonnaise, 33g of 
cheddar cheese, 30g of potato crisps, 150g of whole milk and 7g of milk shake 
powder based on a 70 kg person. The macronutrient content was 33% carbohydrate 
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(133g), 11% protein (43g) and 56% fat (96g). The amount of each food stuff was 
adjusted for each participant based on their bodyweight on the day of first trial and 
identical amounts were consumed on the second trial. Participants were encouraged to 
consume the meal within 15 minutes and kept to the same start and fmish times on 
both trials. Water was available ad libitum during trials and the volume and time of 
ingestion were recorded. 
8.2.9 Environmental temperature and humidity 
Environmental temperature and humidity were monitored during the main trials using 
a hand-held hygrometer (Omega RH85, Manchester, U.K.). 
8.2.10 Blood sampling 
Prior to the start of the aerobic and control trials, participants rested in a semi-supine 
position while a cannula (Venflon, Becton Dickinson, Helsinborg, Sweden) was 
inserted into an antecubital vein. Venous blood samples were subsequently collected 
into pre-cooled 9 mL EDTA monovettes (Sarstedt, Leicester, U.K.) at 0, 0.75, 1.5,2, 
2.5, 3, 4, 5, 5.5, 6, 7, 8 hours. During the aerobic trial at 0.75 hours, blood was 
collected while the participants straddled the treadmill which took approximately I 
minute. All other blood samples were collected whilst participants lay in a semi-
supine position. For the resistance trial participants were venepunctured at baseline 
and at 0.75 hours and were given a few minutes to recover before continuing with the 
resistance session. At 1.5 hours a cannula was inserted and the blood sample was 
taken within 5 minutes. Remaining blood samples were taken via the cfu"lIlula at the 
same sampling points as the other main trials. 
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The EDTA monovettes were spun at 1681 g (4000 revs·min· l ) for 10 minutes in a 
refrigerated centrifuge (Burkard, Hertfordshire, U.K.) at 4°C. The plasma supematant 
was then aliquoted into Eppendorf tubes. These were stored at _80°C for analysis of 
total PYY, glucose and insulin later. 
Separate venous blood samples were drawn into 4.9 mL monovettes at 0, 0.75, 1.5,2, 
2.5,5,5.5 and 8 hours for the determination of plasma acylated ghrelin concentration. 
These monovettes contained EDTA and p-hydroxymercuribenzoic acid (PHl\1B) to 
. prevent the degradation of acylated ghrelin by protease. The monovettes were spun at 
1187 g (3500 revs·min· l ) for 10 minutes in a refrigerated centrifuge at 4°C. The 
supematants were then aliquoted into storage tubes and 100 f.LL of 1 M hydrochloric 
acid (HCL) was added per mL of plasma. Samples were then spun at 1287 g (3500 
revs·min· l ) for 5 min in a refrigerated centrifuge at 4°C before being transferred into 
Eppendorf tubes. The samptes were then stored at _80°C for analysis later. 
At each acylated ghrelin blood sampling point, duplicate 20 f.LL blood samples were 
collected into micropipettes for the measurement of haemoglobin concentration and 
triplicate blood samples were collected into heparinised micro haematocrit tubes for 
the determination of haematocrit. 
8.2.11 Blood biochemistry 
Plasma acylated ghrelin concentrations were determined by enzyme immunoassay. 
Plasma glucose concentrations were determined by enzymatic, colorimetric methods. 
Plasma insulin concentrations were determined by radioimmunoassay. To eliminate 
inter-assay variation, samples from each participant were analyzed in the same run. 
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The within batch coefficients of variation for the assays were as follows: acylated 
ghrelin 4.8%, PYY 1.2%, glucose 3.3% and Insulin 3.3%. 
8.2.12 Statistical analysis 
Data were analyzed using the Statistical Package for the Social Science (SPSS) 
software version 12.0 for Windows (SPSS Inc, Chicago, IL, U.S.). Plasma acylated 
ghrelin, total PYY, hunger, glucose and insulin area under the concentration versus 
time curves were calculated using the trapezoidal rule. One-factor ANOVA was used 
to assess differences between fasting and area under the curve values for acylated 
ghrelin, total PYY, hunger, glucose and insulin for the three trials. Repeated 
measures, two-factor ANOVA was used to examine differences between the three 
trials over time for acylated ghrelin, total PYY, glucose, insulin, hunger, body mass 
and plasma volume change. Post-hoc pair wise comparisons were performed using the 
Bonferroni method. The Pearson product moment correlation coefficient was used to 
examine relationships between variables. Statistical significance was accepted at the 
5% level. There was no statistically significant change in plasma volume and hence 
for simplicity the unadjusted values are reported. Results are given as mean ± SEM 
unless otherwise stated. 
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8.3 Results 
8.3.1 Responses to treadmill running 
The mean percentage of maximum oxygen uptake elicited during aerobic exercise was 
68 ± 2.0% and the mean respiratory exchange ratio was 0.93 ± 0.01. Gross energy 
expenditure during aerobic exercise was 3847 ± 93 kJ (920 ± 22 kcal) with 25 ± 3.9% 
of energy provided from fat and 75 ± 3.9% of energy provided from carbohydrate. 
Average heart rate during running was 167 ± 3 beats·min- l and the median rating of 
perceived exertion (RPE) was 15 i.e. 'hard' (range 13-16). 
8.3.2 Responses to resistance exercise 
The mean weight lifted for each participant during the 90 minute resistance exercise 
session was 10 824 ± 645 kg working at 80 ± 0.3% of 12 rep max. The gross energy 
expenditure from resistance exercise was estimated to be 1488 ± 110 kJ (356 ± 26 
kcal). 
8.3.3 Body mass and fluid consumption 
Two-factor ANOVA revealed no effect of trial (P = 0.217) for body mass. On the 
control trial body mass was 75.1 ± 2.6 kg at the start of the trial and 75.3 ± 2.6 kg at 
the end of the trial. On the resistance trial body mass was 74.7 ± 2.8 kg at the start of 
the trial and 74.8 ± 2.8 kg at the end of the trial. On the aerobic trial body mass was 
74.5 ± 2.5 kg at the start of the triai and 74.8 ± 2.6 kg at the end of the trial. There was 
a difference (One-factor ANOVA, P < 0.001) in water consumption between the 
trials. Post hoc analysis revealed water consumption during the aerobic exercise trial 
(2089 ± 205 mL) was greater than that consumed during the control trial (1216 ± 189 
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mL, P < 0.001) but was not significantly different to that consumed during the 
resistance exercise trial (1572 ± 237 mL, P = 0.082). 
8.3.4 Temperature and humidity 
There was no' difference (Two-factor ANOVA, P = 0.457) in environmental 
temperature between the control, resistance exercise and aerobic exercise trials (23.0 
± 0.5 versus 22.5 ± 1.3 versus 23.1 ±.0.4 QC respectively). Likewise there was no 
difference (Two-factor ANOVA, P = 0.654) in humidity between the control, 
resistance exercise and aerobic exercise trials (37.3 ± 1.9 versus 38.4 ± 1.4 versus 
36.0 ± 2.1 % respectively). 
8.3.5 Hunger 
Fasting hunger did not differ significantly (One-factor ANOVA, P = 0.401) between 
the control, aerobic and resistance trials (8 ± 1 versus 7 ± 1 versus 6 ± 1 respectively). 
Two-factor ANOVA revealed a main effect of time (P < 0.0005) and a trial x time 
interaction effect (P < 0.001) for hunger indicating that responses differed over time 
between the exercise and control trials. Post hoc analysis indicated between trial 
differences for aerobic exercise and control at 0.75, 1, 1.5 and 2 hours (Figure 8.2). 
Post hoc analysis indicated between trial differences for resistance exercise and 
control at 0.5 hours and differences were approaching significance at 1.5 (P = 0.051) 
and 2 (P = 0.054) hours (Figure 8.2). 
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Post hoc analysis indicated between trial differences for aerobic exerCise and 
resistance at 0.5, 0.75 and I hours. 
- 14 ~ 
Cl 
b b 
b,c 
" ::l 12 ~Control 
J: 
-0- Resistance 
~ 
~ 10 -A-Aerobic 
on 
.... 
8 
~ 
Cl 
r.: 6 ::l 
J: 
-0 4 z 
~ 
~ 
Q) 2 Cl 
" ::l
J: 0 
0 1 2 3 4 5 6 7 8 
Time (Hours) 
Figure 8.2 Subjective feelings of hunger using the RPH scale during the aerobic 
exercise, resistance exercise and contro!. Values are mean ± SEM, n = 
12. The checked rectangle indicates the treadmill run. The diagonal 
patterned rectangle indicates the resistance exercise. The black 
rectangles indicate consumption of the test meals. a Control different 
. from resistance exercise P < 0.05, b Control different from aerobic 
exercise P < 0.05, C Resistance different from aerobic exercise P < 
0.05. 
Between trial differences in hunger ratings were also evaluated using AUC values for 
the 2 hours prior to the fIrst meal (0 to 2 hours), the 6 hours after the first meal (2 to 8 
hours) and the full 8 hours (0 to 8 hours). A signifIcant difference was found from 0 to 
2 hours (P = 0.005) and post hoc analysis identified the difference was in the control 
compared with aerobic trial (19 versus 10 mean values respectively, P = 0.004). The 
difference nearly but did not quite reach significance in the resistance compared with 
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the control trial (13 versus 10 mean values respectively, P = 0.067). There was no 
difference between AUC values for the 6 hours after the first meal (2·to 8 hours) or 
for the whole trial (0 to 8 hours) in all three trials. 
8.3.6 Nausea 
Fasting nausea did not differ (P = 0.231) between the control, resistance and aerobic 
exercise trials (IS ± 6 versus 9 ± 4 versus 7 ± 3 mean values respectively). Two-factor 
ANOV A revealed a main effect of time (P = 0.007) but no significant main effect of 
trial or trial x time interaction. The data was examined further using a planned 
contrast using the Helmert statistical test to examine the difference between control 
and both exercise modes combined and the difference between the run and resistance 
training. There was so significant difference between the control and both exercise 
modes (P = 0.7S4) but there was a difference between aerobic exercise and resistance 
training (P = 0.049). Using a repeated analysis these differences occurred 
significantly over time between 2 - 2.5 hours (P = 0.036) and 4.S - 5 hours (P = 
0.016). 
8.3.7 Acylated ghrelin 
It was not possible to read participant 9's acylated ghrelin values as these were greater 
than the highest standard and due to cost implications these could not be diluted and 
re assayed. Acylated ghrelin values are therefore only available for 11 participants. 
Fasting plasma acylated ghrelin concentrations did not differ significantly between the 
control, resistance and aerobic trials (111.0 ± 34.7 versus 103.7 ± 28.8 versus I1S.7 ± 
33.6 pg.mL-1 respectively, P = 0.648). Two-factor ANOVA revealed a main effect of 
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time (P = 0.001) and a trial x time interaction (P = 0.035) for acylated ghrelin 
concentrations. Post hoc analysis indicated between trial differences for aerobic 
exercise and control at 0.75 hours (Figure 8.3). Post hoc analysis indicated between 
trial differences for resistance exercise a..1'\d control at 0.75 and 1.5 hours (Figure 8.3). 
There were no differences between resistance and aerobic exercise. 
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Acylated ghrelin concentrations during the aerobic exercise, resistance 
exercise and control. Values are mean ± SEM, n = 11. The checked 
rectangle indicates the treadmill run. The diagonal patterned rectangle 
indicates the resistance exercise. The black rectangles indicate 
consumption of the test meals. a Control different from resistance 
exercise P < 0.05, b Control different from aerobic exercise P < 0.05. 
There was no significant difference (One-factor ANOV A) in the area under the 
acylated ghrelin concentration versus time curve for the first 0.75 hours of the trials. 
Area under the acylated ghrelin concentration verSlfS time curve was 26% lower over 
the first two hours of the resistance exercise trial (One-factor ANOVA P = 0.014) and 
14.2% (P = 0.388) lower over the full 8 hours compared with the control trial (Figure 
8.4). For the first two hours of the aerobic exercise trial, area under the acylated 
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gbrelin concentration versus time curve was 17% lower (P = 0.415) and 9% lower (P 
= 0.949) over the full eight hours compared with the control trial. 
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Time (Hours) 
Total area under the concentration versus time curve (AVC) for plasma 
acylated ghrelin (mean ± SEM, n = 11). Values are for tbe first 0.75 
bours of the trial (pg·mL'I·0.75 hours), first 3 hours of the trial 
(pg·mL-1·3 hours) and for the full 9 hours of the trial (pg·mL- 1·9 hours). 
a Control different from resistance exercise P < 0.05. 
Fasting plasma acylated ghrelin concentrations were not significantly correlated with 
BM!, body mass, waist circumference, maximum oxygen uptake, fasting hunger, 
fasting plasma insulin concentrations or fasting plasma glucose concentrations. 
8.3.8 Total PYY 
Fasting total PYY concentrations did not differ significantly between the control, 
resistance and aerobic trials (127.7 ± 18.1 versus 142.7 ± 26.5 versus 145.8 ± 20.8 
pg.mL-1 respectively, P = 0.525). TV/o-factor ANOVA revealed a main effect of t:ial 
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(P = 0.005), time (P < 0.0005) and a trial x time interaction (P = 0.027) for total PYY 
concentrations. Post hoc analysis indicated between trial differences between control 
and aerobic exercise (P = 0.038) and resistance and aerobic (P = 0.028). 
Post hoc analysis revealed between trial differences for aerobic exercise and control at 
1.5 and 2.5 hours (Figure 8.5). Post hoc analysis indicated between trial differences 
for resistance exercise and aerobic exercise at 1.5 and 2 hours and was approaching 
significance at 5.5 hours (P = 0.07). There were no significant differences between 
control and resistance exercise. 
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Total PYY concentrations during the aerobic exercise, resistance 
exercise and control. Values are mean ± SEM, 11 = 12. The checked 
rectangle indicates the treadmill run. The diagonal patterned rectangle 
indicates the resistance exercise. The black rectangles indicate 
consumption of the test meals. b Control different from aerobic exercise 
P < 0.05, CResistance different from aerobic exercise P < 0.05. 
There was no significant difference (One-factor ANOVA P = 0.177) in the area under 
the total PYY concentration versus time curve for the first 0.75 hours of the trials. 
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Area under the total PYY concentration versus time curve was 38% higher over the 
first 2 hours of the aerobic exercise trial (One-factor ANOVA P = 0.036) and 22% 
higher over the full 8 hours (P = 0.056) compared with the control trial (Figure 8.6). 
There was no significant difference in the area under the total PYY concentration 
versus time curve over the first'two hours or for the full eight hours of the control trial 
compared with resistance exercise. 
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Total area under the concentration versus time curve (AUC) for total 
PYY (mean ± SEM, n = 12). Values are for the first 0.75 hours of the 
trial (pg·rnL-1·0.75 hours), first 2 hours of the trial (pg·rnL-1·3 hours) 
and for the full 8 hours of the trial (pg'rnL-1'9 hours). b Control 
different from aerobic exercise P < 0.05. 
Fasting total PYY concentrations were not significantly correlated with BM!, body 
mass, waist circumference, maximum oxygen uptake, fasting hunger, fasting plasma 
insulin concentrations or fasting plasma glucose concentrations. 
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8.3.9 Correlations between acylated ghrelin and total PYY 
When removing 2 outliers fasting plasma acylated gbrelin concentrations were not 
significantly correlated with fasting total PYY (r = 0.196 P = 0.614) (Figure 8.7). 
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8.3.10 Glucose 
120.0 
Fasting plasma glucose concentrations did not differ significantly (One-factor 
ANOVA, P = 0.847) between the control, resistance and aerobic trial (5.0 ± 0.1 versus 
5.1 ± 0.1 versus 5.0 ± 0.1 mmol·L·1 respectively). Two-factor ANOVA revealed a 
main effect of trial (P < 0.0005), a main effect of time (P < 0.0005) and a trial x time 
interaction (P = 0.016) for plasma glucose. Post hoc analysis indicated between trial 
differences between control and aerobic exercise (P = 0.011) and resistance and 
aerobic exercise (P = 0.001). Post hoc analysis. indicated between trial differences for 
aerobic exercise and control at 0.75 hours (Figure 8.8). Post hoc analysis indicated 
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between trial differences for resistance exercise and aerobic exercise at 0.75, 3 and 4 
hours. There were no significant differences between control and resistance exercise. 
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Glucose concentrations during the aerobic exercise, resistance exercise 
and control. Values are mean ± SEM, n = 12. The checked rectangle 
indicates the treadmill run. The diagonal patterned rectangle indicates 
the resistance exercise. The black rectangles indicate consumption of 
the test meals. b Control different from aerobic exercise P < 0.05, C 
Resistance different from aerobic exercise P < 0.05. 
For the first 2 hours, total area under the concentration versus time curve for plasma 
glucose was significantly higher on the aerobic exercise trial compared with the 
resistance trial (10.8 ± 0.5 versus 9.7 ± 0.2 mrnol-L,1'2 hours respectively, P = 0.039) 
but did not differ from the control trial (10.8 ± 0.5 versus 10.0 ± 0.2 rnmol'L,I'2 hours 
respectively, P = 0.150). 
8.3.11 Insulin 
Fasting plasma insulin concentrations did not differ significantly (One-factor 
ANOVA, P = 0.751) between the control, resistance or aerobic trials (22.3 ± 3.4 
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versus 24.7 ± 4.0 versus 23.6 ± 3.3 pmol' L·1 respectively). Two-factor ANOVA 
revealed a main effect of time (P < 0.0005) with no significant differences between 
trials or trial x time interaction (Figure 8.9). 
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Insulin concentrations during the aerobic exercise, resistance exercise 
and control. Values are mean ± SEM, n = 12. The checked rectangle 
indicates the treadmill run. The diagonal patterned rectangle indicates 
the resistance exercise. The black rectangles indicate consumption of 
the test meals. 
For the first 2 hours, total area under the concentration versus time curve for plasma 
insulin was significantly higher on the resistance exercise trial compared with the 
control trial (58.7 ± 7.4 versus 38.4 ± 4.9 pmol-L-1·2 hours respectively, P = 0.004) 
but did not differ from the aerobic trial (58.7 ± 7.4 versus 63.1 ± 20.1 pmol'L-1'2 
hours respectively, P = 1.0). 
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8,4 Discussion 
To the author's knowledge, the present study is the first to examine plasma acylated 
ghrelin and total PYY concentrations during resistance exercise. The novel findings 
arising from this study are that there is a suppression of plasma acylated ghrelin and 
hunger during resistance exercise but no increase in total PYY. These findings 
confirm those found in chapters 5, 6 and 7 that acylated ghrelin is suppressed during 
high intensity treadmill running and that of Martins et al (2007) that total PYY is 
increased during aerobic exercise. 
Findings show that acylated ghrelin is suppressed during aerobic exercise compared 
with control confirming the findings of that found in chapter 5. Whilst the duration of 
the run was the same (60 minutes) the exercise intensity of aerobic running in the 
present study (68 ± 2.0% V0 2 rnax) was slightly lower than that previously reported in 
chapter 5 (72 ± 2.0% V0 2 rnax) but similar suppressions were seen. The present study 
also confirms that acylated ghrelin concentrations begin to return to baseline values 
soon after post exercise. 
Kraemer et al (2004b) found no suppressIOn of total ghrelin during resistance 
exercise. Whilst Kraemer et al (2004b) do not report the energy expenditure of their 
resistance protocol, 4 sets of 12 repetitions for four whole body exercises were 
completed at 80% of 10 rep max so whilst it is assumed the energy expenditure is 
greater in the present study, the protocol is still quite challenging. A novel finding 
from this study is that resistance exercise causes a suppression of acylated ghrelin 
during and immediately post exercise returning to baseline values within 0.5 hours. 
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The evidence is accumulating that acylated ghrelin responds differently to an exercise 
stimulus compared with total ghrelin, although a limitation of the study with regard to 
this latter fmding is that total ghrelin concentrations were not measured. Despite 
plasma total ghrelin not being measured in the present study, in a previous study using 
a similar aerobic exercise protocol we found no change in plasma total ghrelin 
concentration during or after aerobic exercise (Bums et al 2007). 
Since acylated ghrelin was suppressed during resistance exercise despite a low energy 
expenditure of 1488 ± 110 kJ it would appear that movement and energy expenditure 
per se regardless of mode suppresses acylated ghrelin as long as it is high intensity. 
There is still a paucity of data on low intensity resistance exercise which needs be 
explored and duration could also be a determinant as the duration of the resistance 
bout was long at 1.5 hours. Chapter 6 shows that acylated ghrelin is suppressed in 
high but not low intensity exercise of the same energy expenditure and there is a 
greater suppression in long duration compared with short duration exercise when the 
energy expenditure is greater as shown in chapter 7. A threshold of intensity and/or 
duration and/or energy expenditure may exist and it is plausible that acylated ghrelin 
may not have been suppressed had the resistance session been much shorter 
performing less sets and/or at a lower rep max. 
Findings show that total PYY is increased during aerobic but not resistance exercise. 
This confirms the fmdings of Martins et al (2007) who found an increase in total PYY 
after one hours intermittent cycling at 65% of maximum heart rate. They did not 
report an exercise energy expenditure but it is assumed to be somewhat less than the 
exercise energy expenditure of treadmill running reported in the present study (3848 ± 
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92 kJ) because of the weight bearing nature of cycling, lower exercise intensity and 
the inclusion of rest intervals. Martins et al (2007) reported their fmdings in pmol.L- t 
and in converting our fmdings to SI units (pg.mL- t x 0.25 = pmoI.L· t ) whilst similar 
exercise trends are seen the values for the present study (including fasting) are higher. 
The reasons for this are unknown, but may be due to different methods of 
determination as Martins et al (2007) used a radio-immunoassay. Martins et al t2007) 
also included female participants and females have been shown to display higher PYY 
values than males (Kim et ai, 2005). 
Similar to Martins et al (2007) only total PYY concentration was measured limiting 
the author's ability to determine the extent of variation between the responses of 
PYYt-36 and PYY3-36 to both exercise and feeding. PYY3-36 is the more biologically 
active form as it contributes to a greater percentage of circulating PYY post feeding 
(Grandt et ai, 1994) but it is unclear as to whether PYYt.36, PYY3-36 or both increase 
during aerobic exercise. Only the measurement of total PYY was commercially 
available at the time but as assays to measure both PYYt.36, and PYY3-36 become 
available these should be used to clarifY the exact PYY exercise response. 
To the author's knowledge this is the first study to examine the effects of resistance 
exercise on total PYY. Since acylated ghrelin and hunger were suppressed it is 
unclear why total PYY did not increase during resistance exercise. PYY did not 
respond and stayed low so it is speculated that exercise induced changes in total PYY 
are more dependant on mode, energy expenditure and exercise intensity than acylated 
gbrelin. 
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The present study confirms that hunger is suppressed during aerobic exercise and to 
some extent in the immediate post-exercise period. This is consistent with results from 
previous studies that have monitored subjective hunger ratings following vigorous 
aerobic exercise (above 60% of maximum oxygen uptake) (Blundell et a12003; King 
and Blundell, 1995; King et al 1994; Martins et ai, 2007; Tsofliou et a12003) and the 
fmdings in chapter 5 and 7. As in previous studies the suppression of hunger was 
short lived and hunger ratings began to return to control values within an hour of the 
cessation of exercise. 
To the author's knowledge no studies have examined the hunger response to 
resistance exercise and the present study shows the presence of 'exercise induced 
anorexia' as a result of resistance exercise. This is likely the result of the suppression 
of acylated ghrelin. 
Our findings confirm previous research that following the ingestion of food, plasma 
levels of total PYY increase (Adrian et ai, 1985). PYY levels have been shown to 
reflect meal size and the nature of food, fat being the most potent nutrient in releasing 
PYY (Adrian et ai, 1985) hence why there was a large increase in PYY post feeding 
due to the high fat content of the test meals. 
1-i the present study the area under the curve values for plasma glucose concentration 
were elevated during the one hour run compared with the same time period during the 
control and resista.nce trials. This is consistent with the fmdings of previous studies 
which also demonstrate an increase in plasma glucose during aerobic exercise (Kjaer 
et al 1986; Kraemer et al 2002) but contradicts the previous resistance exercise 
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fmdings in studies which found an increase (Ghanbari-Niaki, 2006; Kraemer et aI, 
2004b; Robergs et aI1991). A rise in glucose may in part explain the lower area under 
the curve values for plasma acylated ghrelin during the aerobic exercise trial but 
cannot explain the suppression of acylated ghrelin during the resistance trial. 
It has been suggested that insulin may have a role in ghrelin regulation (Haqq et al 
2003). Plasma insulin concentrations were not elevated during either aerobic or 
resistance exercise in the present study, in line with previous findings of aerobic 
exercise (Kjaer et aI, 1986; Kraemer et aI, 2002) but contradicts the findings of 
(Ghanbari-Niaki, 2006) and therefore insulin IS unlikely to contribute to the 
suppression of acylated ghrelin during exercise. 
Riediger et al (2004) reported that in the ARC electrophysiological studies have 
shown ghrelin excitation and PYYJ-J6 inhibition of neurons. Neurons of the ARC are 
. post-synaptically inhibited by PYYH6, suggesting that direct action of PYYJ-36 on 
receptive neurons may cause the suppressive effects on food intake. In man infusion 
of PYYJ-J6 markedly decreases circulating ghrelin levels and attenuates the 
preprandial rise (Batterham et aI, 2003). The action of PYYJ-J6 may lead to a 
reduction in the direct inhibitory effect on ghrelin-stimulated neurons as well as an 
attenuation of circulating levels. The fmdings of the present study show that this may 
not be the case of endogenous PYY as concentrations did not increase during 
resistance exercise yet acy lated ghrelin was suppressed. 
Evidence is accnmulating that potentially there is a relatiunship between the response 
of gut peptide hormones and 'exercise induced anorexia'. The fmdings presented in 
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Chapter 4, 5 and 7 and the present study shows that hunger is suppressed during 
aerobic exercise which coincides with a suppression of acylated glrrelin. Martins et al 
(2007) and the present study shows that hunger is suppressed during aerobic exercise 
which coincides with an increase in total PYY. In addition the present study shows a 
suppression of acylated ghrelin and hunger in resistance exercise to a similar extent of 
that found in the aerobic trial but no significant change PYY. The regulation of 
hunger and energy balance is complex incorporating an interplay of many systems 
and other hormones including glucagon-like peptide-! (GLP-l) and pancreatic 
polypeptide (PP). It is clear that more research is needed to determine how much 
reduction in acylated ghrelin and/or increase in total PYY is required to suppress 
hunger and potentially alter eating behaviour as well as the responses of many others. 
In conclusion, this study demonstrates that plasma acylated ghrelin concentration is 
reduced and total PYY concentration is increased during an acute bout of high 
intensity treadmill running which lends support for the role of acylated ghrelin and 
total PYY in hunger suppression during and immediately after exercise. Resistance 
exercise suppresses acylated ghre1in and hunger but there appears to be no effect on 
total PYY. Further research is required to confirm the influence of other modes, 
durations and intensities of exercise on total PYY as well as to document the 
individual exercise response of PYY [.36 and PYY3.36 when the assays become 
commercially available. 
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CHAPTER IX 
General Discussion 
9.1 Introduction 
The aim of this chapter is to integrate the fIndings from all experimental studies 
described in this thesis. 
The balance of evidence from previous research suggests that acute exercise does not 
increase hunger or energy intake in the hour after exercise yet high intensity exercise 
may lead to a suppression of hunger during and immediately post exercise. The main 
aim of this thesis was to examine the hunger and hunger related hormone responses to 
exercise as it is of interest to know whether the effects of exercise on hunger are 
mediated by acylated ghrelin and total PYY. The studies presented were examined in 
a systematic way to address questions including the effect of exercise intensity, 
duration and mode and begin to identify potential causal mechanisms. Table 9.1 
shows a summary of the study exercise protocols and the hormones, metabolites and 
subjective feelings measured. 
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Table 9.1: Summary of the exercise protocols and the hormones, metabolites and 
subjective feelings measured. Values listed as Mean ± SEM 
Study Trials Mode Intensity Duration Energy Hormones, 
:hapter) (% V0 2m•x) of expenditure metabolites and 
or exercise of exercise subjective feelings 
(% 12 rep (min) kJ measured during th~ 
max) (kca\) study 
1 Control Rest 
(4) Low Intensity Running 37 ± 1.0 60 1835 ±140 Hunger, fullness, 
(438 ± 34) desire to eat, how 
High Intensity Running 71 ± 1.5 60 3488 ± 234 much food, and oral 
. (834 + 56) temperature 
2 Control Rest Hunger, acylated 
(5) Aerobic Running 72 ± 2.0 60 3915 ± 207 ghrelin, glucose and 
(935 ± 50) insulin. 
3 Control Rest 
(6) Low Intensity Running 52 ± 1.0 55 ± 2 2580 ± 51 Hunger, acylated 
(617 ± 12) ghrelin, glucose and 
High Intensity . Running 75 ± 1.0 36 ± 2 2504 ± 55 insulin. 
(599 ± 13) 
4 Control Rest 
(7) Short Duration Running 70 ± 0.7 45 2918 ± 110 Hunger, nausea, 
(697± 26) acylated ghrelin, 
Long Duration Running 70 ± 0.7 90 5949±218 glucose and insulin 
(1422 ± 52) 
5 Control Rest 
(8) Aerobic Running 68 ± 2.0 60 3848 ± 110 Hunger, nausea, 
(920 ± 22) acylated ghrelin, 
Resistance Free 80 ± 0.3 90 1488 ± 93 glucose, insulin and 
Weights (with rest) (356 ± 26) tota\PYY 
The main aim of the initial study was to confirm if high intensity exercise results in 
suppressed hunger termed 'exercise induced anorexia' during and immediately post 
exercise. This was the case and since subsequent studies also found a suppression, the 
effect of exercise on hunger is warrants discussion .. 
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9.2 Hunger 
The findings from the studies presented in this thesis suggest that exercise can 
suppress hunger, but this is dependent on the intensity of exercise, duration, energy 
expenditure and mode. Study 1 showed that high intensity treadmill running 71 ± 1. 5 
% VO, max with an energy expenditure of 3488 ± 234 kJ (834 ± 56 kcal) led to 
'exercise induced anorexia' compared with low intensity exercise 37 ± 1.0 % VO, max 
with an energy expenditure of 1835 ± 140 kJ (438 ± 34 kcal). The duration of both 
runs was 60 minutes. 'Exercise induced anorexia' was seen in study 2 as a result of 60 
minutes treadmill running at 72 ± 2.0% VO, max with an energy expenditure of3915 ± 
207 kJ (935 ± 50 kcal) compared with resting control. There was no evidence of . 
'exercise induced anorexia' in study 3 as a result of high intensity treadmill running at 
75 ± 1.0 % VO, max with an energy expenditure of 2505 ± 55 kJ (599 ± 13 kcal). This 
contradicts previous findings with high intensity treadmill running but the duration 
(36 ± 2 minutes) was shorter resulting in a much lower total energy expenditure. This 
may also be because initial baseline hunger values were lower and possibly less 
subject to change. Similarly to study 1 there was no significant hunger suppression 
in the low intensity exercise trial. 
Study 4 showed 'exercise induced anorexia' in both high intensity exercise trials. The 
45 minute short duration trial elicited an energy expenditure of2918 ± 110 kJ (697 ± 
26 kcal) working at an intensity of 70.1 ± 0.7 % VO, max compared with the 90 
minute long duration run eliciting an energy expenditure of 5949 ± 218 kJ (1422 ± 52 
kcal) working at an intensity of 69.7 ± 0.7 % VO, max. Finally study 5 showed that 
high intensity exercise 60 minutes long, at a workload of 68 ± 2.0% VO, max with an 
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energy expenditure of 1488 ± 110 kJ (920 ± 22 kcal) lead to 'exercise induced 
anorexia'. Based on the findings of this thesis it could be said that high intensity 
treadmill running ~ 68% ~ 45 minutes that elicits an energy expenditure of at least 
2918 kJ (697 kcal) will result in transient 'exercise induced anorexia'. Study 5 
highlighted that resistance exercise of a high intensity also results in 'exercise induced 
anorexia' but a range of intensities and durations needs to be examined. 
Hunger may be suppressed for longer than 15 minutes which contradicts the findings 
of King et al (1994). When solely looking at the high intensity treadmill running 
responses to exercise in studies I and 2, subjective feelings of hunger took up to 2 
hours to return to baseline. In studies 4 and 5 subjective feelings had not returned to 
baseline at 1 hour post exercise at which point a test meal was given masking any 
further effect. It is posited that the greater severity of 'exercise induced anorexia' 
found in the present studies is due to the greater exercise intensity, duration of 
exercise and therefore energy expenditure compared with previous studies examining 
the effects of exercise on hunger. 
There is no effect of exercise on the hunger response to meals. Studies 1, 2, 3, 4 and 5 
all show similar declines in hunger 30 minutes post feeding and there is no difference 
between trials as time progresses. This could be due to similar changes in the 
concentration of gut peptide hormones as shown in studies 2, 3, 4 and 5. 
Having confirmed 'exercise induced anorexia' as a result of high intensity treadmill 
running in study 1 the focus of the thesis moved towards identifying potential changes 
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in gut peptide hormones. The fmdings of study 2 identify 'exercise induced anorexia' 
occurs when acylated ghrelin is suppressed. 
9.3 Acylated ghrelin 
On the balance of the evidence from previous research studies it would appear that 
exercise has no effect on total ghrelin. In particular Burns et al (2007) undertook the 
same exercise protocol to that shown in study 2 and found no change in total ghrelin. 
Since measurements of total ghrelin may mask important changes in acylated ghrelin 
and this had yet to be studied the focus of the thesis was on the measurement of 
acylated ghrelin and it is clear from the studies presented in this thesis that high 
intensity treadmill running suppresses acylated ghrelin. 
To the author's knowledge no published study had examined the hunger and acylated 
ghrelin response to exercise. Study 2 showed that a 60 minute treadmill run 72 ± 2.0% 
V0 2 max with an energy expenditure of 935 ± 50 kcal suppressed acylated ghrelin 
during and post exercise which coincided with suppressed hunger 30 minutes into the 
run. Similarly to feelings of hunger, concentrations of acylated ghrelin began to return 
to baseline values after the termination of exercise and there was a clear suppression 
of acylated ghrelin post feeding after the test meal in both trials. The response of 
acylated ghrelin could therefore be a causal mechanism for 'exercise induced 
anorexia.' 
Having shown the acylated ghrelin response to high intensity treadmill running and 
from an awareness that exercise intensity is a determinant of 'exercise induced 
anorexia', study 3 examined the effect of exercise intensity by matching the energy 
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expenditure of two runs of differing exercise intensity. At 30 minutes, high ntensity 
treadmill running (75 ± 1.0% V0 2 m.x) led to a decline in acylated ghrelin at was 
approaching significance. There was no significant decline in the low intensity (52 ± 
1.0% VO, m.x) trial and neither the low or high intensity treadmill runs lead to a 
significant suppression of hunger putting the findings of study 2 into question but the 
sample size was small and energy expenditure was lower. However, the findings of 
study 4 clearly show suppressions of acylated ghrelin in both high intensity treadmill 
runs of short and long duration which again co-incided with 'exercise induced 
anorexia'. Acylated ghrelin remains suppressed throughout the duration of both runs 
and returns to baseline levels after the termination of exercise. Finally study 5 showed 
that acylated ghrelin was suppressed as a result high intensity treadmill running which 
was again associated with suppressed feelings on hunger. Resistance exercise also 
lead to a significant decline in acylated ghrelin which was associated with 'exercise 
induced anorexia'. 
It would be assumed that higher fasting acylated ghrelin would be associated with 
higher subjective feelings of hunger so due to the number of participants measured 
throughout the studies within this thesis, correlation analysis between fasting acylated 
ghrelin and hunger as well as a number of other variables was performed. The number 
examined was 36 as one partiCipant volunteered for three of the studies and ghrelin 
data was not available for one of the participants in study 5. There were no significant 
correlations as shown in Table 9.2 and is likely that a larger data set would be needed 
to improve the statistical power. The only correlation that was approaching statistical 
significance was tbe relationship between fasting acylated ghrelin and weight and a 
negative correlation was found. This supports the work of Cummings et al (2002) who 
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found that after weight loss, ghrelin levels rise so that lighter individuals have higher 
acylated ghrelin values which may be a defense mechanism which leads to a drive to 
eat. 
Table 9.2 Correlation between fasting acylated ghrelin and other variables 
r P 
Hunger 0.204 0.226 
BM! -0.205 0.222 
Weight -0.282 0.091 
Body Fat(%) -0.252 0.132 
Waist Circumference -0.231 0.169 
VO, max 0.228 0.176 
n =36 
The findings of study 2 show there was a tendency for higher hunger ratings over the 
iast five hours of the aerobic exercise trial compared with the control trial. This was 
probably because participants were in energy deficit during the exercise trial 
compared with the control trial. However, the nine hour value for plasma acylated 
ghrelin concentration did not support the notion that hunger was elevated at the end of 
the exercise trial. In fact, acy lated ghreiin concentrations at nine hours would suggest 
that hunger was still suppressed on the exercise trial compared with the control trial 
which was not the case. This apparent contradiction required further confirmation a!ld 
subsequently hunger and ghrelin responses for all three trials were similar at 8 hours 
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in study 3. This may be the result of a 500 kcal greater energy intake and being fed a 
second test meal later in the day influencing hunger responses in study 3. 
Comparisons with the literature are not possible since to the author's knowledge no 
published study has examined the acylated ghrelin response to exercise. The findings 
of this thesis demonstrate temporal associations between the response of acylated 
ghrelin and 'exercise induced anorexia' in high intensity treadmill running and 
resistance exercise. Since decreasing acylated ghrelin is potentially a causal 
mechanism for suppressed feelings of hunger it is unclear why there was no reported 
suppressed feelings of hunger in study 3. The control of hunger is a complex process 
involving an interplay of many different hormones and therefore the response of other 
hormones may have resulted in a failure of exercise to stimulate 'exercise induced 
anorexia' in these cases. Therefore study 5 also measured the exercise response to the 
gut peptide hormone total PYY. 
9.4 Total PYY 
The decision to measure PYY as opposed to other hormones such as CCK or GLP-I 
was made because PYY was receiving attention in the feeding literature and at the 
time of compiling the study to the author's knowledge no published study had 
examined the influence of exercise on PYY. Study 5 measured the PYY response to 
60 minutes high intensity treadmill running (68 ± 1.0% V0 2 mal() with an energy 
expenditure of920 ± 22 kcal, 90 minutes of resistance exercises working at 80 ± 0.3% 
12 rep max with an energy expenditure of 356 ± 26 kcal and a resting contro\. There 
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was a significant increase in total PYY during the tTeadmill run but no significant 
difference in the resistance or resting control trials. 
A limitation of the pyy findings is that total pyy was measured so the individual 
changes of pyy 3.36 and pyy 1.36 cannot be distinguished. pyy 3.36 is the more 
biologically active form as it contributes to a greater percentage of circulating pyy 
post feeding (Grandt et ai, 1994) and is more closely associated with inhibition of 
hunger than total pyy (Batterham et ai, 2003) however only the measurement of total 
pyy was commercially available at the time. Future studies should measure the 
influence of exercise on pyy 3.36. 
9.5 The effect of glucose and insulin on acylated ghrelin and total PYY 
Glucose and insulin were measured because they may be important in the regulation 
of ghrelin and pyy concentrations (Boey et ai, 2007; Flanagan et ai, 2003; Shiya et 
ai, 2002). In all high intensity treadmill runs there was a surge in plasma glucose 
which could potentially lead to a suppression of acylated ghrelin and increase in total 
pyy as these changes are also seen postprandially. It is also interesting to note that in 
study 3 there was no increase in glucose during low intensity exercise which is 
possibly why there was no suppression of acylated ghrelin. Research supports that 
glucose suppresses ghrelin since Tschop et al (2000) found a decrease when filling the 
stomach with a 50% solution but not with an equal volume of water and Flanagn et a] 
(2003) showed a suppression as a result of hyperglycaemic clamp. This is mimicked 
. during exercise since prolonged high intensity exercise begins to lower blood glucose 
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concentration stimulating the release of glucagon which elicits an almost 
instantaneous release of glucose from the liver so that it is possible that exercise 
induced hyperglycemia may be responsible for subsequent changes in gut peptide 
hormones. This is supported by Banasch et al (2006) who found suppressions of 
ghrelin as a result of the infusion of glucagon like peptide 2. However exercise 
induced glucose release may not be the sole mechanism for suppression of acylated 
ghrelin during exercise since the resistance trial of study 5 demonstrated a suppression 
of acylated ghrelin but no change in plasma glucose. 
The findings of this thesis would indicate that insulin does not contribute to changes 
in gut peptide hormones as there was only a significant change in insulin during the 
short duration exercise trial of study 4 but in all other high intensity treadmill running 
trials there was a suppression of acylated ghrelin in the absence of any change to 
plasma insulin. 
9.6 Other potential causal mechanisms influencing hunger, ghrelin and PYY 
Exercise has been shown to increase feelings of nausea (Halvorsen and Ritland, 1992) 
and it was suggested that suppressed hunger may be the result of increased nausea as 
opposed to an exercise effect per se. The inclusion of a nausea V AS in studies 4 and 5 
show a significant increase iD. nausea during exercise showing that nausea may 
confound 'exercise induced anorexia'. 
It was initially thought that the reduction in gut blood flow during aerobic exercise 
could limit supply leading to a suppression in acylated ghrelin. Whilst there is no 
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supporting evidence it is assumed that gut blood flow is not reduced during resistance 
exercise to as great an extent as aerobic exercise and as a result of a suppression of 
acylated ghrelin, reductions in gut blood flow as a mechanism is unlikely. 
There is some evidence to support a suppressive effect of GH on ghrelin from patients 
with GH deficiency (Dall et al 2002; Eden et al 2003). Exercise of even moderate 
intensity stimulates GH release after a lag phase of 10 to 20 minutes and levels 
usually remain elevated for at least 1 hour after exercise (Lassarre, 1974). Vestergaard 
et al (2007) hypothesized that circulating ghrelin is suppressed by exercise induced 
GH release. Findings confirmed this was the case when examining healthy and fit 
subjects exercising with and without GH administration. An exercise induced rise in 
GH during both aerobic and resistance exercise in the studies presented in this thesis 
could have suppressed acylated ghrelin. Since GH was not measured, this cannot be 
stated with confidence and to the authors knowledge no trials have examined the 
acylated ghrelin response to exercise induced GH secretion with or without additional 
GH administration and this as a potential acylated ghrelin suppressing mechanism 
remains to be elucidated. 
Corticosteroids (a class of steroid hormones that are produced in the adrenal cortex) 
have been shown to inhibit ghrelin production (Proulx et al 2005). Ebal et al (2007) 
found reduced food intake in rats who exercised for 5 weeks. They propose a 
regulatory feedback loop whereby glucocorticoids (such as cortisol) inhibit ghrelin 
secretion since they increase in the exercising rat which reflects an activation of the 
hypothalamo-hypophysoadrenal axis which interferes with food intake. The response 
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of the glucocorticoids to exercise is reported by Lac et al (1999) and is another 
potential mechanism that needs to be examined. 
9.7 Hyperghrelinemia 
A small number of participants studied displayed atypically high ghrelin values. 
Initially this phenotype was seen only in participants of ethnic origin but was then 
displayed in a Caucasian male in the study described in Chapter 8. An examination of 
the participants BMI, body mass, body fat %, fitness and hunger responses were not 
different from other participants so the reason for hyperghrelinemia is unknown. 
Beaumont et al (2003) have shown that ghrelin can bind to high density lipoprotein 
(HDL) so potentially people who have high HDL may have higher ghrelin values. The 
measurement of HDL in participants who display atypically high ghrelin values 
compared with participants with normal ghrelin values therefore warrants 
investigation. 
9.8 Limitations 
"An expert is a man who has made all the mistakes which can be made in a very 
narrow field" 
Niels Bohr 
The studies in this thesis have a number oflimitations: 
I) Participants were generally male, young, fit and healthy. How well these fmdings 
apply to female, old and unhealthy populations is unknown. 
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2) Low sample size in each study may have limited the power to detect significant 
associations between acylated ghrelin, total PYY and other variables. 
3) A clock was on show at all times. As the participants had an awareness of the study 
protocol and the timing of meals, hunger ratings may have been affected if 
participants anticipated being fed. 
4) Total ghrelin concentration was not measured, limiting the author's ability to 
determine the extent of variation between the responses of acylated ghrelin and total 
ghrelin to exercise and feeding. 
6) Total PYY concentration was measured limiting the author's ability to determine 
the extent of variation between the responses of PYY 1.36 and PYY 3-36 to exercise and 
feeding. 
7) Ghrelin concentration may be influenced by the duration of sleep (Steiger, 2007) 
yet amount of sleep was not controlled for in any of the studies nor were participants 
questioned on whether they had slept well on arrival at the laboratory. 
8) Participants began every trial in the fasted state. As well as to control any potential 
effects of food intake it was anticipated that ghrelin levels and hunger would be high 
and therefore more susceptible to change. However this is likely to reduce ecological 
validity since people are most likely to have some fonn of breakfast prior to 
undertaking exercise and it has been shown that timing of exercise to meal 
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consumption may influence hunger and its hormonal regulators (Cheng et ai, 2008). 
Participants undertook three trials in a random crossover design 1) meal followed by 
exercise 2) exercise followed by meal consumption 3) meal consumption only. Fifty 
minutes of moderate intensity exercise diminished hunger in the initial post exercise 
period of the exercise followed by meal trial and suppressed the post meal rise in 
hunger that was appear not during the meal and the exercise then meal trials. PYY 
tended to be higher when participants exercised either before or after consuming a 
meal in comparison to the meal only trial (Cheng et ai, 2008). 
9.9 Future research recommendations 
"Science never solves a problem without creating ten more" 
George Bernard Shaw 
Further research is required to confirm the influence of other modes, durations and 
intensities of exercise on hunger, plasma acylated ghrelin and total PYY 
concentrations and to document responses in different groups including females, older 
adults, the untrained and the overweight and obese. 
The completion of this thesis arose from personal interest in the effects of exercise on 
suppressed feelings of hunger post vigorous running and team sports. However 
through personal experience and in discussion with others, the author has noted that 
after swimming, hunger is not suppressed and may even increase. The reasons for this 
are unknown and swimming as a mode of exercise in particular warrants 
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investigation. Nor has any work on solely upper body exercise such as arm cranking 
been undertaken which would be particularly important in wheelchair users. 
The focus of this thesis has been the measurement of acylated ghrelin during and post 
exerCise. More frequent measurements and longer trials are needed in particular to 
determine how soon gut peptide hormones respond to exercise and whether there is 
I 
any prolonged effects that are not masked by feeding. There is still little or no data on 
the effects of exercise on other hormones implicated in the regulation of hunger. The 
role of cholecystokinin (CCK) in pancreatic secretion and gallbladder contraction was 
already well established when it was demonstrated that CCK also reduced meal size 
in a dose-dependent manner in rats. CCK was the first gut hormone implicated in the 
control of hunger and the anorectic effects of CCK have since been confirmed in 
human studies (Kissileff et al. 1981; Muurahainenn et al. 1988; Moran & Schwartz, 
1994). A number of other hormones and metabolites could be measured. Glucagon-
like (GLP-l) and oxyntomodulin (Oxm) are produced by posttranslational processing 
of the preproglucagon gene in the CNS and the intestine and colon. Both peptides are 
released into the circulation in response to nutrient intake and appear to function as 
satiety signals. 
There is still a paucity of data on the effects of exercise on subsequent energy intake 
and how soon food would be consumed and what is the relationship between acylated 
ghrelin and PYY. This would involve the provision of buffet style meals as opposed 
to test meals in which participants are free to eat as and when they choose. Numerous 
research questions would include: 
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1) Does exercise influence the timing of energy intake post exercise? 
2) Does exercise influence the macronutrient selection of foods consumed 
shortly after exercise? 
3) What is the effect of exercise on energy intake and macronutrient selection 
the day after exercise? 
4) Is energy intake lower if eating is undertaken immediately post exercise? 
There are also other findings in the studies presented in this thesis that warrant further 
investigation, in particular whether the macronutrient content of the test meal 
" 
influences the suppression of acylated ghrelin. It also needs to be identified whether 
there is a plateau at which acylated ghrelin is suppressed as a result of exercise. 
Referring to the acylated ghrelin response to high intensity treadmill running in study 
4 the same exercise intensity was maintained for both runs. It would be interesting to 
see if acylated ghrelin would be suppressed any further with an increase in intensity 
and to what extent would the concentration of acylated ghrelin return to baseline 
levels if the exercise intensity was lowered as opposed to terminated. 
Confirmation of the findings presented in this thesis and perusing the above research 
topics would have important implications regarding the role of exercise in 
manipulating hunger and weight management. 
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9.1.0 Conclusion 
The growing obesity epidemic together with the advances in the understanding of the 
complex physiology that regulates bodyweight have lead to increased interest in 
hormonal signals implicated in weight homeostasis and as such a need has arisen to 
examine the effect of exercise on hunger related hormones. 
The main findings from the studies presented in this thesis are: 
1) High intensity treadmill running transiently suppresses hunger and acylated 
ghrelin concentration and increases total PYY. 
2) Resistance exercise suppresses hunger and acylated ghrelin but has no effect 
on total PYY. 
3) There is a threshold of exercise intensity, duration and expenditure which 
needs to be reached before 'exercise induced anorexia' is observed and these 
factors affect hunger and the change in gut peptide hormones. 
4) Changing concentrations of acylated ghrelin and total PYY in response to 
feeding and exercise are possibly related to changes in glucose but it is 
unlikely they are mediated by changes in insulin. 
5) Whilst the findings of this thesis are useful in identifying potential causal 
mechanisms for the influence of exercise on hunger, more work is needed to 
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address the effect of exercise on energy intake and how exercise can play a 
more effective role in the prevention of overweight and obesity, weight loss 
and the prevention of weight regain. 
"The hunger and thirst for knowledge, the keen delight in the chase, the good 
humored willingness to admit that the scent was false, the eager desire to get on with 
the work, the cheerful resolution to go back and begin again, the broad good sense, 
the una" 
Frederic William Maitland 
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APPENDIX A 
LOUGHBOROUGH UNIVERSITY 
ETHICAL ADVISORY COMMITTEE 
RESEARCH PROPOSAL 
INVOLVING HUMAN PARTICIPANTS 
Title: The Influence of aerobic and resistance exercise on appetite. 
RefNo: R06-PI05 
Applicant: Or OJ Stensel, OR Broom, C Mathers, J Zakrzewski, N Whitehead, J King 
Department: SSES 
Date of clearance: 16 November 2006 
Comments of the Committee: 
The Committee agreed to issue clearance to proceed. 
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LOUGHBOROUGH UNIVERSITY 
SCHOOL OF SPORT AND EXERCISE SCIENCES 
INFORMATION FOR PARTICIPANTS 
The influence of resistance and aerobic exercise on 
appetite 
INVESTIGATORS 
Mr. David Broom, Mr. James King, Miss Nichola Whitehead, Miss Julia 
Zakrzewski, Miss Charlotte Mathers and Dr. David Stensel 
School of Sport and Exercise Sciences 
·BACKGROUND 
There is evidence to suggest that appetite is suppressed after continuous 
bouts of high intensity aerobic exercise, a phenomenon known as exercise 
induced anorexia. Appetite is regulated by several factors including 
active ghrelin, which is a hormone that is secreted by the stomach. Very 
little is known about the effects of aerobic and resistance exercise on 
active ghrelin. TIle proposed study will therefore investigate the effect 
of a iTeadmil1 run and free weight resistance exercise session on active 
ghrelin. 
INCLUSION CRITERIA 
Volunteers will: i) be male ii) have no personal history of cardiovascular 
disease, metabolic disease or dyslipidaemia, (iii) not be dieting or have any 
extreme dietary habits (iv) be non-smoking (v) not be taking drugs known 
to affect digestion or metabolism; (vi) have a BMI < 30 kg.m-2 i.e. not 
classified obese (vi) have experience of resistance exercise. 
STUDY DEMANDS 
If you volunteer to participate in this study you will be required to visit 
the laboratory on 6 occasions as follows: 
o Aerobic preliminary procedures and screening including 
measurement of height, weight, blood pressure, body composition 
and activity status 
o Determination of 12 rep max for 10 resistance exercises 
• Resistance familiarisation 
• Three Main Trials 
o Aerobic Exercise trial 
o Resistance Exercise trial 
o Control trial 
PRELIMINARY PROCEDURES 
You will be asked to attend the laboratory for a preparatory session 
during which we will: 
• explain the objectives of the study and its requirements; 
o ask you to complete a confidential questionnaire regarding your 
health; 
. c familiarise you with the testing procedures and equipment; 
o familiarise you with dietary recording; 
o answer any questions you may have. 
Following this you will be asked to complete several exercise tests as 
follows: 
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Submaximal treadmill test: You will run on a treadmill for 16 minutes. 
The speed of the treadmill will be increased every four minutes. You will 
periodically be asked to breathe through a mouthpiece while wearing nose 
clips during the run. 
Maximum oxygen uptake (VOzmax) test: You will run on a treadmill until 
volitional fatigue which will take between 8 and 12 minutes. The incline of 
the treadmill will be increased every three minutes. You will periodically 
be asked to breathe through a mouthpiece while wearing nose clips during 
the run. 
Determination of 12 rep max: On a separate day you will lift free 
weights to determine your 12 rep max for 10 exercises (in order: squat, 
dumbbell lateral raise, bench preSs, upright row, lunges, bicep curl, 
barbell pullover, seated shoulder press, triceps extension, bent over row). 
You can rest between each exercise for as long as you like. 
Resistance session familiarisation: On a separate day you will undertake 
the full resistance exercise session to ensure that you can complete it. 
Resistance exercise will be performed using free weights and will involve 
three sets of 12 repetitions of the 10 exercises. Each will be performed 
at 80'10 of 12 repetition maximum with a 3 minutes work and rest interval 
giving a duration of 90 minutes. 
MAIN TRIALS 
There will be three main trials. The order of these will be randomly 
assigned: 
AEROBIC EXERCISE trial - you will report to the laboratory at 9.00 am 
having fasted overnight. You will spend the day (9.00 am to 5.00 pm) in 
the laboratory. Shortly after arrival a cannula will be placed in a vein in 
your arm so that blood samples can be extracted. ·Thirteen venous blood 
samples will be collected throughout the day and appetite and motivation 
to eat will be measured using questionnaires. You will perform high 
intensity exercise (70'10 of maximum oxygen uptake) for 60 minutes. 
Samples of your expired air and heart rate will be collected during 
exercise. At 11 am you will be provided with a test meal consisting of a 
cheese, butter and mayonnaise sandwich, ready salted crisps, and 
strawberry milkshake. You will receive an identical test meal at 2 pm. 
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RESISTANCE EXERCISE trial - you will report to the laboratory at 
9.00 am having fasted overnight. You will spend the day (9.00 am to 5.00 
pm) in the laboratory. Shortly after arrival a baseline blood sample will be 
taken via venepuncture. You will then undertake the same resistance 
exercise session that you undertook during the resistance familiarisation. 
Mid way through this session you will be venepunctured again. Once 
resistance exercise is completed you will be cannulated and a further 
eleven venous blood samples will be collected throughout the day and 
appetite and motivation to eat will be measured using questionnaires. 
Samples of your expired air and heart rate will be collected during 
exercise. At 11 am you will be provided with a test meal consisting of a 
cheese, butter and mayonnaise sandwich, ready salted crisps, and 
strawberry milkshake. You will receive an identical test meal at 2 pm. 
CONTROL trial - you will report to the laboratory at 9.00 am having 
fasted overnight. You will spend the day (9.00 am to 5.00 pm) in the 
laboratory. Shortly after arrival a cannula will be placed in a vein in your 
arm so that blood samples can be extracted. Thirteen venous blood 
samples will be collected throughout the day and appetite and motivation 
to eat will be measured using questionnaires. At 11 am you will be provided 
with a test meal consisting of a cheese, butter and mayonnaise sandwich, 
ready salted crisps, and strawberry milkshake. You will receive an 
identical test meal at 2 pm. 
PREPARATION FOR THE TESTS 
o Recording your diet: you will be asked to weigh and record everything 
you eat and drink for two day's prior to any of the main trials. You will 
then consume identical amounts of the Same food and drink prior to 
the next main trials. This is very important in order to control for diet 
and we will discuss this with you prior to the main trials. No alcohol 
should be consumed on the days when you are recording your diet. 
o Controlling physical activity: this is crucial to the success of the 
experiment and you should undertake exactly the same type and 
amount of activity the day before the start of each main trial. 
o Ten-hour overnight fast: you will finish eating by 11 pm on the 
evenings before the main trials. You may continue to drink water after 
this time. You will report to the laboratory at 9 am the following 
morning without eating breakfast. 
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o Travelling to the laboratory: if you live within 400 m of the 
laboratory you should walk in slowly on the morning of each main trial. 
Please do not run or cycle. If you live more than 400 m from the 
laboratory then you should drive in. If you do not have access to a car 
please inform us and we will arrange for you to be collected. 
HOW MUCH TIME WILL IT TAKE? 
o Aerobic preliminary procedures including screening and Q + A-I hour 
30 minutes maximum 
a Determination of 12 rep max - 1 - 1 hour 30 minutes 
o Resistance familiarisation session - 1 hour 30 minutes 
o Main trials: three days in total - 8 hours for each trial 
You will .be encouraged to bring work and reading material with you for 
the main trials. Alternatively you may watch television or listen to music. 
POSSIBLE RISKS AND DISCOMFORTS 
High intensity treadmill exercise and resistance exercise using free 
weights will cause breathlessness. The maximum oxygen uptake test will 
lead to physical exhaustion, but you should recover within a few minutes. 
In a tiny minority of individuals, even in young adults, the possibility 
exists that such exercise triggers disturbances to normal physiology: 
these include abnormal blood pressure, fainting or a change in the normal 
rhythm of the heart. There are also risks associated with performing 
exercise including musculoskeletal injury but these are minimal and 
measures will be taken to prevent any occurrences. 
Venous cannulation can cause air or plastic embolism, but good practice 
minimises this risk and personnel conducting the procedure have been 
trained and are very experienced. Cannulation can also lead to local· 
thrombophlebitis (inflammation) in a superficial vein but the absolute 
level of risk is Iow. 
BENEFITS OF THE STUDY 
The study will provide important information regarding 1-he effects of 
resistance and aerobic exercise on the hormonal control of appetite. We 
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will provide you with feedback on your own results and will be happy to 
discuss these with you. 
CONFIDENTIALITY 
Although information will be stored on computer, each subject will be 
entered as a number rather than by name, in accordance with the Data 
Protection Acts of 1984 and 1998. Data will be used for research 
purposes only and confidentiality will be maintained in any publications 
arising from the study. Participants are able to access any data on 
themselves held by the investigators on request. Data shall not be kept 
longer than is necessary for the purposes of this investigation. 
CONTACTS 
Please feel free to ask any questions, at any stage. Contact information 
for the staff involved in the study is as follows: 
Mr. David Broom, D.R.Broom@lboro.ac.uk, tel: 01509 226351 
Dr David Stensel, D.J.Stensel@lboro.ac.uk, tel: 01509 226344 
Miss Charlotte Mathers, C.L.Mathers-04@student.lboro.ac.uk 
Miss Julia Zakrzewski, J.zakrzewski-04@student.lboro.ac.uk 
Miss Nichola Whitehead, N.J.Whitehead-04@student.lboro.ac.uk 
Mr. James King, J.A.King-04@student.lboro.ac.uk 
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APPENDIX C 
THE INFLUENCE OF RESISTANCE AND AEROBIC EXERCISE ON 
APPETITE 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
The purpose and details of this study have been explained to me. I 
understand that this study is designed to further scientific knowledge and that 
all procedures have been approved by the Loughborough University Ethical 
Advisory Committee. 
I have read and understood the information sheet and this consent form. 
I have had an opportunity to ask questions about my participation. 
I understand that I am under no obligation to take part in the study. 
I understand that I have the right to withdraw from this study at any stage for 
any reason, and that I will not be required to explain my reasons for 
withdrawing. 
I understand that all the information I provide will be treated in strict 
confidence. 
I agree to participate in this study. 
Your name 
Your signature 
Signature of investigator 
Date 
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APPENDIXD 
HEALTH SCREEN FOR STUDY VOLUNTEERS Name or Number ................ . 
It is important that volunteers participating in research studies are currently in good health and have had no 
significant medical problems in the past. This is to ensure (i) their own continuing well-being and (ii) to 
avoid the possibility of individual health issues confounding study outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
I. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .............................. Yes D 
(b) attending your general practitioner.. ................................... Yes D 
( ) h · I " I' • Y D c on a osplta waltmg lst ................................ ~.................... es 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP ................................................................ Yes D 
(b) attend a hospital outpatient department .............................. Yes D 
(c) be admitted to hospital ...................................................... Yes D 
3. Have you ever had or been diagnosed with any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes D 
(b) Asthma .......... : ..................................................................... Yes D 
(c) Eczema ............................................................................... YesD 
(d) Diabetes .............................................................................. Yes D 
(e) A blood disorder ................................................................. Yes D 
(t) Head injury ......................................................................... Yes D 
(g) Digestive problems ............................................................. Yes D 
(h) Heart problems ................................................................... Yes D 
(i) Problems with bones or joints ......................................... Yes D 
(j) Disturbance of balance!coordination .................................. Yes D 
(k) Numbness in hands or feet ................................................. Yes D 
(I) Disturbance of vision .......................................................... Yes D 
(m) Ear / hearing problems ........................................................ Yes D 
(n) Thyroid problems ............................................................... Yes D 
(0) Kidney or liver problems .................................................... Yes D 
(P) Allergy to nuts .................................................................... Yes D 
(q) High cholesterol ................................................. .Y es D 
(r) High triacylglcyerol or any other form of dyslipidaemia ... Yes 0 
4. Has any, otherwise healthy, member of your family under the 
age of35 died suddenly during or soon after exercise? ............ Yes 0 
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NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
NoD 
5. Are you: 
Ca) Currently active .................................................... yes 0 
Cb) Dieting .............................................................. Yes 0 
C c) A smoker or have you ever smoked .............................. Yes 0 
NoD 
NoD 
NoD 
If YES to any qnestion, please describe briefly if you wish Ceg to confirm problem was/is short-lived, 
insignificant or well controlled.) ........................................................................................................ . 
Thank you for your cooperation! 
Loughborough University 
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APPENDIXE 
LOUGHBOROUGH UNIVERSITY, SCHOOL OF SPORT AND EXERCISE SCIENCES 
PHYSICAL ACTIVITY QUESTIONNAIRE 
During one week, how many times on average do you do the following kinds of exercise 
for more than 15 minutes? 
(a) Strenuous Exercise (heart beats rapidly) 
For example; running, jogging, squash, hockey, 
football, basketball, vigorous swimming, 
vigorous long distance cycling. 
____ times per week. 
(b) Moderate Exercise (not exhausting) 
For example; fast walking, tennis, ea~y cycling, 
badminton, easy swimming, dancing. 
____ times per week. 
(c) Mild Exercise (minimal effort) 
For example; yoga, archery, fishing, bowling, 
golf, easy walking. 
_____ times per week. 
255 
APPENDIXF 
Subject No.: Trial: 
Time: 
Appetite 
Please indicate how hungry you are now by circling the relevant number. 
Not Hungry Fairly Hungry Hungry Very Hungry 
o 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Place a vertical mark on the horizontal line depending on the intensity of your hunger 
based on the following question. Consider the two extreme anchors (not at all and 
very) to be the most extreme. That is, if you place a mark on the not at all 
(equal to 0) then this is the least hunger you have ever felt. 
How hungry do you feel? 
Not at all hungry Very Hungry 
r-----------------------~ 
How nauseous do you feel? 
Not at all nauseous Very nauseous 
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